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Abstract 
Tissue ablation is a common medical procedure that involves manipulation 
of the target tissue with an aim to restore normal structure and function.  Ablative 
treatments are performed throughout the human body for treating various 
carcinomas and disease conditions.  Although a routine clinical procedure, in a 
small percentage of patients it may cause collateral damage to surrounding vital 
structures which can have severe clinical implications.  As such, the collateral 
damage results in altered tissue properties those are dependent on the level of 
ablative energy and extent of tissue injury. Therefore, assessment of tissue 
properties is fundamental to advancing the understanding of underlying basic 
and clinical science of ablations, especially to maximize therapy efficacy and 
minimize procedural complications.  Thus, a thorough understanding of tissue 
properties is critical to the successful outcome of nearly all ablation procedures. 
Unique laboratory methodologies were developed that were reliably used 
to assess the physiological and biomechanical properties of respiratory 
diaphragm, esophagus, cardiac trabeculae, and vastus lateralis tissues following 
exposure to five different therapeutic ablative modalities: radiofrequency ablation, 
cryoablation, high-intensity focused ultrasound ablation, microwave ablation, and 
chemical ablation (with acetic acid, ethanol, hypertonic sodium chloride, and 
urea).  The changes in physiological properties were quantified by measuring 
changes in peak force (strength of contractions) and baseline force (resting 
muscle tension) in response to ablations.  The changes in biomechanical 
  vi 
properties were quantified by measuring the stress-strain characteristics, 
avulsion forces, and elastic moduli in response to ablations.  Dose effect 
responses of each ablative modality were quantified.  In addition, biomechanical 
properties of non-contractile tissues such as pericardium, aorta, lungs, and 
trachea were also measured. 
To our knowledge these are the first reports of such methodological 
comparative assessment of tissue properties following treatment with therapeutic 
ablative modalities at clinically relevant doses.  The understanding of tissue 
properties has wide applications ranging from applied research to the 
development of novel tools, ablation techniques, and innovative clinical treatment 
options.  These findings may provide novel insights into the effects of ablations 
on various tissues which may in turn allow further improvements in ablative 
techniques to increase the overall safety and efficacy of ablative procedures.  
Knowledge gained from these studies may be used for procedure planning, 
modeling and dosing optimization.  Furthermore, these methodologies could be 
utilized in a realistic framework for developing bench top testing of device-tissue 
interactions that can aid in novel medical device design.  It is clear that the 
understanding of collateral damage at the cellular level, isolated tissue level, and 
whole organ level will be important to the future of this evolving era of ablations. 
 
  vii 
Table of Contents 
 
Acknowledgements ............................................................................................... i 
Abstract ................................................................................................................ v 
List of Tables ........................................................................................................ix 
List of Figures .......................................................................................................xi 
1. A Review of Therapeutic Ablation Modalities and Biophysics .......................... 1 
Preface ............................................................................................................. 1 
Executive Summary .......................................................................................... 3 
Introduction ....................................................................................................... 4 
Ablative Modalities Investigated ........................................................................ 4 
Radiofrequency Ablation ................................................................................... 8 
Biophysics of Radiofrequency and Resultant Tissue Injury .............................. 8 
Cryoablation .................................................................................................... 15 
Biophysics of Cryoablation and Resultant Tissue Injury ................................. 15 
High-Intensity Focused Ultrasound Ablation ................................................... 20 
Biophysics of High-Intensity Focused Ultrasound and Resultant Tissue Injury
 ........................................................................................................................ 20 
Microwave Ablation ......................................................................................... 24 
Biophysics of Microwave Ablation and Resultant Tissue Injury ....................... 25 
Chemical Ablation ........................................................................................... 28 
Biophysics of Chemical Ablation and Resultant Tissue Injury ......................... 29 
Conclusion ...................................................................................................... 35 
2. The Comparative Assessment of Clinically Applied Ablative Therapies: Part I. 
Methodologies for determining the physiological and biomechanical properties of 
contractile tissues in response to varied therapeutic dosages ............................ 37 
Preface ........................................................................................................... 37 
Executive Summary ........................................................................................ 39 
Introduction ..................................................................................................... 41 
Materials and Methods .................................................................................... 44 
Discussion ....................................................................................................... 63 
Conclusion ...................................................................................................... 65 
3. The Comparative Assessment of Clinically Applied Ablative Therapies: Part II. 
The assessment of physiological and biomechanical properties of isolated 
respiratory diaphragm in response to varied therapeutic dosages ..................... 77 
Preface ........................................................................................................... 77 
Executive Summary ........................................................................................ 79 
Introduction ..................................................................................................... 81 
Materials and Methods .................................................................................... 86 
Results ............................................................................................................ 88 
Discussion ....................................................................................................... 93 
Conclusion .................................................................................................... 104 
  viii 
4. The Assessment of Physiological and Biomechanical Properties of Isolated 
Swine Esophagus in Response to Clinically Applied Ablative Therapies ......... 129 
Preface ......................................................................................................... 129 
Executive Summary ...................................................................................... 130 
Introduction ................................................................................................... 131 
Methods ........................................................................................................ 136 
Results .......................................................................................................... 138 
Discussions ................................................................................................... 144 
Conclusions .................................................................................................. 150 
5. Comparative Assessment of Physiological and Biomechanical Properties of 
Human Esophagus in Response to Therapeutic Ablative Treatments .............. 176 
Preface ......................................................................................................... 176 
Introduction ................................................................................................... 177 
Methods ........................................................................................................ 178 
Results .......................................................................................................... 180 
Discussions ................................................................................................... 181 
6. Assessment of Physiological and Biomechanical Properties of Human Vastus 
Lateralis in Response to Therapeutic Ablative Treatments .............................. 196 
Preface ......................................................................................................... 196 
Introduction ................................................................................................... 197 
Methods ........................................................................................................ 198 
Results .......................................................................................................... 199 
Discussion ..................................................................................................... 201 
7. The Assessment of Physiological and Biomechanical Properties of Isolated 
Swine and Human Trabeculae in Response to Clinically Applied Ablative 
Therapies ......................................................................................................... 212 
Preface ......................................................................................................... 212 
Introduction ................................................................................................... 212 
Methods ........................................................................................................ 213 
Results .......................................................................................................... 215 
Discussions ................................................................................................... 218 
Conclusions .................................................................................................. 220 
Thesis Summary ............................................................................................... 229 
References ....................................................................................................... 237 
Appendix 1: Assessment of Physiological Properties of Respiratory Diaphragm: 
Preliminary Ablation Studies Performed in Tissue Baths .................................. 267 
Appendix 2: Study Data Management .............................................................. 275 
Appendix 3: Statistical Results of Swine Diaphragm ........................................ 296 
Appendix 4: Statistical Results of Swine Esophagus ........................................ 312 
Appendix 5: Calculation of Tissue Ablated Area in Response to Ablative 
Modalities ......................................................................................................... 330 
Appendix 6: Assessment of Biomechanical Properties of Swine and Human Non-
Contractile Tissues ........................................................................................... 341 
Appendix 7: Conus Arteriosus as an Alternate Pacing Site .............................. 347 
  ix 
 
List of Tables 
Table 1: Table of anatomical locations where ablations are performed ................ 6 
Table 2: Criteria for determination of avulsion location of any given muscle 
bundle ................................................................................................................. 76 
Table 3: Mean  SD characteristics of swine diaphragm muscle bundles that 
underwent physiological testing in tissue baths (n=212)................................... 125 
Table 4: Tabulation of the avulsion location of swine diaphragm muscle bundles 
(n=733) as a percentage for each ablative modality ......................................... 126 
Table 5: Mean  SD dimensional characteristics and biomechanical parameters 
of swine diaphragm muscle bundles that avulsed at or near the center of the 
muscle bundle .................................................................................................. 127 
Table 6: Percent change in biomechanical properties of swine diaphragm muscle 
bundles post ablation with different ablative modalities .................................... 128 
Table 7: Mean  SD characteristics of swine esophageal muscle bundles that 
underwent physiological testing in tissue baths (n=168)................................... 172 
Table 8: Tabulation of the avulsion location of swine esophagus muscle bundles 
(n=563) as a percentage for each ablative modality ......................................... 173 
Table 9: Mean  SD dimensional characteristics and biomechanical parameters 
of swine esophagus muscle bundles that avulsed at or near the center of the 
muscle bundle .................................................................................................. 174 
Table 10: Percent change in biomechanical properties of swine esophagus 
muscle bundles post ablation with different ablative modalities ........................ 175 
Table 11: Mean  SD characteristics of human esophageal muscle bundles that 
underwent physiological testing in tissue baths (n=48) .................................... 192 
Table 12: Tabulation of the avulsion location of human esophagus muscularis 
layer muscle bundles (n=120) and squamous epithelium layer tissue bundles 
(n=44) as a percentage for each ablative modality ........................................... 193 
Table 13: Mean  SD dimensional characteristics and biomechanical parameters 
of human esophagus muscularis layer muscle bundles and squamous epithelium 
layer tissue bundles that avulsed at or near the center of the bundle ............... 194 
Table 14: Percent change in biomechanical properties of human esophagus 
muscularis layer muscle bundles and squamous epithelium layer tissue bundles 
post ablation with different ablative modalities ................................................. 195 
Table 15: Mean  SD dimensional characteristics and biomechanical parameters 
of human vastus lateralis muscle bundles that avulsed at or near the center of 
the muscle bundle ............................................................................................ 209 
Table 16: Percent change in biomechanical properties of human vastus lateralis 
muscle bundles post ablation with different ablative modalities. ....................... 210 
Table 17: Tabulation of the avulsion location of human vastus lateralis muscle 
bundles (n=78) as a percentage for each ablative modality ............................. 211 
  x 
Table 18: Mean  SD dimensional characteristics and biomechanical parameters 
of human and swine trabeculae muscle bundles .............................................. 228 
Table 19: Dose table for RFA, showing the catheter tip ablation temperature, 
average power, ablation duration, and energy during RFA of swine diaphragm
 ......................................................................................................................... 297 
Table 20: Dose table for MWA of swine diaphragm, showing average power, 
duration and energy .......................................................................................... 297 
Table 21: Dose table for HIFU ablations of swine diaphragm, showing average 
power, duration, and energy ............................................................................. 298 
Table 22: Biomechanical parameters of all swine diaphragm muscle bundles . 301 
Table 23: Percent change in biomechanical properties of swine diaphragm 
muscle bundles post ablation with different ablative modalities ........................ 302 
Table 24: Dose table for RFA, showing the catheter tip ablation temperature, 
average power, ablation duration, and energy during RFA of swine esophagus
 ......................................................................................................................... 313 
Table 25: Dose table for MWA of swine esophagus, showing average power, 
duration, and energy ......................................................................................... 314 
Table 26: Dose table for HIFU ablations of swine esophagus, showing average 
power, duration, and energy ............................................................................. 314 
Table 27: Biomechanical parameters of swine esophagus muscle bundles. .... 319 
Table 28: Percent change in biomechanical properties of swine esophagus 
muscle bundles ................................................................................................. 320 
Table 29: Mean  SD dimensional characteristics and biomechanical parameters 
of swine and human non-contractile tissue bundles ......................................... 346 
 
 
  xi 
List of Figures 
Figure 1: Illustration of anatomical locations where ablations are performed ....... 6 
Figure 2: Effect of applied catheter tip force and energy on lesion size .............. 14 
Figure 3: Effect of electrode size and applied power on lesion size ................... 14 
Figure 4: Tissue bath system setup for performing physiological studies ........... 66 
Figure 5: Muscle bundle undergoing cryoablation near its center in the ablation 
dish with the catheter imparting 0.1 N (10 grams) of force ................................. 66 
Figure 6: Muscle bundle undergoing RF ablation near its center in the ablation 
dish with catheter imparting 0.1 N (10 grams) force ........................................... 67 
Figure 7: Custom designed HIFU ablation setup ................................................ 68 
Figure 8: Muscle bundle undergoing HIFU ablation ............................................ 69 
Figure 9: Custom designed microwave ablation setup ....................................... 70 
Figure 10: Muscle bundle undergoing microwave ablation ................................. 71 
Figure 11: Muscle bundle undergoing chemical ablation .................................... 72 
Figure 12: Uniaxial force measurement system .................................................. 73 
Figure 13: Illustration showing representative examples of avulsion location of 
muscle bundles ................................................................................................... 74 
Figure 14: Force-displacement graph of a muscle bundle .................................. 75 
Figure 15: Calculation of elastic moduli .............................................................. 76 
Figure 16: Dose effects of percent change in peak force of swine diaphragm post 
radiofrequency ablation (RFA) .......................................................................... 106 
Figure 17: Dose effects of percent change in baseline force of swine diaphragm 
post radiofrequency ablation (RFA) .................................................................. 106 
Figure 18: Dose effects of percent change in peak force of swine diaphragm post 
cryoablation (CRA) ........................................................................................... 107 
Figure 19: Dose effects of percent change in baseline force of swine diaphragm 
post cryoablation (CRA) ................................................................................... 107 
Figure 20: Dose effects of percent change in peak force of swine diaphragm post 
microwave ablation (MWA) ............................................................................... 108 
Figure 21: Dose effects of percent change in baseline force of swine diaphragm 
post microwave ablation (MWA) ....................................................................... 108 
Figure 22: Dose effects of percent change in peak force of swine diaphragm post 
HIFU (high-intensity focused ultrasound) ablation ............................................ 109 
Figure 23: Dose effects of percent change in baseline force of swine diaphragm 
post HIFU (high-intensity focused ultrasound) ablation .................................... 109 
Figure 24: Dose effects of percent change in peak force of swine diaphragm post 
acetic acid ablation ........................................................................................... 110 
Figure 25: Dose effects of percent change in baseline force of swine diaphragm 
post acetic acid ablation ................................................................................... 110 
Figure 26: Dose effects of percent change in peak force of swine diaphragm post 
ethyl alcohol ablation ........................................................................................ 111 
  xii 
Figure 27: Dose effects of percent change in baseline force of swine diaphragm 
post ethyl alcohol ablation ................................................................................ 111 
Figure 28: Dose effects of percent change in peak force of swine diaphragm post 
NaCl ablation .................................................................................................... 112 
Figure 29: Dose effects of percent change in baseline force of swine diaphragm 
post NaCl ablation ............................................................................................ 112 
Figure 30: Dose effects of percent change in peak force of swine diaphragm post 
urea ablation ..................................................................................................... 113 
Figure 31: Dose effects of percent change in baseline force of swine diaphragm 
post urea ablation ............................................................................................. 113 
Figure 32: Dose effects of percent change in peak force of swine diaphragm post 
injection of Krebs-buffer solution ...................................................................... 114 
Figure 33: Dose effects of percent change in baseline force of swine diaphragm 
post injection of Krebs-buffer solution ............................................................... 114 
Figure 34: Percent change in peak force of control and control-remove swine 
diaphragm muscle bundles ............................................................................... 115 
Figure 35: Percent change in baseline force of control and control-remove swine 
diaphragm muscle bundles ............................................................................... 115 
Figure 36: Dose effects on peak force of swine diaphragm for all thermal ablative 
modalities ......................................................................................................... 116 
Figure 37: Dose effects on baseline force of swine diaphragm for all thermal 
ablative modalities ............................................................................................ 116 
Figure 38: Dose effects on peak force of swine diaphragm for all chemical 
ablative modalities ............................................................................................ 117 
Figure 39: Dose effects on baseline force of swine diaphragm for all chemical 
ablative modalities ............................................................................................ 117 
Figure 40: Avulsion location for each treatment displayed as percentage for all 
muscle bundles tested in this investigation ....................................................... 118 
Figure 41: Average model of stress-strain characteristics of non-ablated “control” 
swine diaphragm muscle bundles (n=187) ....................................................... 118 
Figure 42: Dose effects of radiofrequency ablation (RFA) on biomechanical 
properties of swine diaphragm muscle bundles ................................................ 119 
Figure 43: Dose effects of cryoablation (CRA) on biomechanical properties of 
swine diaphragm muscle bundles ..................................................................... 119 
Figure 44: Dose effects of microwave ablation (MWA) on biomechanical 
properties of swine diaphragm muscle bundles ................................................ 120 
Figure 45: Dose effects of high-intensity focused ultrasound (HIFU) ablations on 
biomechanical properties of swine diaphragm muscle bundles ........................ 120 
Figure 46: Dose effects of chemical ablation with acetic-acid on biomechanical 
properties of swine diaphragm muscle bundles ................................................ 121 
Figure 47: Dose effects of chemical ablation with ethanol on biomechanical 
properties of swine diaphragm muscle bundles ................................................ 121 
Figure 48: Dose effects of chemical ablation with hypertonic sodium chloride on 
biomechanical properties of swine diaphragm muscle bundles ........................ 122 
  xiii 
Figure 49: Dose effects of chemical ablation with urea on biomechanical 
properties of swine diaphragm muscle bundles ................................................ 122 
Figure 50: Dose effects of Krebs injections on biomechanical properties of swine 
diaphragm muscle bundles ............................................................................... 123 
Figure 51: A swine diaphragm muscle ablated with 50 µl of acetic acid ........... 124 
Figure 52: Dose effects of percent change in peak force of swine esophagus post 
radiofrequency ablation (RFA) .......................................................................... 152 
Figure 53: Dose effects of percent change in baseline force of swine esophagus 
post radiofrequency ablation (RFA) .................................................................. 152 
Figure 54: Dose effects of percent change in peak force of swine esophagus post 
cryoablation (CRA) ........................................................................................... 153 
Figure 55: Dose effects of percent change in baseline force of swine esophagus 
post cryoablation (CRA) ................................................................................... 153 
Figure 56: Dose effects of percent change in peak force of swine esophagus post 
microwave ablation (MWA) ............................................................................... 154 
Figure 57: Dose effects of percent change in baseline force of swine esophagus 
post microwave ablation (MWA) ....................................................................... 154 
Figure 58: Dose effects of percent change in peak force of swine esophagus post 
high-intensity focused ultrasound ablation (HIFU) ............................................ 155 
Figure 59: Dose effects of percent change in baseline force of swine esophagus 
post high-intensity focused ultrasound ablation (HIFU) .................................... 155 
Figure 60: Dose effects of percent change in peak force of swine esophagus post 
chemical ablation with acetic acid ..................................................................... 156 
Figure 61: Dose effects of percent change in baseline force of swine esophagus 
post chemical ablation with acetic acid ............................................................. 156 
Figure 62: Dose effects of percent change in peak force of swine esophagus post 
chemical ablation with ethanol .......................................................................... 157 
Figure 63: Dose effects of percent change in baseline force of swine esophagus 
post chemical ablation with ethanol .................................................................. 157 
Figure 64: Dose effects of percent change in peak force of swine esophagus post 
chemical ablation with sodium chloride ............................................................ 158 
Figure 65: Dose effects of percent change in baseline force of swine esophagus 
post chemical ablation with sodium chloride ..................................................... 158 
Figure 66: Dose effects of percent change in peak force of swine esophagus post 
chemical ablation with urea .............................................................................. 159 
Figure 67: Dose effects of percent change in baseline force of swine esophagus 
post chemical ablation with urea ....................................................................... 159 
Figure 68: Dose effects of percent change in peak force of swine esophagus post 
injection with Krebs-buffer solution ................................................................... 160 
Figure 69: Dose effects of percent change in baseline force of swine esophagus 
post injection with Krebs-buffer solution ........................................................... 160 
Figure 70: Percent change in peak force of swine esophagus for control and 
control-remove muscle bundles ........................................................................ 161 
  xiv 
Figure 71: Percent change in baseline force of swine esophagus for control and 
control-remove muscle bundles ........................................................................ 161 
Figure 72: Dose effects on peak force of swine esophagus for all thermal ablative 
modalities ......................................................................................................... 162 
Figure 73: Dose effects on baseline force of swine esophagus for all thermal 
ablative modalities ............................................................................................ 162 
Figure 74: Dose effects on peak force of swine esophagus for all chemical 
ablative modalities ............................................................................................ 163 
Figure 75: Dose effects on baseline force of swine esophagus for all chemical 
ablative modalities ............................................................................................ 163 
Figure 76: Avulsion location for each treatment displayed as percentage for all 
swine esophagus muscle bundles tested for biomechanical assessment ........ 164 
Figure 77: Average model of stress-strain characteristics of swine esophagus 165 
Figure 78: Dose effects of radiofrequency ablation (RFA) on biomechanical 
properties of swine esophagus muscle bundles ............................................... 166 
Figure 79: Dose effects of cryoablation (CRA) on biomechanical properties of 
swine esophagus muscle bundles .................................................................... 166 
Figure 80: Dose effects of microwave ablation (MWA) on biomechanical 
properties of swine esophagus muscle bundles ............................................... 167 
Figure 81: Dose effects of high-intensity focused ultrasound ablation (HIFU) on 
biomechanical properties of swine esophagus muscle bundles ....................... 167 
Figure 82: Dose effects of chemical ablation with acetic-acid on biomechanical 
properties of swine esophagus muscle bundles ............................................... 168 
Figure 83: Dose effects of chemical ablation with ethanol on biomechanical 
properties of swine esophagus muscle bundles ............................................... 168 
Figure 84: Dose effects of chemical ablation with sodium chloride on 
biomechanical properties of swine esophagus muscle bundles ....................... 169 
Figure 85: Dose effects of chemical ablation with urea on biomechanical 
properties of swine esophagus muscle bundles ............................................... 169 
Figure 86: Dose effects of Krebs injections on biomechanical properties of swine 
esophagus muscle bundles .............................................................................. 170 
Figure 87: A swine esophagus muscle ablated with 50 µl of acetic acid .......... 171 
Figure 88: Human esophagus electro-mechanical response ............................ 182 
Figure 89: Comparison of electro-mechanical response of swine and human 
esophageal muscle bundles ............................................................................. 183 
Figure 90: Variability in electro-mechanical response of human esophagus .... 184 
Figure 91: Stress-Strain response of swine and human esophagus muscularis 
layer .................................................................................................................. 185 
Figure 92: Comparative assessment of human and swine esophagus 
biomechanical properties of muscularis layer ................................................... 185 
Figure 93: Stress-Strain response of swine and human esophagus squamous 
epithelium layer ................................................................................................ 186 
Figure 94: Comparative assessment of human and swine esophagus 
biomechanical properties of squamous epithelium layer .................................. 186 
  xv 
Figure 95: Dose effects of percent change in peak force of human esophagus 
post RFA .......................................................................................................... 187 
Figure 96: Dose effects of percent change in baseline force of human esophagus 
post RFA .......................................................................................................... 187 
Figure 97: Dose effects of percent change in peak force of human esophagus 
post CRA .......................................................................................................... 188 
Figure 98: Dose effects of percent change in baseline force of human esophagus 
post CRA .......................................................................................................... 188 
Figure 99: Dose effects of percent change in peak force of human esophagus 
post HIFU ablation ............................................................................................ 189 
Figure 100: Dose effects of percent change in baseline force of human 
esophagus post HIFU ablation ......................................................................... 189 
Figure 101: Percent change in peak force of “control” human esophagus muscle 
bundles ............................................................................................................. 190 
Figure 102: Percent change in baseline force of “control” human esophagus 
muscle bundles ................................................................................................. 190 
Figure 103: Avulsion location for each treatment displayed as percentage for all 
human esophagus muscle bundles tested for biomechanical assessment ...... 191 
Figure 104: Avulsion location for each treatment displayed as percentage for all 
human esophageal squamous epithelium tissue bundles tested for 
biomechanical assessment .............................................................................. 191 
Figure 105: Average power versus catheter tip temperature for human vastus 
lateralis ............................................................................................................. 202 
Figure 106: Representative examples of human vastus lateralis samples ablated 
with MWA (A), B (CRA), C (RFA).  Control samples (non-ablated) are shown in D
 ......................................................................................................................... 203 
Figure 107: Dose effects of percent change in peak force of human vastus 
lateralis post RFA ............................................................................................. 204 
Figure 108: Dose effects of percent change in baseline force of human vastus 
lateralis post RFA ............................................................................................. 204 
Figure 109: Dose effects of percent change in peak force of human vastus 
lateralis post CRA ............................................................................................. 205 
Figure 110: Dose effects of percent change in baseline force of human vastus 
lateralis post CRA ............................................................................................. 205 
Figure 111: Dose effects of percent change in peak force of human vastus 
lateralis post MWA ............................................................................................ 206 
Figure 112: Dose effects of percent change in baseline force of human vastus 
lateralis post MWA ............................................................................................ 206 
Figure 113: Percent change in peak force of control and control-remove human 
vastus lateralis muscle bundles ........................................................................ 207 
Figure 114: Percent change in baseline force of control and control-remove 
human vastus lateralis muscle bundles ............................................................ 207 
Figure 115: Avulsion location for each treatment displayed as percentage for all 
human vastus lateralis muscle bundles tested in this investigation .................. 208 
  xvi 
Figure 116: Comparative electro-mechanical response of swine and human 
trabeculae ......................................................................................................... 221 
Figure 117: Percent change in peak force of human trabeculae muscle bundles 
post RFA .......................................................................................................... 222 
Figure 118: Percent change in baseline force of human trabeculae muscle 
bundles post RFA ............................................................................................. 222 
Figure 119: Percent change in peak force of human trabeculae muscle bundles 
post HIFU ablation ............................................................................................ 223 
Figure 120: Percent change in baseline force of human trabeculae muscle 
bundles post HIFU ablation .............................................................................. 223 
Figure 121: Percent change in peak force of control and control remove muscle 
bundles of human trabeculae ........................................................................... 224 
Figure 122: Percent change in baseline force of control and control remove 
muscle bundles of human trabeculae ............................................................... 224 
Figure 123: Percent change in peak force of swine trabeculae muscle bundles 
post RFA .......................................................................................................... 225 
Figure 124: Percent change in baseline force of swine trabeculae muscle 
bundles post RFA ............................................................................................. 225 
Figure 125: Percent change in peak force of control muscle bundles of swine 
trabeculae ......................................................................................................... 226 
Figure 126: Percent change in baseline force of control muscle bundles of swine 
trabeculae ......................................................................................................... 226 
Figure 127: Stress-strain characteristics of swine and human trabeculae muscle 
bundles ............................................................................................................. 227 
Figure 128: Average model of stress-strain characteristic of swine (left) and 
human (right) trabeculae .................................................................................. 227 
Figure 129: RFA and CRA performed in tissue baths ....................................... 271 
Figure 130: RF interference in tissue bath during peak force analysis ............. 272 
Figure 131: RF interference in tissue bath during baseline force analysis ........ 272 
Figure 132: Dose effects of percent change in peak force of swine diaphragm 
post RFA in tissue bath .................................................................................... 273 
Figure 133: Dose effects of percent change in baseline force of swine diaphragm 
post RFA in tissue bath .................................................................................... 273 
Figure 134: Dose effects of percent change in peak force of swine diaphragm 
post CRA in tissue bath .................................................................................... 274 
Figure 135: Dose effects of percent change in baseline force of swine diaphragm 
post CRA in tissue bath .................................................................................... 274 
Figure 136: Steps highlighting data acquisition and analysis for physiological and 
biomechanical studies ...................................................................................... 276 
Figure 137: Methods for Physiological Assessment: Dissection ....................... 277 
Figure 138: Methods for Physiological Assessment: Tissue Baths ................... 278 
Figure 139:  Methods for Physiological Assessment: Stabilization ................... 279 
Figure 140: Methods for Physiological Assessment: Pre-Ablation Data Collection
 ......................................................................................................................... 280 
  xvii 
Figure 141: Methods for Physiological Assessment: Ablations (Swine Diaphragm)
 ......................................................................................................................... 281 
Figure 142: Methods for Physiological Assessment: Ablations (Swine 
Esophagus) ...................................................................................................... 282 
Figure 143: Hyperthermic and hypothermic tissue damage ............................. 283 
Figure 144: Hyperthermic and hypothermic thermal spectrum ......................... 284 
Figure 145: Volume analysis of chemical agents .............................................. 285 
Figure 146: Methods for Physiological Assessment: Post-Ablations Recovery 286 
Figure 147: Methods for Biomechanical Assessment: Arrange Samples ......... 287 
Figure 148: Methods for Biomechanical Assessment: Application of Super Glue
 ......................................................................................................................... 288 
Figure 149: Methods for Biomechanical Assessment: Mounting on Uniaxial 
Machine ............................................................................................................ 289 
Figure 150: Methods for Biomechanical Assessment: Recording Sample 
Dimensions ....................................................................................................... 290 
Figure 151: Methods for Biomechanical Assessment: Perform Pull ................. 291 
Figure 152: Methods for Biomechanical Assessment: Assign Avulsion Location
 ......................................................................................................................... 292 
Figure 153: Pictorial representation of Avulsion ............................................... 293 
Figure 154: A representative example of force-stretch graph ........................... 294 
Figure 155: Methods for Biomechanical Assessment: Measure Mass ............. 295 
Figure 156: Plot of average power and catheter tip ablation temperature for swine 
diaphragm ........................................................................................................ 296 
Figure 157: Plot of average power and catheter tip ablation temperature for swine 
diaphragm ........................................................................................................ 297 
Figure 158: Raw data of force versus stretch data of swine diaphragm control 
muscle bundles ................................................................................................. 298 
Figure 159: Stress-strain curve of swine diaphragm control muscle bundles ... 299 
Figure 160: Change in cross-sectional area of muscle bundles as a function of 
stretch ............................................................................................................... 299 
Figure 161: Cauchy’s stress-strain curve of swine diaphragm control muscle 
bundles ............................................................................................................. 300 
Figure 162: Statistical analysis for swine diaphragm RFA peak force .............. 303 
Figure 163: Statistical analysis for swine diaphragm RFA baseline force ......... 303 
Figure 164: Statistical analysis for swine diaphragm CRA peak force .............. 304 
Figure 165: Statistical analysis for swine diaphragm CRA baseline force ........ 304 
Figure 166: Statistical analysis for swine diaphragm MWA peak force ............. 305 
Figure 167: Statistical analysis for swine diaphragm MWA baseline force ....... 305 
Figure 168: Statistical analysis for swine diaphragm HIFU peak force ............. 306 
Figure 169: Statistical analysis for swine diaphragm HIFU baseline force ....... 306 
Figure 170: Statistical analysis for swine diaphragm acetic acid peak force .... 307 
Figure 171: Statistical analysis for swine diaphragm acetic acid baseline force307 
Figure 172: Statistical analysis for swine diaphragm ethanol peak force .......... 308 
Figure 173: Statistical analysis for swine diaphragm ethanol baseline force .... 308 
  xviii 
Figure 174: Statistical analysis for swine diaphragm hypertonic sodium chloride 
peak force ......................................................................................................... 309 
Figure 175: Statistical analysis for swine diaphragm hypertonic sodium chloride 
baseline force ................................................................................................... 309 
Figure 176: Statistical analysis for swine diaphragm urea peak force .............. 310 
Figure 177: Statistical analysis for swine diaphragm urea baseline force ......... 310 
Figure 178: Statistical analysis for swine diaphragm Krebs injection peak force
 ......................................................................................................................... 311 
Figure 179: Statistical analysis for swine diaphragm Krebs injection baseline 
force ................................................................................................................. 311 
Figure 180: Relationship between average power and catheter tip ablation 
temperature for all experimental runs of RF ablation on swine esophagus ...... 312 
Figure 181: Relationship between average power and catheter tip ablation 
temperature for all experimental runs of RF ablation on swine esophagus ...... 313 
Figure 182: Raw data of force versus stretch of swine esophagus control muscle 
bundles ............................................................................................................. 315 
Figure 183: Stress-strain curve of swine esophagus control muscle bundles .. 316 
Figure 184: Change in CSA of muscle bundles as a function of stretch ........... 316 
Figure 185: Cauchy’s stress-strain curve for swine esophagus muscle bundles
 ......................................................................................................................... 317 
Figure 186: Swine esophagus change in peak force profile after RF ablation .. 318 
Figure 187: Statistical analysis for swine esophagus RFA peak force .............. 321 
Figure 188: Statistical analysis for swine esophagus RFA baseline force ........ 321 
Figure 189: Statistical analysis for swine esophagus CRA peak force ............. 322 
Figure 190: Statistical analysis for swine esophagus CRA baseline force ........ 322 
Figure 191: Statistical analysis for swine esophagus MWA peak force ............ 323 
Figure 192: Statistical analysis for swine esophagus MWA baseline force ...... 323 
Figure 193: Statistical analysis for swine esophagus HIFU peak force ............ 324 
Figure 194: Statistical analysis for swine esophagus HIFU baseline force ....... 324 
Figure 195: Statistical analysis for swine esophagus acetic acid peak force .... 325 
Figure 196: Statistical analysis for swine esophagus acetic acid baseline force
 ......................................................................................................................... 325 
Figure 197: Statistical analysis for swine esophagus ethanol peak force ......... 326 
Figure 198: Statistical analysis for swine esophagus ethanol baseline force ... 326 
Figure 199: Statistical analysis for swine esophagus hypertonic sodium chloride 
peak force ......................................................................................................... 327 
Figure 200: Statistical analysis for swine esophagus hypertonic sodium chloride 
baseline force ................................................................................................... 327 
Figure 201: Statistical analysis for swine esophagus urea peak force .............. 328 
Figure 202: Statistical analysis for swine esophagus urea baseline force ........ 328 
Figure 203: Statistical analysis for swine esophagus Krebs injection peak force
 ......................................................................................................................... 329 
Figure 204: Statistical analysis for swine esophagus Krebs injection baseline 
force ................................................................................................................. 329 
  xix 
Figure 205: Cryoablated swine diaphragm muscle bundles post completion of 
physiological assessment protocol ................................................................... 335 
Figure 206: TTC staining of muscle bundles .................................................... 335 
Figure 207: Cryoablated swine diaphragm muscle bundles after 2 hours of TTC 
staining ............................................................................................................. 336 
Figure 208: Cross-sectional slices of swine diaphragm .................................... 336 
Figure 209: Control (Krebs-buffer injected) swine diaphragm muscle bundles 
after 2 hours of TTC staining ............................................................................ 337 
Figure 210: Cross-sectional slices of Krebs-buffer injected swine diaphragm 
muscle bundles ................................................................................................. 337 
Figure 211: Ablated area determination using ImageJ software tool ................ 338 
Figure 212: Dose effects of chemical and thermal ablative modalities on swine 
trabeculae and diaphragmatic muscle bundles on calculation of percent ablated 
area .................................................................................................................. 339 
Figure 213: Dose effects on percent ablated area of swine trabeculae and 
diaphragmatic muscle bundles in response to ablations with acetic acid and 
ethanol .............................................................................................................. 339 
Figure 214: Inter-species comparison of biomechanical properties of non-
contractile tissues ............................................................................................. 345 
Figure 215: Illustration of different pacing sites in the RV ................................. 352 
Figure 216: A look into a cadaver RVOT through the pulmonary valve ............ 353 
Figure 217: Longitudinal section of RVOT showing smooth morphology ......... 354 
Figure 218: Percent trabeculations in RVOT (conus arteriosus) region ............ 355 
 
  1 
1. A Review of Therapeutic Ablation Modalities and 
Biophysics 
 
 
 
Preface 
 
 This review serves as an introduction to various therapeutic ablation 
modalities used clinically throughout the body for treatment of different diseases.  
Also discussed in detail is the underlying biophysics of five ablation modalities 
and how tissue injury results from ablative treatments.  A thorough literature 
search was performed from multiple sources to assemble this article which is 
submitted to the Journal of Medical Devices in June 2014 and is currently under 
review.  The reader can not only grasp the widespread therapeutic applications 
of ablative energies, but also use this information for innovation as it relates to 
designing new tools, techniques, and procedures for medical device design. 
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Executive Summary 
 
Understanding basic science and technical aspects is essential for 
scientists and engineers to develop and enhance ablative modalities, and for 
clinicians to effectively apply therapeutic ablative techniques.  An overview of 
ablative modalities, anatomical locations, and indications for which ablations are 
performed is presented.  Specifically, basic concepts and underlying biophysics 
of tissue injury of five currently used therapeutic ablative modalities are reviewed: 
radiofrequency ablation, cryoablation, microwave ablation, high-intensity focused 
ultrasound, and chemical ablation (ablative agents: acetic acid, ethanol, 
hypertonic sodium chloride, and urea). Each ablative modality could be refined 
for expanding applications, either independently or in combination, for future 
therapeutic use. 
 
Key words: radiofrequency, cryoablation, microwave, high-intensity focused 
ultrasound, chemical ablation 
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Introduction 
 
The fields of medical device design and applied therapies are evolving at 
a rapid pace.  New techniques and procedures are being developed in response 
to the demanding challenges of increasing overall efficacy and successful 
outcomes of procedures.  The medical community, including physicians, 
scientists, and engineers, is challenged by four most pressing issues: (1) 
reducing procedure times; (2) reducing procedure costs; (3) minimizing 
procedure invasiveness; and (4) increasing procedure safety and effectiveness to 
achieve better outcomes.  Though this is applicable in every branch of medicine, 
we consider here the particular specialties dealing with tissue ablations. 
 
Ablative Modalities Investigated 
 
Ablation is a common medical procedure that involves manipulation of the 
target tissue with an aim to restore normal structure and function.  Reports 
describing the clinical use of ablations date back to the late eighteenth century 
[1], and these therapeutic techniques have now secured a prominent place in 
medicine.  Since then, scientists and engineers have continued to innovate and 
explore the electromagnetic spectrum and different sources of energy that are 
safe and potentially useful for various tissue ablation procedures. 
To date, numerous ablative modalities are used in research and clinical 
medicine.  The therapeutic ablative techniques reviewed in this article include: 
radiofrequency ablation (RFA), cryoablation (CRA), microwave ablation (MWA), 
high-intensity focused ultrasound (HIFU) ablation, and chemical ablation (CHA). 
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Importantly, ablation treatments are performed throughout the human body for 
various disease states, often utilizing different ablative modalities. Figure 1 
illustrates a detailed list of anatomical locations where ablations are performed, 
along with the indications and ablative modalities that have been used.  In 
addition, Table 1 lists some of the references for choice of ablation modality 
describing both for research and/or clinical practice for each anatomical location 
[2-91]. 
In general, ablative modalities can be divided into two primary categories, 
thermal and chemical ablation.  Although procedure indications, patient selection 
criteria, available tools and techniques, and choice of ablative modality used vary 
among treatments, both categories take advantage of various physical, chemical, 
and biological properties of tissues to induce local cell injury, ultimately leading to 
cellular necrosis.  The thermal ablation technique alters the focal temperature of 
the tissue being ablated with heating or cooling, causing direct or indirect cell 
death.  Specifically, RFA, MWA, and HIFU ablative techniques induce heat within 
the target tissue to cause cell injury, whereas CRA therapy induces cooling at the 
target location to cause tissue destruction.  In contrast, CHA agents, such as 
ethanol, acetic acid, hypertonic sodium chloride solution, or urea rely on focal 
cellular toxicity and protein denaturation to produce cellular necrosis. 
Familiarity with the underlying science, biophysical mechanisms, and 
technical aspects of ablative techniques is essential for clinicians to effectively 
treat ablative cases.  This article provides an overview of five currently used 
  6 
ablative techniques to achieve thermal and chemical ablation of tissues. 
Specifically, the article addresses the basic science and principles of biophysics 
of ablative techniques as they relate to tissue injury. 
 
Brain [2-5] Tonsils [22-25] Liver [48-50] Cervix [76] 
Occipital [6, 7] Esophagus [26-29] Gallbladder [51-53] 
Celiac Plexus [77-
78] 
Dental [8-10] Heart [30-35] Renal [54-57] Veins [79-81] 
Ear [11, 12] Lung [36-39] Adrenal Gland [58-61] Spine [82-85] 
Face [13-15] Breast [40-42] Prostate [62-67] Bone [86-89] 
Thyroid [16, 17] Spleen [43-44] Bladder [68-70] Toe [90, 91] 
Parathyroid [18-21] Pancreas [45-47] Uterus [71-75]  
 
Table 1: Table of anatomical locations where ablations are performed 
 
 
 
 
Figure 1: Illustration of anatomical locations where ablations are performed 
List of anatomical locations where ablations are performed, disease condition, 
and the ablation modalities used. AF=atrial fibrillation; AVN=atrioventricular node; 
BPH=benign prostatic hyperplasia; Cryo=cryoablation; HCC=hepatocellular 
carcinoma; HIFU=high-intensity focused ultrasound; HTN=hypertension; 
IRE=irreversible electroporation; MWA=microwave ablation; OCD=obsessive 
compulsive disorder; PDT=photodynamic therapy; RFA=radiofrequency ablation; 
SND=sinus node dysfunction; SVT=supraventricular tachycardia; VT=ventricular 
tachycardia. 
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Radiofrequency Ablation 
 
Radiofrequency catheter ablation was first introduced by Huang and 
colleagues in 1985 [92].  In the past three decades, it has become one of the 
most useful and widely employed therapies for treating various forms of 
diseases, and indications for its use continue to expand.  RF ablative energy is a 
form of alternating electrical current that, when dissipated, generates a lesion in 
the tissue by mode of resistive (electrical) heating.  Typically, alternating currents 
of around 500 KHz are utilized.  Note that lower frequencies are more likely to 
stimulate surrounding tissues (muscles and nerves), however higher frequencies 
dissipate energy in the tissues in the form of heat.  Developing an insightful 
understanding into the biophysics of RF energy delivery and the underlying 
mechanisms of tissue injury will aid in optimizing therapy and ultimately enhance 
its safety and efficacy. 
 
Biophysics of Radiofrequency and Resultant Tissue Injury 
 
The mode of tissue heating by radiofrequency energy is by resistive 
heating, similar to heat produced by electrical sources.  As electrical current 
passes through a resistive medium (tissue), there is voltage drop, and heat is 
produced.  The heat produced in the tissue is analogous to the heat produced 
when current flows through an incandescent light bulb.  Resistive heat produced 
within the tissue is proportional to the RF power density at the electrode which, in 
turn, is proportional to the square of the current density at the electrode.  Within 
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tissue, the current density decreases in proportion to the square of the distance 
from the electrode.  Therefore, RF resistive heating of the tissue decreases in 
proportion to the fourth power as a function of distance from the RF electrode.  
As a result, only a narrow rim of tissue in close contact with the RF electrode is 
heated directly. Note that there is resultant heating of deeper layers of tissue that 
occurs passively through conduction, and is not considered to be harmful.  In 
fact, depending on the therapeutic application, heating of deeper layers is often 
required to create a transmural lesion.  The depth of both the resistive and 
conductive heating increases at higher power levels, which also results in an 
increase in the lesion volume.  Numerous factors affect the quality of RF delivery 
and the resulting lesion size. Some of these factors are listed below: 
1. Target Selection:  If the target selection is poor, simply increasing the 
size and depth of lesion will not improve the chances of a successful 
therapeutic ablation.  To optimize target location, it is necessary to 
understand the anatomy and pathophysiology of the target region in its 
entirety.  The proximity of the electrode to the target where ablation needs 
to be performed is one of the most important factors for ablation success. 
2. Tissue Composition:  Variations in tissue composition result in different 
tissue thermal conductivities and electro-mechanical properties.  These 
differences result in heterogeneous tissue responses to applied energies, 
which further result in different lesion sizes.  For example, lesion size is 
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significantly impacted by formation of dense scar, and an insulating layer 
of fat can prevent the formation of a clinically acceptable lesion [93]. 
3. Power: In general, lesion size is proportional to the applied RF power. 
That is, a greater amount of RF power deposited in the tissue results in 
more tissue heating and a greater depth of thermal injury and lesion size 
as shown in Figure 3.  In addition, efficiency of power delivery within the 
tissue plays an important role, as energy coupling can change not only 
with convective cooling effects, but also with scarring at the electrode-
tissue interface.  It should be noted that saline-irrigated RF ablation 
catheters have been utilized which, by design, produce a lower tip 
temperature (for a given RF power) but higher temperatures deeper within 
the tissues.  This is particularly useful for cardiac ablations of ventricular 
myocardium since deeper transmural lesions are often required. 
4. Electrode Temperature: In general, lesion size increases in proportion 
with electrode temperature until the point of tissue coagulation, which 
usually results in the rise in tissue impedance.  This effect is confounded 
by the effects of convective cooling, perfusion, and relative motion 
between the RF electrode and target location. 
5. Peak Tissue Temperature: This factor is the primary determinant of the 
ultimate RF lesion size.  It should be noted that because of convective 
cooling effects, perfusion effects, and/or relative motion at the electrode-
tissue interface, the electrode temperature (measured by a variety of 
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temperature sensors on RF electrodes) may often underestimate the peak 
tissue temperature. 
6. Electrode Contact Pressure: A greater electrode-tissue contact pressure 
results in an increase in the lesion size as shown in Figure 2.  This is 
achieved because of improved electrical coupling between the electrode-
tissue interface, increased electrode contact surface area with the tissue, 
and reduced shunting of current in the form of convective current losses 
[94].  In addition, a greater contact pressure may prevent relative motion 
between the electrode-tissue interface resulting in more efficient RF 
energy coupling and delivery.  However, excessive pressures may bury 
the electrode within the tissue resulting in an increased probability of 
tissue charring, thus reducing RF energy coupling and delivery. 
7. Convective Cooling: Convective cooling occurs due to regional blood 
flow and perfusion at the target tissue location. In general, target locations 
that are highly perfused (e.g., heart) are more susceptible to convective 
cooling effects than target locations that are less perfused (e.g., prostate). 
Convective cooling results in decreased lesion size as it draws heat 
energy away from the target location, resulting in less heat energy 
available to create the lesion.  Lesion size is ultimately a function of tissue 
heating which, in turn, is a function of magnitude of RF power that is 
converted into heat at the electrode-tissue interface. It should be noted 
that high electrode pressure (above the capillary perfusion pressure of 40 
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mm of Hg) could play a significant role in altering the convective cooling 
effects. 
8. Electrode Size: The use of a larger electrode size will generally result in a 
larger lesion size as shown in Figure 3. This results from an increase in 
the contact surface area which allows not only efficient RF energy 
coupling, but also delivery of higher power without excessive current 
densities at the electrode-tissue interface. Moreover, coagulum formation 
that results in sudden rise in impedance can be avoided. 
9. Duration of Applied Energy: Tissue temperature follows a 
monoexponential rise during RF energy delivery, until a steady state is 
achieved. Although steady state is often achieved within 8 to 15 seconds 
after start of RF energy delivery, the duration of energy must be titrated 
based on both the unique pathophysiological features of the target 
location and the extent of desired lesion.  An illustration is shown in Figure 
2. 
10. Electrode-Tissue Impedance: According to Ohm’s law, an applied 
voltage is equal to the product of current and impedance. Thus, for smaller 
impedance, greater current delivery can be achieved for a given applied 
voltage. Note that the relative relationship in impedance between 
electrode-tip and tissue-interface is complex, hence it is important to have 
good electrode contact with optimum pressure at the target tissue 
interface in an attempt to maximize energy coupling and optimize energy 
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delivery [95]. A greater current delivery results in greater resistive heat 
loss at the electrode-tissue interface, thus forming a larger lesion size. 
11. Electrode Orientation: An orientation that results in a larger electrode-
tissue contact area generally causes a larger lesion size. In many clinical 
situations, electrode orientation can be manipulated during therapy 
delivery to optimize coupling and thus, maximize energy delivery to the 
target area. 
12. Electrode Geometry: In order to maximize therapy efficacy, it is best to 
customize electrode geometry to conform to the target location where the 
lesion is desired. Electrode shapes that allow greater electrode-tissue 
contact area generally result in higher coupling efficiency and higher 
power delivery, resulting in a larger lesion size. 
13. Electrode Material: Materials with high heat transfer characteristics allow 
for greater current delivery at the electrode-tissue interface, thus resulting 
in a larger lesion size. These materials are not only effective in transferring 
energy at the electrode-tissue interface, but are also effectively cooled by 
blood perfusion. 
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Figure 2: Effect of applied catheter tip force and energy on lesion size 
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Figure 3: Effect of electrode size and applied power on lesion size 
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Cryoablation 
 
Reports of using extreme hypothermia date back to 1930s, with 
investigations on life expectancy, recovery, and death following exposure to 
extreme cold [96]. Numerous cryosurgical devices were pioneered in 1960 that 
used liquid nitrogen as a refrigerant [97, 98]. Since then, harnessing cryoenergy 
has been an area of intense interest and investigation, and numerous clinical 
systems are now available to perform cryoablations throughout the body. For 
example, the safety and efficacy of cryoenergy ablation on myocardial tissue 
have been well recognized, where the effect of hypothermia on the conduction 
system was achieved using carbon dioxide [99]. 
 
Biophysics of Cryoablation and Resultant Tissue Injury 
 
Although the exact mechanism whereby cell death is produced by 
hypothermia is still not clearly understood, cryoablation works by freezing tissue 
in a discrete and focused manner to destroy cells in a target location. It has been 
reported that the application of cryoenergy results in the formation of an ice-ball 
at the target area that causes freezing, thawing, hemorrhage, inflammation, 
fibrosis, and apoptosis [100]. Freezing typically extends radially into the tissue, 
establishing a temperature gradient. The lowest temperatures and fastest 
freezing rates are typically found at the cryoprobe-tissue interface, with slower 
freezing rates at deeper aspects of the target volume. Hypothermia causes: (1) 
the intracellular and extracellular environment to become cold and eventually 
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freeze; (2) cells to become less fluid as metabolism slows; (3) slowing in cellular 
functional kinetics; (4) loss of ion pump transport capabilities; and (5) intracellular 
pH to become more acidic [101]. The hallmark of permanent tissue injury induced 
by cryoablation has been considered to be ice formation. Specifically, as the 
targeted region is cooled, it is characterized by the formation of extra- and 
intracellular ice crystals [102, 103]. Formation of ice crystals causes compression 
and distortion which severely damages the cellular components, cellular 
membrane and underlying cellular machinery [103]. Ice crystal formation also 
results in osmolarity changes across the cell membrane, which further 
contributes to overall cell death and necrosis. The initial compression effects are 
followed by tissue destruction that occur during the ensuing thawing period that 
can last several hours [104, 105]. Initial rewarming causes intracellular ice 
crystals to enlarge and aggregate into large masses that further exacerbate 
cellular destruction. Hemorrhage and inflammation characterize the subsequent 
phase of cryoablation that involves water migration across the cells to reestablish 
the osmolarity equilibrium gradient that was altered by the formation of ice 
crystals. As a result, altered solute-solvent concentration within and outside the 
cell causes damage to the cell membrane, eventually leading to lysis of the cell. 
Furthermore, restoration of blood flow to previously frozen tissue results in 
edema and ischemic necrosis. Finally, cryoinjury results which triggers apoptosis, 
and thus a mature lesion ensues within days to weeks [106]. Numerous factors 
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affect the quality of cryotherapy delivery and thus the resulting lesion size. Some 
of these factors are listed below: 
1. Target Selection: In general, this would be similar to what has been 
described in the RFA section. 
2. Tissue Composition: In general, this would be similar to what has been 
described in the RFA section. 
3. Freezing Duration: Experimental studies have demonstrated that the 
lesion depth is determined by the duration of freezing [107]. It is well 
documented that longer cryoduration results in a larger lesion size [108]. 
Hence, thicker tissue substrates may require much longer applications of 
cryotherapy to achieve transmural lesions as compared to thin areas. 
However, some studies have investigated improved lesion formation and 
size by applying double freeze cycles (i.e., freezing-thawing-
freezing)[109]. That is, refreezing thick areas potentiates cell death 
because of repeated freeze/thaw cycle and increases lesion size. 
4. Lethal Temperatures: Depending on the target location and relative 
blood perfusion, lethal temperatures are typically reached within 15 to 30 
seconds of cryotherapy initiation. Although irreversible damage to cells 
occurs at temperatures as low as -50 to -80°C, cryomapping at 
temperatures close to -20°C are often utilized to evaluate the clinical 
effectiveness of therapy applications [110].  
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5. Cryoprobe Tip Temperature: In general, lower cryoprobe tip 
temperatures result in larger cryolesions. However, other variables such 
as rate of cooling and perfusion effects play an important role. 
6. Catheter Adhesion: As long as there is some contact with the target 
tissue, the formation of an ice-ball at the tip of the catheter during 
cryoablation causes the catheter to adhere to the adjacent tissue being 
ablated (cryoadhesion). This allows for potentially sensing the electrical 
activity of the underlying tissue (e.g., the heart) without risk of catheter 
motion or dislodgement. Moreover, cryoablations can then be performed 
with minimal risk of dislodgement under natural movements from 
respiration or cardiac rhythm. Good catheter tip adhesion with the tissue 
results in a larger lesion size. 
7. Rate of Freezing: A faster rate of cooling has been observed to be more 
lethal, contributing to faster cellular death, hence resulting in a larger 
lesion size [110]. At the borderline zone though, a combination of lower 
temperatures and reduced rate of cooling contribute to reversible cell 
damage. Hence, during therapy planning, rate of cooling and application 
duration are typically pre-determined to achieve a transmural lesion. 
8. Contact Pressure: Increased catheter tip contact pressure results in a 
faster rate of freezing because of compression of tissue and decreased 
convection effects due to blood perfusion warming. Hence, an increased 
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catheter tip pressure is likely expected to result in a larger lesion size 
[111]. 
9. Cryoprobe Size: Cryoprobe size is an important determinant of 
procedural success and lesion character. Typically catheters with 
cryoprobe tips (4, 6, and 8 mm) and cryoballoon are available clinically. 
Lesion size has been shown to increase with catheter tip size [105]. A 
large sized catheter tip that can accommodate large diameter refrigerant 
channels, coupled with a larger cryoprobe-tissue contact surface area, is 
likely expected to result in a larger lesion size. Note, for ablation of the 
cardiac pulmonary-vein ostium, a cryoballoon system has been developed 
and utilized quite successfully [112].   
10. Blood Perfusion: Areas having low perfusion result in larger cryolesion 
formation due to reduced warming convective effects from blood. 
11. Cryoprobe Orientation: A catheter orientation that results in larger 
cryoprobe-tissue contact area generally results in a larger lesion size. 
Unlike RFA, cryoprobe orientation can only be slightly manipulated during 
therapy delivery due to cryoadhesion between the cryoprobe and the 
tissue. 
12. Cryoprobe Geometry: In order to maximize therapy efficacy, it is best to 
customize cryoprobe geometry to conform to the target location where the 
lesion is desired. Cryoprobe shapes that allow greater cryoprobe-tissue 
contact area result in larger lesion size. 
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High-Intensity Focused Ultrasound Ablation 
 
Ultrasound (US) consists of mechanical pressure waves with frequencies 
above 20 kHz (beyond human audible range of 20 Hz to 20 KHz). For medical 
imaging, US transducers in the frequency range of 1–20 MHz are utilized. 
Ultrasound requires a medium for propagation which alternates compressions 
and rarefactions of particles, thus advancing the pressure wave within the 
medium. The field of US in clinical practice is no longer limited to simple 
diagnostic imaging or percutaneous guidance procedures. When high intensity 
US waves are focused in a small region, they can be used for therapeutic 
purposes such as inducing deep hyperthermia and ultimately tissue ablation. 
Hence, HIFU systems operating in the frequency range of approximately 500 
KHz–7.5 MHz are emerging as a non- or minimally invasive method for treatment 
of various forms of diseases. 
 
Biophysics of High-Intensity Focused Ultrasound and Resultant Tissue 
Injury 
 
The field of tissue ablation is evolving towards greater use of noninvasive 
or minimally invasive modalities such as HIFU. Unlike RFA or CRA, HIFU can be 
employed as a noninvasive or minimally invasive modality that can be used to 
ablate tissues lying deep within the body. In order to understand HIFU, it is 
important to compare the characteristic energy levels of HIFU versus diagnostic 
US. Most commonly used diagnostic US transducers deliver US intensities in the 
range of 0.1 to 300 mW/cm2 and pressures in the range of 1KPa to 3KPa [113]. 
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In contrast, HIFU transducers deliver US with intensities typically in the range of 
100 to 10,000 W/cm2 and pressures in the range of 10 to 30 MPa [114]. 
HIFU can create controlled ablative tissue lesions through two primary 
modes of tissue injury: thermally induced injury (from thermal energy) and 
mechanically induced injury (from mechanical energy). The major ablative effect 
of HIFU is from heat generation within tissues due to absorption of the applied 
acoustic energy. The amount of acoustic energy transferred from the acoustic 
wave to the tissue is directly proportional to the intensity of the wave and the 
innate absorption coefficient of that specific tissue. In continuation, the amount of 
heat dissipated in the tissue is dependent on numerous factors, such as: (1) 
frequency of incident wave; (2) thermal conductivity of the tissue; (3) tissue 
density; (4) and local tissue perfusion. The heat generated raises the local 
temperature to ablative levels causing coagulation necrosis within a few seconds. 
The temperature at the transducer focus can reach over 65°C within seconds, 
denaturing cellular proteins and resulting in coagulative necrosis [115]. 
Mechanical effects are representative of higher intensities, but generally not 
present at lower intensities [116]. Mechanical phenomena such as 
microcavitation as a result of oscillations and collapse of gas bubbles within the 
tissue can occur, and can further lead to near instantaneous boiling temperatures 
[117, 118]. Specifically, violent collapse and destruction of bubbles cause 
disruption of cell membrane, organelles, and cellular proteins from which one 
may anticipate mechanical damage rather than thermal damage to the cell. 
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It is important to note that the cells exhibit an intrinsic protective behavior 
when exposed to hyperthermia. When exposed to stressful heat, mammalian 
cells produce heat-shock proteins [119, 120]. Scientists believe that such 
activated proteins help to protect the cells against damage from heat. However, 
HIFU heats the tissues so quickly that the cells most often do not have time to 
transcribe these heat-shock proteins as a protective mechanism. Numerous 
factors affect the quality of HIFU delivery and the resulting tissue lesions. Some 
of these factors are listed below: 
1. Target Selection: In general, this would be similar to what was described 
in the RFA section. 
2. Tissue Composition: In general, this would be similar to what was 
described in the RFA section. 
3. HIFU Duration: Although tissue injury is dependent on mechanical and 
thermal effects, in general, longer HIFU duration will result in a larger 
lesion size. HIFU energy is continuously absorbed and converted into heat 
within the tissue. This thermal effect can cause substantial tissue injury if 
the temperature elevation reaches above the threshold of injury potential 
and is maintained for an adequate period of time. Importantly, if not 
precisely controlled, this can cause collateral damage to surrounding vital 
structures. To minimize injury to surrounding structures, techniques such 
as temporal modulation have been utilized where the output of the HIFU 
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system is switched on and off at a predetermined rate (approximately 1 
Hz) to achieve controlled conductive heat transfer [121].  
4. Incident Energy: HIFU has the power to create controlled, localized 
tissue injury through both thermal (absorption of acoustic energy which is 
converted into heat) and mechanical (oscillation and collapse of micro-
bubbles and cavitation) effects. An increase in incident energy (power 
and/or intensity) may cause boiling of tissue water which may lead to the 
formation of vapor cavities [122]. Hence, a precise control of incident 
energy is needed to achieve complete ablation of target tissue volumes. 
Techniques such as power modulation have been attempted to control 
induced tissue necrosis and thus minimize complications [121]. 
5. Lesion Separation: Successful HIFU treatment requires complete 
ablation of target tissue volume. In order to destroy the entire tissue 
volume, it is essential to place a contiguous array of lesions side-by-side 
with their lesion borders touching each other throughout the target lesion 
volume. In doing so, a phenomenon called lesion-to-lesion interaction has 
been reported [123], which occurs when the spatial separation of 
individual exposures are such that an existing lesion appears to affect the 
formation of the subsequent lesions. In some cases, this phenomenon 
may cause focal aberrations that may fail to cover the entire tissue 
volume. It has been suggested that by allowing the tissue to cool between 
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exposures, it may be possible to form arrays of overlapping lesions, thus 
successfully ablating the complete target region [124].  
6. Tissue Edema: Although HIFU has the merit of being relatively 
noninvasive in nature, there is a high potential for the portion of skin and 
subcutaneous tissue along the pathway of focused ultrasound to be 
affected, thus causing tissue edema. Since large tumors require longer 
ablation time, the resulting cutaneous and subcutaneous tissue edema 
may not only reduce the targeting ability of the diagnostic ultrasound, but 
also negatively affect the precision of deposition of focused ultrasound 
onto the target lesion. Hence, large tumors may need “planned” repeated 
HIFU treatments, or at least subsequent treatment, once a residual lesion 
has been detected by US imaging. 
7. Blood Flow: Areas having low perfusion result in larger lesion formation 
due to reduced convective cooling effects from blood [125].   
 
Microwave Ablation 
 
Microwaves (MW) are high frequency electromagnetic radiations 
occupying the 300 MHz to 300 GHz frequency range of the electromagnetic 
spectrum. The Federal Communications Commission (FCC) permits several 
unrestricted bands for medical use; some of the most common frequencies used 
for microwave ablation are 915 MHz, 2.45 GHz, and broadband frequencies 
between the range of 1 GHz and 10 GHz [126]. The earliest use of microwaves 
  25 
for ablative therapy date back to the early 1990s, when Langberg et al [127] used 
microwaves to ablate the cardiac atrioventricular junction using a helical 
microwave antenna. Since then, numerous advances in this field have prompted 
clinicians to develop newer antenna designs and therapeutic ablation techniques. 
Unlike RFA, the application of microwaves causes dielectric heating of tissues 
and the underlying biophysics are discussed below. 
 
Biophysics of Microwave Ablation and Resultant Tissue Injury 
 
MWA is one of the more recent techniques in the field of clinical ablation 
therapies that relies on dielectric heating of tissue rather than electrical resistive 
heating as with RFA. At such high frequencies, dielectric heating of tissue occurs 
when electromagnetic radiation stimulates oscillations of dipole molecules such 
as water within the cellular and extracellular medium, which converts the 
electromagnetic energy into oscillating kinetic energy. This energy is dissipated 
as heat at the target location which results in thermal injury. These 
electromagnetic waves can propagate in free space and in conductive mediums 
like the human body, thus allowing for a greater amount of heat deposited in 
deeper structures. With regard to biological tissues, there are inherent 
differences in tissue properties related to thermal conductivity and dielectric 
constant. Moreover, tissue properties along with tissue electrical conductivity and 
relative permittivity vary as a function of frequency. These differences are 
significant among different types of tissues in the human body which makes them 
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respond differently to these high frequency microwaves. Along their propagation 
path within the body, MWs are extracted and absorbed in various tissues. 
Tissues with higher water concentration (e.g., muscle, blood) absorb more waves 
which results in higher heating due to dielectric dissipation of energy converted 
into kinetic energy, as compared to tissues with lower water concentration (e.g., 
bone). However, tissues with lower water concentration absorb less MWs, thus 
allowing deeper penetration of waves. Some of the considered advantages of 
MWA are: (1) MW antennas radiate electromagnetic waves in the surrounding 
medium [127]; (2) wave propagation in conductive medium allows for deeper 
heating [128]; (3) unlike RFA, a return/dispersive electrode on patient skin is not 
required [126]; and (4) MWA does not require tissue contact for energy delivery 
and ablation [126]. In regards to the propagation of MWs in biological medium 
and their ability to cause hyperthermia injury, the important factors for 
consideration are listed below: 
1. Target Selection: In general, this would be similar to what was described 
in the RFA section. 
2. Operating Frequency: MW penetration and rate of hyperthermia in tissue 
are highly dependent on operating MWA frequency. Typically, lower 
frequency waves provide a deeper field penetration inducing deeper 
heating, as observed with 915 MHz waves compared to 2.45 GHz [129]. 
Lower frequencies (915 MHz) have been utilized to achieve deeper 
ablations, for example of hepatic tumors [130]. On the other hand, higher 
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frequencies (2.45 GHz) have been utilized to induce shallow ablations, for 
example of endometrial lining of the uterus [74, 131]. 
3. Therapy Duration: Longer ablation duration results in a larger lesion size 
[132]. For example, for a linear antenna, a prolonged energy application 
will result in significantly larger width and depth of lesion as compared to 
the length of lesion. 
4. Antenna Size: The lesion created by MWA is highly dependent on the 
antenna size which includes its geometry, shape, and dimensions. 
Typically a large sized antenna will result in a larger lesion. The shape of 
the antenna governs the energy density of the generated electromagnetic 
field around the antenna which, in turn, governs the resultant shape and 
size of the lesion. 
5. Tissue Composition: The propagation of MWs in biological tissue is 
regulated by tissue composition and dielectric permittivity. Biological 
tissues not only differ in water content [133], but also in their respective 
conductivities and dielectric constants as a function of frequency [134, 
135]. These differences are significant in affecting MWs as they propagate 
within the body. As the MW field propagates in the tissue medium, energy 
is extracted from the MW field and absorbed in the tissue medium (i.e., 
converted into heat). This absorption of the MW field results in progressive 
reduction in MW power and intensity along its propagation path. Tissues 
with high water content extract the MW energy more efficiently by 
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stimulating oscillations of water-dipoles and converting the 
electromagnetic energy into kinetic energy (heat). Hence, MWs propagate 
through low-water content tissue relatively easily to deliver energy to 
deeper seated tissues. 
6. Catheter Temperature: Higher catheter temperatures generally result in 
larger lesion size for catheters that are not cooled at the MW antenna. 
However, as the MW antenna need not be in electrical contact with the 
tissue, application of MW energy is often combined with simultaneous 
cooling of the antenna that results in an even larger lesion size with cooler 
catheter temperatures [136]. Antenna cooling may allow creation of a 
lesion at a distance from the MW antenna while preventing thermal injury 
to the tissue in close proximity to the catheter [137]. For example, in one 
application, nerves adjacent an artery may be ablated by a cooled MW 
antenna catheter placed within the artery, without thermal injury or 
collateral damage to the artery itself. 
7. Blood Perfusion: Areas having low circulatory blood perfusion result in 
larger MW lesion formation due to reduced convective cooling effects. 
 
Chemical Ablation 
 
Chemical ablation is a non-surgical technique that uses homogeneous or 
heterogeneous chemical agents at lethal concentrations that are directly injected 
into the target lesion site. CHA works by denaturing proteins, creating focal tissue 
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damage and tissue lesion, ultimately leading to tissue necrosis in the location of 
injection [138]. 
 
Biophysics of Chemical Ablation and Resultant Tissue Injury 
 
The structural organization of proteins determines their biological function. 
Disruption of protein structure often results in loss of cellular function. Loss of 
protein structure from denaturation may be temporary or permanent, and varies 
depending on the mode of interaction of the denaturing/ablative agent with the 
active protein. It should be noted that the use of many other chemical agents 
have been described in the literature, for example, silver nitrate-dextran paste 
[139], benzalkonium chloride [140], and doxorubicin [141], to name a few. 
However, this review will not cover all such agents, but will focus on only four. 
Listed below are biological interactions of four chemicals that have been used as 
ablative agents: acetic acid, ethanol, hypertonic sodium chloride, and urea. The 
resultant lesion size as a result of chemical ablation depends on the factors listed 
below: 
1. Target Selection: In general, this would be similar to what was described 
in the RFA section with an understanding of injecting chemical agents in 
target locations. 
2. Agent Concentration: The concentration of a given ablative agent must 
be selected based on the target site and extent of desired lesion. As 
concentration of the agent increases, so does the resulting lesion size, the 
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scale of induced injury, and lethal damage. Higher concentrations 
minimize the volume required for chemical ablation [138]. 
3. Agent Volume: This factor is selected based on the target location and 
surrounding blood flow. Therefore, a precise control over administered 
volume is needed to localize the agent at the target location, thus 
preventing or minimizing collateral damage and systemic toxicity. Often, a 
fraction (10% to 50%) of the target volume is selected as total dose during 
any one session. However, if a larger volume is needed, the dose is often 
divided and administered in multiple sessions [142]. Doing so ensures 
localization of agent in the target lesion volume, thus minimizing collateral 
damage and maximizing therapy efficacy. 
4. Blood Flow: An increased blood flow at the target site not only washes 
out the agent from the administered location, but also dilutes the agent's 
concentration at an enhanced rate, thus minimizing lesion size and tissue 
necrosis. 
5. Rate of Administration: An increase in the rate of administration of an 
ablative agent will typically result in a larger volume of agent, hence 
increased lesion size. 
6. Type of Agent: To date, each of the commonly utilized ablative agents 
have a specific toxicological profile and a therapeutic index that makes 
them unique in terms of interactions with the target tissue and underlying 
cellular components. In general, every chemical agent has unique 
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therapeutic properties that can be used to not only to select the 
appropriate agent for administration, but also to tailor the ablation therapy 
for specific use. 
 
Urea 
 
Urea is an endogenous agent capable of being filtered by the kidneys, and 
is believed to have a high therapeutic index. Urea solution is known to denature 
proteins through a combination of processes. One process involves direct 
interaction with the proteins whereby urea forms hydrogen bonds with hydrogen 
atoms linked to oxygen or nitrogen, such as those found on peptide groups. This 
mutual influence weakens the intermolecular bonds and interactions that stabilize 
the structural organization of the protein, thus weakening its overall secondary 
and tertiary structure. This results in gradual unfolding of the protein, permitting 
water and urea to access the hydrophobic inner core of the protein, thus 
speeding up the overall denaturation process. The other indirect process by 
which urea denatures proteins is by affecting the attributes of the solvent in which 
the proteins are immersed. By changing the structure and hydrodynamics of the 
solvent, similar to putting a non-polar solute into the mix, urea further encourages 
the destabilization of internal bonds. In other words, it appears that the direct 
interaction of urea with proteins through hydrogen bonding is the likely beginning 
of protein unraveling, which is assisted by the indirect solvent and solute 
interactions that result in protein denaturation and thereby chemical ablation. 
  32 
Ethanol 
 
Ethanol at elevated concentrations has toxic effects at the cellular level. It 
diffuses into cells, producing rapid dehydration, membrane lysis, and protein 
denaturation, which in turn is followed by fibrosis, microvascular 
occlusion/thrombosis, and subsequent regional ischemia [138, 143]. The 
combination of these factors leads to an overall coagulation necrosis. Further, 
ethanol can disrupt the intra-molecular hydrogen bonding by forming new 
hydrogen bonds between the protein chain and the alcohol molecule, thus 
destroying the three-dimensional structure of the protein, denaturing it, hence 
resulting in tissue ablation. 
 
Acetic Acid 
Acetic acid has been shown to have a strong ability to penetrate cells and 
dissolve lipids, collagen, and proteins [144]. The lethal effect increases with 
concentration, however, and the use of concentrations of approximately 50% 
have been reported [145, 146].  Even at these concentrations, the effects of 
acetic acid are much greater than similar volumes of ethanol, urea, or sodium 
chloride. Importantly, tissue injections of acetic acid result in low focal pH in 
surrounding areas that induces swelling of collagen fibers. This process 
facilitates dissociation of intermolecular cross-links leading to protein 
denaturation and deamidation [147]. The effects of acetic acid on protein 
structure could be the consequence of one or all three repercussions arising from 
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the addition of the acid. First, the addition of an acid to a medium would likely 
result in an increase in the concentration of hydrogen ions which could then 
protonate the carboxyl and amino groups, as well as other ionizable groups in the 
side chains of the constituent amino acids. This would alter the interactions and 
affect the overall conformations of proteins. Second, as the pH of the 
environment decreases, most proteins (which at physiological pH are above their 
isoelectric points and have a net negative charge) will approach their isoelectric 
pH and tend to get precipitated, since charge repulsion will be minimal or zero. 
Below the isoelectric point, the affected proteins will likely contain more positive 
charges, which may cause them to repel each other, and the intra-molecular 
repulsion may be great enough to cause permanent unfolding of these 
molecules. Third, the presence of the ionized carboxyl group of acetic acid could 
compete with the acidic functional groups of a given protein for its positively 
charged side-chain moieties. This would disrupt existing salt bridges that hold the 
structure of the protein in its biologically active form. Hence, a combination of 
these mechanisms would result in protein denaturation resulting in chemical 
ablation. 
 
Sodium Chloride 
Hypertonic saline creates a marked osmotic imbalance across the cell 
membrane that can then result in intracellular dehydration and eventual cell 
death [138]. It is observed that an increase in salinity does not affect the pH as 
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much as it denatures proteins, because the ions from the salt bind to ionic "R" 
side-chain groups. The positive and negative ions in the salt exhibit a 
replacement reaction with similarly charged groups, thus interfering with dipolar 
interactions, and in turn disrupt the ionic salt bridges that stabilize tertiary and 
quaternary protein structures. An increase in focal salt concentrations also alters 
the protein-solvent interactions and changes the dielectric constant, providing a 
destabilizing influence on the structure of the protein resulting in chemical 
ablation. 
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Conclusion 
 
The ablative modalities discussed in this review are currently in use 
worldwide. The tissue response to any given ablation modality is unique. A better 
understanding of the biophysics of ablation allows one to gain insights into the 
mechanisms of action and predictive tissue injury both at the cellular and 
subcellular level that will result from utilization of these ablative techniques. Each 
therapeutic approach, although similar in purpose, has specific and optimal 
indications. The information presented in this review can help inform the clinician 
when faced with practical technical options. Importantly, in those cases where 
patients are unable to undergo invasive surgical procedures due to advanced 
tumor state, severity of organ dysfunction, and/or poor clinical status, less 
invasive techniques such as percutaneous ablation techniques have been 
employed for treatment and management of various disease states. Such 
therapies being non- or minimally invasive are a genuine clinical need that has 
promoted the continued development and refinement of current procedures and 
techniques, and has also fueled innovations in the field of medical device design. 
In the future, introduction of advanced ablative techniques will hopefully lead to 
curative treatments with high safety and efficacy. 
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2. The Comparative Assessment of Clinically Applied 
Ablative Therapies: Part I. Methodologies for 
determining the physiological and biomechanical 
properties of contractile tissues in response to varied 
therapeutic dosages 
 
 
 
Preface 
 
This paper discusses the detailed methodologies that were developed to 
assess the physiological and biomechanical properties of tissues in response to 
ablations.  This paper was submitted to the International Journal of Hyperthermia 
in July 2014 and is currently under review. 
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Executive Summary 
 
Purpose: Although tissue ablation is a routine clinical procedure, it may cause 
collateral damage to surrounding vital structures in a small percentage of 
patients, which can have severe clinical implications. As such, the collateral 
damage results in altered tissue properties that are, in turn, dependent on the 
extent of tissue injury. Therefore, assessment of tissue properties is fundamental 
to advancing the understanding of underlying basic and clinical science of 
ablation, especially to maximize therapy efficacy and minimize procedural 
complications. There is a need to develop laboratory methodologies that can be 
reliably used to assess the physiological and biomechanical properties of tissues 
following exposure to various ablative modalities. 
 
Materials and Methods: Unique experimental methodologies were developed to 
comparatively assess changes in tissue properties in response to five different 
therapeutic ablation modalities: (1) radiofrequency ablation, (2) cryoablation, (3) 
microwave ablation, (4) high-intensity focused ultrasound ablation, and (5) 
chemical ablation (using acetic acid, ethanol, hypertonic sodium chloride, and 
urea). In particular, physiological assessment included measurement of change 
in peak force (strength of contractions) as well as baseline force (resting muscle 
tension); and biomechanical assessment included measurement of uniaxial 
stress-strain characteristics of tissue samples in response to ablation. Tissue 
bath studies were performed to measure physiological responses relative to 
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applied therapies, and uniaxial stress tests were performed to assess resultant 
biomechanical responses. 
 
Conclusion: Results from these studies may enable comparative assessment of 
ablation modalities, and also allow further improvements in ablative techniques to 
increase the overall safety and efficacy of ablative procedures. 
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Introduction 
 
 Reports of the therapeutic use of ablation in the field of medicine date back 
to as early as the late eighteenth century [1]. Today, ablations are commonly 
performed worldwide, in numerous anatomical locations throughout the human 
body as a means to treat a plethora of disorders. Specifically, tissue ablation is 
defined as a medical procedure which involves the skillful, focused destruction of 
the target tissue so as to restore normal structure and function. However, in a 
small percentage of cases, it can cause collateral damage of surrounding vital 
organs which can have severe clinical implications. 
 In one clinical example, complications resulting from ablations in the liver for 
treatment of hepatocellular carcinoma (HCC) include: (1) collateral damage to 
the respiratory diaphragm [2]; (2) hemoperitoneum, intraperitoneal hemorrhage, 
hepatic infarction, hepatic perforation, diaphragmatic necrosis, visceral organ 
perforation and gastric perforation [3-5]; (3) pneumothorax [6]; (4) pleural effusion 
[7]; and/or (5) cardiac tamponade [8]. In an effort to improve on therapies, 
numerous ablative modalities have been used for the treatment of HCC, some of 
which include: radiofrequency ablation (RFA), microwave ablation (MWA), 
cryoablation (CRA), chemical ablation (CHA) using percutaneous ethanol 
injection, high-intensity focused ultrasound ablation (HIFU), transarterial 
chemoembolization, radioembolization, radiation therapy, stereotactic 
radiotherapy, systemic chemotherapy, irreversible electroporation, and 
molecularly targeted therapies [9-10]. Ultimately, the management of HCC is 
  42 
based on tumor size, number, location, stage, extra-hepatic spread, clinical 
status of the patient, and underlying liver function. 
 Similarly, injuries to the phrenic nerve, chest wall, and diaphragm have 
been reported as a result of ablations in the lung for treatment of lung cancer [11-
13]. Numerous ablation modalities have been used for treatment of lung cancer, 
including: RFA, CRA, MWA, CHA, and HIFU [14]. 
 In an additional example, in the heart, ablations are routinely performed in 
the left and right atria to isolate the pulmonary veins for treatment and 
management of atrial fibrillation (AF)[15, 16]. These ablative procedures are 
associated with high risk of esophageal thermal injury because of the close 
proximity of the esophagus to the left atrial posterior wall that renders it 
susceptible to unintended collateral damage. Esophageal injury can range from 
superficial ulceration and gastroparesis, to the rare but catastrophic 
atrioesophageal (AE) fistula [17]. AE fistulas are a known complication resulting 
in collateral damage from ablative procedures performed in the left atrium with 
variable incidences as high as 1%, and a high rate of mortality [18]. Additionally, 
AE fistulas have been shown to result from application of many different forms of 
ablative energies that include: (1) RFA [19-20]; (2) CRA [21-22]; and (3) HIFU 
ablation [23]. Ablations are also performed in the cardiac chambers (atria or 
ventricles) for management and treatment of arrhythmogenic substrates such as 
supraventricular tachycardia, idiopathic ventricular tachycardia, and ventricular 
ectopic beats [24-27] that could be associated with collateral injury of 
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surrounding structures. 
 Ablative procedures performed for pulmonary vein isolation are also 
associated with a significant incidence of phrenic nerve injury (PNI)[28-30]. The 
close proximity of the phrenic nerves to the pulmonary veins makes them 
susceptible to injury from ablative energies. Since the phrenic nerves supply 
motor and sensory information to the diaphragm, PNI can cause significant 
diaphragmatic dysfunction and paralysis [31-33]. 
 In view of the complications discussed above, in our laboratory we have 
been able to study isolated contractile samples of the respiratory diaphragm, 
esophagus, and cardiac trabeculae for both physiological and biomechanical 
assessment. We hope to provide comparative assessment of ablation modalities 
that can eventually be used to better understand ablation procedures and 
develop insights into minimizing these complications. The ablation modalities 
investigated in these studies include: RFA, CRA, MWA, HIFU ablation, and CHA. 
In this paper, we provide detailed methodologies that can be utilized for unique 
reproducible comparative assessment of these tissue properties. 
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Materials and Methods 
 
Tissue Preparation 
 These studies were approved by the University of Minnesota Institutional 
Animal Care and Use Committee. Fresh tissue biopsies were obtained from 
healthy castrated male Yorkshire-cross swine (n=85, mean weight of 
approximately 70 kg) which were euthanized as part of another unrelated 
protocol. Whenever possible, fresh human tissue biopsies (n=24) were obtained 
through research collaboration with LifeSource (St. Paul, MN, USA). 
Experimental samples included respiratory diaphragm, esophagus, and cardiac 
trabeculae, with multiple individually prepared samples used from each biopsy. In 
these investigations, these three tissues were used since they are susceptible to 
collateral damage from clinical ablation procedures of interest in our laboratory. 
However, it should be noted that any contractile tissue can be used utilizing 
these unique methodologies.  
 Following resection, each biopsy was pinned in a dissection dish and 
dissected in oxygenated, temperature-controlled normal or modified cardiac 
muscle Krebs-Ringer solution. The normal Krebs-Ringer solution contained (mM) 
118.1 NaCl, 3.4 KCl, 1.2 KH2PO4, 1.0 MgSO4.7H2O, 11.0 D-Glucose C6H12O6, 
25.0 NaHCO3, and 2.5 CaCl2.2H2O (pH = 7.4, 37 °C); and the modified cardiac 
Krebs-Ringer solution contained (mM) 118.0 NaCl, 16.0 D-Mannitol, 11.5 D-
Glucose, C6H12O6, 20.0 NaHCO3, 0.32 2Na-EDTA.2H2O, 4.5 KCl, 1.46 
MgCl2.6H2O, 1.2 NaH2PO4.H2O, 1.81 CaCl2.2H2O, and 10U/L Insulin (pH = 7.4, 
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37 °C). The muscle bundle preparation involved cleaning up the biopsy by 
removing excess fat and surrounding connective tissue so that well defined 
muscle bundles could be prepared. The diaphragm and trabeculae muscle 
bundles were dissected in an identifiable cylindrical shape having lengths of 15 to 
25 mm and diameters of 2 to 4 mm. In the case of esophageal tissue, the 
esophagus is composed of many cellular layers. As one traverses from inside to 
outside the esophagus, those layers are: (1) mucosa (composed of stratified 
squamous non-keratinized epithelium, lamina propria, and muscularis mucosa), 
(2) submucosa (composed of mucus glands, ducts lined with stratified cuboidal 
epithelium), and (3) muscularis externa (composed of inner layer of circular 
muscle cells and outer layer of longitudinal muscle cells). In preparing 
esophageal muscle bundles, the external muscularis and internal squamous 
epithelium layers were first separated, and then muscle bundles of the 
muscularis layer were prepared along the circular layer of muscle fibers in an 
identifiable cuboidal shape having lengths of 15 to 25 mm, widths of 3 to 5 mm, 
and thickness of 1.5 to 3 mm. The dissected muscle bundles were then tied on 
both ends with 2-0 silk sutures with a free loop on either end so that they could 
be mounted in either the tissue baths for physiological studies or on the uniaxial 
pull machine for biomechanical studies. In all cases, control muscle bundles were 
prepared for physiological testing, biomechanical testing, and control 
experiments where no ablations were performed. 
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Physiological Testing in Tissue Baths 
 The tissue bath system used in these investigations (Figure 4) is an 
adaptation of one that was previously described [34, 35]. Tissue bath studies 
were performed to investigate changes in physiological properties of tissues in 
response to different ablative modalities. Muscle bundles were mounted in 16 
parallel, 50 ml tissue baths containing Krebs–Ringer buffer at 37°C and gassed 
with 95% O2 and 5% CO2 to maintain tissue viability. Each tissue bath was water 
jacketed and connected to a heater pump (Haake Model DC1, Germany) that 
maintained a temperature of 37°C throughout the duration of the experiment. The 
lower end of the muscle bundle was secured to a fixed hook, and the upper end 
was attached to a force transducer (Model FT03 with peak capacity of 50 grams, 
Natus Neurology, Warwick, RI, USA). The acquired data was amplified, digitized 
(data acquisition card: PCI-MIO-16E-4, National Instruments, Austin, TX, USA), 
and saved on a computer using custom built data acquisition software (LabView, 
Ver 6.1, Austin, TX, USA). Each force transducer was calibrated at 0 gram 
weight, by hanging a 10 gram weight prior to each study. 
 On any given study day, physiological data from the same tissue type were 
collected from all 16 tissue baths simultaneously. Following mounting, the muscle 
bundles were allowed to acclimate for approximately one hour, during which time 
the stimulation voltage and length-tension relationship were determined and 
optimized for each muscle bundle before starting an ablation study protocol [35]. 
The muscle bundle length resulting in maximal peak force (twitch force) was 
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used for the remainder of the study. The muscle bundle samples were randomly 
assigned to the ablation group or the control group. Each muscle bundle was 
tested just once for any given treatment. Peak forces (strength of contractions) 
as well as baseline forces (resting muscle tensions) were measured pre- and 
post-ablation for every muscle bundle. Following a given ablative treatment, 
tissues were allowed to recover for a period of at least 3 hours, to assess tissue 
damage (necrosis) and recovery as a result of exposure to different ablative 
modalities of varying doses. 
 
Stimulation Protocol 
 The muscle bundles in each tissue bath were electrically stimulated by field 
stimulation simultaneously with a pair of bilateral platinum electrodes (length: 
50.0 mm, width: 10.0 mm, thickness: 0.3 mm) immersed within the tissue bath, 
positioned near to but not touching the muscle bundle sample (Figure 4). The 
diaphragm and trabeculae muscle bundles were stimulated once every 10 
seconds with a square-wave pulse width of 1.0 ms, whereas the esophageal 
muscle bundles were stimulated once every 30 seconds with a train of 8 square-
wave pulses of 1.0 ms duration and a pulse interval of 30 ms. The electrical field 
stimulation elicited an electro-mechanical twitch response that was digitally 
recorded using a force transducer at a sampling rate of 250 Hz. If reproducible 
mechanical twitches could not be elicited with stimulation, or the peak force was 
<1 gram, the muscle bundle was discarded. 
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Calculation of Percent Change in Peak Force and Baseline Force 
 Although peak force and baseline force data were acquired continuously for 
the entire duration of the experiment, data were analyzed at 14 unique time 
points: pre-ablation (2 minutes of data averaged just before ablation), post-
ablation (2 minutes of data averaged right after ablation), and 12 additional time 
points at 15-minute intervals post-ablation (2 minute data averaged) for a period 
of 3 hours. Data were used to calculate the percent change in peak force and 
baseline force for all muscle bundles using the following formulas (at any given 
time t): 
 
% Change in Peak Force = [ (PFt – PFpre-ablation) / (PFpre-ablation) ]  100% 
% Change in Baseline Force = [ (BFt – BFpre-ablation) / (BFpre-ablation) ]  100% 
 
 All tissue bath data was analyzed as percent change in peak force and 
baseline force with respect to the pre-ablation time point; thus, every graph has 
13 bars within each ablation dose, where the leftmost bar represents the percent 
change right after ablation and every subsequent bar represents percent change 
at 15-minute intervals. Data were analyzed by grouping all the samples exposed 
to the same ablation dose, and performing statistical analyses by calculating the 
mean and standard deviation of the percent change in peak force and baseline 
force for every ablation modality. 
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Ablative Modalities Investigated 
 In general, ablation modalities can be divided into two categories, thermal 
and chemical ablation. Thermal ablation modalities employed were RFA, CRA, 
MWA, and HIFU ablation. Four CHA agents were employed, which included: 
97% glacial acetic acid, 200 proof ethanol, 30% hypertonic sodium chloride 
solution, and 8 M urea. Clinically available RFA and CRA systems along with 
respective catheters manufactured by Medtronic Inc. were used as thermal 
ablative modalities. A custom-designed HIFU system operating at 2.5 MHz with 
80% duty cycle was used as the ultrasonic ablative system. A custom-built MWA 
system operating at 1.3 GHz was used to perform MWA. For performing CHA, 
chemical agents were directly injected into a given muscle bundle. 
 
Cryoablation 
 CRA equipment from CryoCath (Medtronic Inc., Minneapolis, MN, USA) 
was used to perform CRA. This system uses a refrigerant (liquefied nitrous oxide, 
N2O) to remove heat from a specific area in the tissue to freeze the tissue at 
temperatures close to -75°C and destroy it. The Freezor MAX CRA catheter (tip 
length: 8 mm, catheter diameter: 9 Fr) was used for these studies. A 
thermocouple integrated into the tip of the catheter allowed real-time temperature 
monitoring during the ablation procedure. The CRA system was operated in the 
clinical mode, and dose effects were typically studied by selecting up to 4 
different durations of exposure (15 sec, 30 sec, 60 sec, and 120 sec). A special 
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acrylic fixture was built to mount the CRA catheter to the uniaxial machine’s force 
transducer, to apply a constant force of 0.1 N (10 grams) on the muscle bundle. 
Thus, all CRAs were performed under constant catheter force  as shown in 
Figure 5. 
 To perform CRA, the muscle bundle was unmounted from the tissue bath, 
pinned in the ablation dish, and stretched to the same length as in the tissue bath 
(same baseline force). CRA was performed near the center of the muscle bundle. 
Following completion of ablation, the thaw time for ice-ball melt was measured. 
The total time the muscle bundle was in the ablation dish was typically <3 min. 
The muscle bundle was then removed from the ablation dish, mounted back on 
the tissue bath, and data were collected for a period of at least 3 hours to study 
recovery and post-ablation effects on muscle physiology. 
 
RF Ablation 
 A RF Atakr II system (Medtronic Inc.) was used to perform RFA. This 
system generates a sinusoidal waveform at a frequency of 484 KHz with a 
maximum power output of 100 W. At such high frequencies, there was no tissue 
capture or unintended stimulation; instead the energy was dissipated as heat in 
the tissue. A RF Contactr catheter (electrode length: 8mm, catheter diameter: 7 
Fr) was used for these studies. The Atakr II RF generator provides high power 
output with the integral safety of closed-loop temperature control using the 
embedded thermocouple in the ablation catheter. All ablations were performed in 
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temperature mode in which the system adjusted the power applied to achieve the 
user-set temperature and maintained it for the duration of ablation. The system 
power was set at 50 W, ablation duration at 60 seconds, and typically up to 5 
different doses were investigated by altering the set-point temperature from 50°C 
to 70°C in steps of 5°C. A laptop computer connected to the Atakr II RF 
generator via the serial communication port enabled digital recording of ablation 
parameters during RFA. For each sample, average and maximum power, 
temperature, voltage, current, and impedance were recorded. A special acrylic 
fixture was built to mount the RFA catheter to the uniaxial machine’s force 
transducer to apply a constant force of 0.1 N (10 grams) on the muscle bundle. 
Thus, all RFAs were performed under constant catheter force as shown in Figure 
6. 
 To perform RFA, the muscle bundle was unmounted from the tissue bath, 
pinned in the ablation dish, and stretched to the same length as in tissue bath 
(same baseline force). RFA was performed near the center of the muscle bundle. 
The total time the muscle bundle was in the ablation dish was typically <2 min. 
Following ablation, the muscle bundle was removed from the ablation dish, 
mounted back on the tissue bath, and data were collected for a period of at least 
3 hours. 
 
HIFU Ablation 
 The HIFU ablation system was custom built in the lab as shown in Figure 7. 
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The HIFU transducer was a high-efficiency, broad bandwidth single element 
transducer (Model: H-108, Sonic Concepts, Bothell, WA, USA) that was excited 
with a 2.5 MHz sinusoidal waveform. The signal was amplified and focused 
ultrasound wave acoustic energy was used to perform ablations. The transducer 
was completely immersed (for acoustic coupling) in an ablation chamber that 
contained approximately 4 liters of temperature-controlled oxygenated Krebs-
Ringer buffer. A given muscle bundle was placed in front of the transducer’s focal 
point for HIFU ablations. After gaining experience from pilot studies, system 
settings were set at 80% duty cycle with system forward-power of 50-60 W and 
durations of 2-10 sec. Typically up to 6 different doses were investigated by 
adjusting the HIFU forward-power and ablation duration. 
 To perform HIFU ablations, the muscle bundle was unmounted from the 
tissue bath, stretched and pinned on a vertical rubber pad (acoustic material) to 
the same length as in the tissue bath (same baseline tension). A micro-positioner 
and transducer-focusing aid were used to position the muscle bundle at the focal 
point of the acoustic energy delivered by the HIFU transducer. HIFU ablation was 
performed near the center of the muscle bundle as shown in Figure 8. The total 
time the muscle bundle was in the ablation chamber was typically <1 min. 
Following ablation, the muscle bundle was removed from the ablation chamber, 
mounted back on the tissue bath, and data were collected for a period of at least 
3 hours. 
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Microwave Ablation 
 The MWA system was custom built in the lab as shown in Figure 9. The 
MWA generator (Prostatron, 100 W maximum power) produced microwaves at 
1.3 GHz which were used for ablations. A stub-tuner was placed between the 
MWA generator and microwave antenna to ensure impedance matching for 
optimizing microwave energy delivery. Dose effects were studied by selecting the 
microwave incident power between 10 and 20 W, and exposure duration 
between 60 and 240 sec. Typically up to 6 different doses were investigated by 
adjusting the microwave incident power and ablation duration. During the 
ablation, incident power and reflected power were recorded, and average power 
was used to calculate the MWA energy. A special acrylic fixture was built to 
mount the MWA antenna to the uniaxial machine’s force transducer to apply a 
constant force of 0.1 N (10 grams) on the muscle bundle. Thus, all MWA were 
performed under constant catheter force (Figure 10). 
 To perform MWA, muscle bundle was unmounted from the tissue bath, 
pinned in the ablation dish, and stretched to the same length as in the tissue bath 
(same baseline force). A thin sheet of plastic film was placed between the 
microwave antenna and the tissue to ensure ablation from electric field dielectric 
heating, and not from electrical conduction between the tissue and conductive 
Krebs-Ringer solution. MWA was performed near the center of the muscle 
bundle. The total time the muscle bundle was in the ablation dish was typically <5 
min. Following completion of ablation, the muscle bundle was removed from the 
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ablation dish, mounted back on the tissue bath, then data were collected for a 
period of at least 3 hours. 
 
Chemical Ablation 
 Four different chemical ablative agents were employed in these 
investigations. The chemical agents included: 97% glacial acetic acid (Item 
320099-500ml, molecular formula: C2H4O2, molecular weight: 60.05 gms/mol, 
Sigma-Aldrich, St. Louis, MO, USA); 200 proof ethanol (Item 2716, molecular 
formula: C2H5OH, molecular weight: 46.07 gms/mol, Decon Labs, PA, USA); 
30% hypertonic sodium chloride (Item 7581-06, molecular formula: NaCl, 
molecular weight: 58.44 gms/mol, Macron Fine Chemicals, PA, USA); and 8 M 
urea (Item U4883-6x25ml, molecular formula: CH4N2O, molecular weight: 60.06 
gms/mol, Sigma-Aldrich). A special syringe with an ultra-fine short needle and 
resolution of 5 µL was used for injections (Item 328438, 31 G x 5/16 in., 3/10 mL 
Lo-DoseTM Ultra-FineTM short needle with permanently attached needle, BD 
Syringes, NJ, USA). Typically up to 6 different agent volumes between 10 and 
100 µL were investigated depending on the desired dose and/or tissue type. 
 To perform chemical ablations, the tissue bath was lowered without altering 
the muscle bundle in any way, and the chemical ablative agent was injected near 
the center of the muscle bundle (Figure 11). Extreme care was exercised during 
injections, especially to localize the entire volume of the ablative agent within the 
muscle bundle (prevent agent from oozing out) to maximize ablation efficiency 
  55 
and repeatability. The rate of injection was approximately 5 µL per second, and 
all injections were typically completed within 30 seconds. Following completion of 
ablation, the tissue bath was raised and data were collected for a period of at 
least 3 hours. 
 
Control Samples 
 There were three sets of controls. The first set of controls included muscle 
bundles that were left in the tissue bath throughout the duration of the 
physiological testing protocol. The second set of controls was for the thermal 
ablation modalities. These muscle bundles were unmounted from the tissue bath 
and subjected to the same thermal ablation conditions, except that they were not 
ablated. The third set of controls was for the chemical ablation modalities. These 
muscle bundles were injected with Krebs-Ringer buffer solution instead of the 
chemical ablative agents. 
 
Biomechanical Characterization under Uniaxial Stress 
 The biomechanical properties of any tissue describe how that tissue will 
react to internal and/or external physical forces. Biomechanical properties can be 
determined through a series of standardized mechanical tests, one of which is 
the uniaxial stress test. After completion of the physiological testing protocol, the 
muscle bundles were subjected to avulsion (tearing apart) uniaxial stress tests 
for assessment of changes in biomechanical properties as a result of ablative 
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treatments. Since avulsion is a destructive test, biomechanical characterization 
was the last step done in the overall study protocol. Uniaxial pull tests (tensile 
strength measurements) were performed using a digital uniaxial force 
measurement system (Chatillon TCD 110 Series, Largo, FL, USA). This system 
was equipped with two force transducers (load cells), one that could measure a 
maximum force of 10 N (accuracy: 0.01 N, resolution: 0.001 N) and the other a 
maximum force of 100 N (accuracy: 0.1 N, resolution: 0.01 N). Therefore, it was 
essential to choose the right force transducer for each tissue type, as exceeding 
the maximum transducer rating could not only damage the transducer resulting in 
erroneous readings, but also limit the utilization of maximum dynamic range 
available for recordings. The pull protocol was designed after conducting an 
extensive literature search and gaining experience from many pilot studies on 
different tissue types.  
 Results from pilot studies were not only helpful in selection of the proper 
force transducer, but were also essential in developing the overall study protocol. 
Since the tissues under investigation exhibit the features of hysteresis, 
relaxation, and creep, they have been modeled as viscoelastic materials. The 
biomechanical properties of the tissues do not change as quickly as the 
physiological properties. Therefore, the criterion for tissue viability was relaxed so 
that tissues could be used after the completion of physiological testing. Tissue 
pull testing was performed at room temperature (22.5  2°C). The uniqueness of 
this protocol was that it allowed for a slow, controlled pull of samples until 
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avulsion occurred. However, it should be noted that there appeared to be an 
optimal rate of pull that was determined in preliminary experiments. After careful 
assessment, the pull protocol was selected to have a constant speed (rate of 
pull) of 10 mm per min (velocity: 0.167 mm/s, and strain rate of approximately 
8.3310-3 s-1) over the avulsion stretch distance. Sample alignment has been 
considered to be less of a concern with soft biological tissues than with harder 
materials, but the problems of firmly gripping the tissue on the test machine are 
much more severe. The gripping solution is often specific to the characteristics of 
the specimen, dimension, material, and the conditions of the test. More 
importantly, the gripping technique must be capable of securely holding soft 
tissue without causing damage to the tissue itself.  
 Taking these factors into consideration, a novel method of securing the 
tissue sample was devised that would not only minimize tissue slippage, but also 
prevent tissue damage. This was achieved by tying the sutures on either end of 
the muscle bundle and dissecting in a unique way so as to impart a dog-bone 
shape to the muscle bundle. This shape has been shown to be especially 
important while performing pull testing of any material that calls for firm grip on 
either end to prevent slippage [36]. In conjunction with the dog-bone shape, liquid 
super glue (Loctite Liquid, Henkel Corp., Rocky Hill, CT, USA) was applied on 
either end of the muscle bundle at the suture-tissue interface. This allowed for 
added support, enhanced grip, and increased bonding strength at an otherwise 
vulnerable location (tissue-suture interface) due to increased stress caused by a 
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reduction in cross-sectional area from tying suture knots. Care was taken to 
localize application of super glue only at the muscle bundle ends to strengthen 
the suture-tissue interface. 
 
Force-displacement Measurements 
 Once the super glue dried (<2 min), tissue samples were mounted on the 
uniaxial pull machine via custom-designed hooks of stainless steel material 
(made from needle of polypropylene sutures, Ethicon, Somerville, NJ, USA). The 
bottom suture loop was secured to the lower immobile hook mounted on the vice 
and the top suture loop was fixed to the uniaxial pull machine’s force transducer 
(Figure 12). During execution of pilot studies we observed that tissue fiber 
orientation strongly influenced the tensile strength measurements, so all tissue 
samples were stretched along the longitudinal axis of the sample until avulsion 
occurred. During execution, the system console displayed 3 quantities [load (N), 
stretch distance (mm), and speed (10 mm/min)]. The load and stretch were 
continuously acquired at a sampling rate of 100 Hz and saved to the hard drive 
for post-processing. Before starting the pull test, the initial tissue sample 
dimensions (length and diameter for cylindrical samples and length, width, and 
thickness for cuboidal samples) were recorded for each tissue sample to allow 
determination of elastic modulus for each sample. Three readings of diameter, or 
width and thickness, towards the top, middle, and bottom of the muscle bundle, 
and three readings of the length of each muscle bundle were obtained, and the 
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averages recorded in the data sheet. A force-displacement graph was generated 
and recorded for each sample. 
 
Determination of Avulsion Location 
 There are numerous factors to consider that determine where a given 
muscle bundle would avulse along its longitudinal axis. For example, the muscle 
bundle could avulse at or near the center, or at the sutures. Some of the factors 
that determine where the muscle bundle avulses include: (1) the quality of 
dissection; (2) strength of suture knots placed at the ends of the muscle bundle, 
suture material, and/or style of suture knots; (3) type and drying time of various 
super glue formulations; (4) type of ablation, location of ablation, and ablation 
dose; (5) tissue type, species, dimensions of tissue, tissue health, fiber 
orientation, and/or shape of tissue sample (dog-bone versus straight cylinder); 
(6) the applied uniaxial pull parameters including velocity of pull, rate of strain, 
preconditioning the tissue, tissue securing mechanism, relative degree of tissue 
damage following securing; and (7) skill level of the operator. 
 Although the goal was to have every tissue sample avulse in the center, this 
was not always the case due to the confounding factors discussed above. Thus, 
a systematic assessment was performed to determine the exact location of 
avulsion for each muscle bundle. A guideline was established to mark the 
avulsion location of each muscle bundle as shown in Figure 13. Five different 
locations were determined and a number assigned to every sample based on the 
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avulsion location as described in Table 2. 
 
Stress-Strain Characteristics 
 Stress-strain curves for each sample were calculated using the obtained 
force-displacement data. A representative example of a force-displacement 
graph of a muscle bundle with six biomechanical parameters that were calculated 
is shown in Figure 14. Nominal stress-strain characteristics were determined for 
all samples. The tissue samples were assumed to be incompressible so the 
volume of the samples was assumed to be conserved during the stretch. It was 
observed that the reduction in cross-sectional area was significant as the muscle 
bundle was stretched along its longitudinal axis. Assuming a constant volume 
model, the reduction in cross-sectional area was calculated, which was further 
used to calculate the “true stress-strain” relationship for each sample (Cauchy 
stress). The Cauchy stress relationship (load/deformed area) accounts for 
reduced cross-sectional area as the muscle bundle is stretched [37]. 
 A custom designed software program was used to calculate the elastic 
modulus of each sample and the statistics for the entire treatment group. As 
shown in Figure 15, the program allowed the placement of two free-form points 
(x1, y1, x2, and y2) on the linear region of the force-displacement graph. The 
elastic modulus of each sample was derived by calculating the slope of the initial 
linear region (before avulsion) using the following equation: 
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Elastic Modulus (EM) = Stress / Strain (N/m2) 
Stress = Force / Area = F / A (N/m2), where Area, A = r2 = d2/4 
Strain = Change in length / Original length = l / L 
Therefore, EM = (F/A) / (l/L) = (F/l) x (L/A) (N/m2) 
 The force data (F) and change in length (l) were obtained from the uniaxial 
pull machine. The original length (L) and cross-sectional area (A) were measured 
before the pull test started. Therefore, using these quantities, the elastic modulus 
for any given sample could be calculated, and data were further used to calculate 
the statistics of the entire treatment group. 
 
Muscle Bundle Mass 
 After completion of the uniaxial tests, the sutures on both ends of each of 
the muscle bundle were cut and discarded. The wet mass of each muscle bundle 
was measured using a weighing scale with a resolution of 10 mg. 
 
Statistical Analyses 
 Data analysis was performed using Excel (office 2010) and Matlab (Ver. 
R2012b). Data were presented as the mean  STD, and p<0.05 was considered 
statistically significant. Peak forces and baseline forces (at each ablation dose 
and at each time point), and biomechanical avulsion parameters (at each 
ablation dose) were analyzed using analysis of variance (ANOVA analysis). The 
Tukey test was used post-hoc to compare different levels of each fixed factor 
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(Minitab, ver.17) for every ablation modality investigated. A separate ANOVA 
model was created for each ablation modality and for both peak force and 
baseline force. The variables entered into the ANOVA model for thermal ablation 
modalities were sample, time, and dose, where sample was treated as a random 
factor. The variables entered into the ANOVA model for the chemical ablation 
modality were sample, time, dose, and agent (chemical agent or Krebs), where 
sample was treated as a random factor. 
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Discussion 
 
 We have developed experimental methodologies that can be reliably used 
to assess the physiological and biomechanical properties of a wide range of 
contractile tissues following exposure to various ablation modalities. To our 
knowledge, similar studies performed in a methodological comparative style have 
not been reported to date in the literature. Importantly, we propose that the 
understanding of tissue properties has wide applications ranging from applied 
research to the development of novel tools, ablation techniques, and/or novel 
clinical treatment options. Furthermore, results from such investigations may 
enable comparative assessment of ablation modalities as a means to better 
determine their effects on various tissues post-ablation, including healthy or 
disease specimens. The stress-strain relationships evaluated in our described 
investigation can not only be used to measure native intra- and inter-tissue 
variability in mechanical behavior, but they also provide critical insights in the 
therapeutic mechanisms by which ablations effect the mechanical behavior of 
affected tissues. In other words, the critical assessment and interpretation of 
obtained experimental results can be further used to reduce complication rates, 
understand mechanisms of disease recurrence, and increase overall 
effectiveness and efficacy of ablative procedures. Moreover, increasing 
knowledge in this area is fueling the demand to introduce new procedures, 
modify current ones, and reduce procedural times, all of which positively impact 
development of novel treatments. 
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 It is important to note that our experimental approach not only allows one to 
determine the relative viability of a given sample before and after a chosen 
ablative therapy, but it also provides knowledge as to the viability of the sample 
relative to assessment of its biomechanical characteristics. We were also able to 
apply these methodologies to a variety of contractile tissue types from both swine 
and human samples, hence allowing for translational insights. Furthermore, not 
all obtained human samples are healthy specimens, thus allowing one to gain 
insights into physiological and biomechanical changes of a given tissue type 
relative to different disease states. It is important to note that our described 
methodologies are mature and highly reproducible. This has been possible after 
executing many pilot trials and a given degree of skill in sample preparation.  
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Conclusion 
 
 In summary, we describe here a novel experimental approach that may 
allow for important comparative understanding of both physiological and 
biomechanical tissue properties associated with the current applications of 
ablative therapies. These methodologies were developed with the important 
perspective that they could be utilized in a realistic framework for developing 
bench top testing of device-tissue interactions that can aid in novel medical 
device design. 
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Figure 4: Tissue bath system setup for performing physiological studies 
A) Data from sixteen muscle bundles (4 shown) were acquired simultaneously. 
B) One tissue bath showing the muscle bundle. 
 
 
Figure 5: Muscle bundle undergoing cryoablation near its center in the 
ablation dish with the catheter imparting 0.1 N (10 grams) of force 
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Figure 6: Muscle bundle undergoing RF ablation near its center in the 
ablation dish with catheter imparting 0.1 N (10 grams) force 
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Figure 7: Custom designed HIFU ablation setup 
A) Custom designed system setup for performing high-intensity focused 
ultrasound (HIFU) ablations. The function generator generated a sinusoidal 
waveform of 2.5 MHz frequency with 80% duty cycle that was fed to the RF 
amplifier for amplification. The amplified signal was routed to the RF bird power 
meter which indicated the forward HIFU power. The signal was further routed to 
the matching circuit and finally to the acoustic HIFU transducer. The HIFU 
transducer was completely immersed in the HIFU ablation tank containing 
temperature-controlled oxygenated Krebs-Ringer solution. B) Illustration of HIFU 
transducer along with its focusing aid. The stem of the focusing aid was 
calibrated for the HIFU transducer, such that it allowed the transducer to be 
positioned exactly in front of the muscle bundle being ablated, so that acoustic 
energy could be focused at the center of the muscle bundle. C) Illustration of a 
muscle bundle sample mounted on a rubber pad acoustic material, and 
positioned at the focal point of the HIFU transducer undergoing HIFU ablation. 
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Figure 8: Muscle bundle undergoing HIFU ablation 
Muscle bundle in the high-intensity focused ultrasound (HIFU) ablation chamber 
pinned on a rubber pad and positioned at the focal spot of the HIFU transducer 
undergoing HIFU ablation near the center of the muscle bundle. 
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Figure 9: Custom designed microwave ablation setup 
Custom designed system setup for performing microwave ablations (MWA). The 
MW generator generated a sinusoidal waveform of 1.3 GHz frequency that was 
fed to the stub tuner via a coaxial cable. The rungs on the stub tuner were 
calibrated to achieve optimum impedance match at 1.3 GHz ablation frequency. 
The signal was ultimately routed to the MW antenna for performing MWAs. 
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Figure 10: Muscle bundle undergoing microwave ablation 
Muscle bundle undergoing microwave ablation near its center in the ablation dish 
with microwave antenna imparting 0.1 N (10 grams) force. A thin sheet of plastic 
film was placed between the microwave antenna and the muscle bundle to 
ensure ablation from electric field dielectric heating, and not from electrical 
conduction between the tissue and conductive Krebs-Ringer solution. 
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Figure 11: Muscle bundle undergoing chemical ablation 
Illustration of injection of a chemical ablation agent near the center of a muscle 
bundle. The muscle bundle is mounted on the tissue bath apparatus 
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Figure 12: Uniaxial force measurement system 
Uniaxial force measurement system for performing uniaxial biomechanical testing 
of various tissues. C: system console to control the operation of uniaxial system; 
T: muscle bundle undergoing tensile strength test; F: force transducer (load cell) 
connected to the movable arm of the uniaxial machine; UH and LH: custom 
designed upper and lower tissue holder hooks, respectively. The upper hook is 
connected to the force transducer and lower hook is held firmly to the vice as the 
muscle sample is pulled to measure tensile strength. 
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Figure 13: Illustration showing representative examples of avulsion 
location of muscle bundles 
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Figure 14: Force-displacement graph of a muscle bundle 
Example of force-displacement graph of a muscle bundle illustrating the six 
biomechanical parameters that were calculated for each sample from the 
obtained force-displacement data. The initial sample dimensions were measured 
for each sample so that normalized data could be calculated. 
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x1, y1
x2, y2
Group Statistics for Elastic Modulus
Mean: 0.3431 MPa
Standard Deviation: 0.1961
Sample_0300.tsv
Length: 26.02 mm
Diameter: 3.82 mm
Avulsion Location: 5 – Lower Suture  
Figure 15: Calculation of elastic moduli 
Example of force-displacement graph of a given muscle bundle illustrating the 
selection of two free-form points on the linear region of the graph to calculate the 
elastic modulus. The text below shows the dimensions and avulsion 
characteristics of the given muscle bundle, along with the mean and standard 
deviation of the entire population. The panel on right shows the elastic modulus 
of all samples in the treatment group. 
 
Determination Avulsion Location 
Sample Data 
Included in 
Analysis? 
1 
Sample slipped out of the top suture; Sample 
avulsed at or near top suture 
No 
2 
Sample avulsed in between the center and 
top region of the muscle bundle 
Yes 
3 Sample avulsed in the center Yes 
4 
Sample avulsed in between the center and 
bottom region of the muscle bundle 
Yes 
5 
Sample slipped out of the bottom suture; 
Sample avulsed at or near the bottom suture 
No 
 
Table 2: Criteria for determination of avulsion location of any given muscle 
bundle 
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3. The Comparative Assessment of Clinically Applied 
Ablative Therapies: Part II. The assessment of 
physiological and biomechanical properties of isolated 
respiratory diaphragm in response to varied therapeutic 
dosages 
 
 
Preface 
 
 
This paper discusses the detailed methodologies that were developed to assess 
the physiological and biomechanical properties of tissues in response to 
ablations.  This paper was submitted to the International Journal of Hyperthermia 
in July 2014 and is currently under review. 
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Executive Summary 
 
Purpose: Ablation is a common medical procedure used worldwide for the 
treatment of cardiac arrhythmias, lung cancers, hepatocellular carcinomas, and 
other conditions. In some cases, ablative treatment can cause collateral injury to 
the respiratory diaphragm, which can have important clinical implications. 
Collateral damage may result in altered diaphragmatic properties and/or 
respiratory dysfunction. It is important to understand the physiological and 
biomechanical properties of the diaphragm that may be potentially affected by 
various modes of ablative therapies. Such knowledge may help maximize the 
efficacy of ablative procedures and minimize procedural complications.  
 
Materials and Methods: We characterized physiological and biomechanical 
properties of swine diaphragm muscle bundles when exposed to five therapeutic 
ablation modalities (radiofrequency ablation, cryoablation, high-intensity focused 
ultrasound ablation, microwave ablation, and chemical ablation using acetic acid, 
ethanol, hypertonic sodium chloride, and urea). Physiological properties were 
assessed by performing in-vitro tissue bath studies to measure changes in peak 
forces (strength of contractions) as well as baseline forces (resting muscle 
tension). Biomechanical properties were assessed by performing uniaxial stress 
tests to measure force-displacement responses, stress-strain characteristics, and 
alterations of avulsion forces, strains, energies, and elastic moduli.  
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Results: We observed dose-dependent sustained reductions in peak forces and 
transient increases in baseline forces following treatment with all ablative 
modalities. Yet, no dose-dependent responses were consistently observed 
relative to the biomechanical responses following ablations.  
 
Conclusions: These data may provide novel insights into the effects of ablation 
on the diaphragm which may enable further improvements in ablative techniques 
to increase safety and efficacy of ablative procedures. 
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Introduction 
 
The respiratory diaphragm is a dome-shaped internal skeletal muscle 
separating the thoracic and abdominal cavity that plays an important function in 
respiration [1]. Any form of injury to the diaphragm or its innervation can 
significantly alter its function, which may compromise respiration. Although injury 
to the diaphragm can occur in many ways, this article focuses on diaphragmatic 
injury especially in the form of collateral damage from ablative therapies used for 
treating various diseases, such as: hepatocellular carcinoma (HCC), atrial 
fibrillation (AF), lung carcinoma, and continuous mechanical ventilation resulting 
in ventilator-induced diaphragmatic dysfunction (VIDD). Because of the 
diaphragm’s susceptibility to collateral damage, we consider that it is essential to 
understand both the physiological and biomechanical properties of diaphragmatic 
tissue under various therapeutic ablative treatments. This will not only allow us to 
understand the interactions of diaphragmatic tissue in response to ablation, but it 
will also help in developing tools and techniques, and refining procedures to 
minimize or prevent collateral damage. The ablative modalities employed in this 
investigation were: radiofrequency ablation (RFA), cryoablation (CRA), high-
intensity focused ultrasound ablation (HIFU), microwave ablation (MWA), and 
chemical ablation (CHA). Four chemical agents were used: 99.97% glacial acetic 
acid, 200 proof ethanol, 30% hypertonic sodium chloride solution, and 8M urea. 
The in vitro physiological assessments included alterations in peak forces 
(strength of contractions) as well as changes in baseline forces (resting muscle 
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tension) of isolated diaphragmatic muscle bundles stimulated within tissue baths 
[2, 3]. Biomechanical assessment included measurement of uniaxial stress-strain 
characteristics of the same tissue samples employing a uniaxial testing machine. 
 
Diaphragm Dysfunction from Continuous Mechanical Ventilation 
Although mechanical ventilation is a life-saving intervention, it is often 
associated with numerous complications of diaphragmatic dysfunction. A large 
body of evidence suggests that there is a decrease in diaphragmatic strength 
with an increased duration of mechanical ventilation [4]. This may result in an 
early-onset and progressive decrease in diaphragmatic force-generating capacity 
leading to VIDD. The mechanisms of VIDD are not fully elucidated, but have 
been reported to include muscle atrophy [5], oxidative stress [6, 7], structural 
injury [8], muscle fiber remodeling [9], and/or mitochondrial dysfunction [10]. The 
experimental methodologies described in this investigation may help provide 
insights into the pathophysiology of VIDD by comparative assessment of normal 
versus diseased samples, thereby reducing associated complications. 
 
Diaphragm Injury during Treatment of Lung Cancer 
Diaphragm has been shown to be susceptible to damage from RFA 
therapeutic applications in the lungs, during treatments for cancer [11, 12]. 
Although common complications such as pneumothorax, pleural effusion, and 
parenchymal hemorrhage can be treated conservatively, fatal complications such 
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as massive hemorrhage, pulmonary artery pseudoaneurysms, and diaphragmatic 
injury may require extensive medical management. For example, a case of 
intestinal obstruction due to left diaphragmatic hernia was reported to have 
developed following RFA treatment of pulmonary metastasis [13]. In another 
study, the diaphragm suffered collateral damage following the therapeutic 
application of RFA of the laterobasal segment of the lower lobe of the right lung, 
which was performed to treat lung metastasis from uterine cervical cancer [14]. 
 
Diaphragm Injury during Treatment of Cardiac Arrhythmias 
It has been noted that the diaphragm is highly susceptible to secondary 
damage leading to diaphragmatic paralysis after traumatic phrenic nerve injury 
(PNI) following endocardial ablations of the heart. PNI can occur following 
cardiac ablations performed with different energy sources including 
radiofrequency, cryoablation, ultrasound, and laser [15]. For example, right hemi-
diaphragmatic paralysis developed after cardiac RFA [16] and cryoballoon 
ablation [17] of pulmonary veins for the management of AF. In another case, 
permanent right diaphragm paralysis was reported following PNI from RFA 
cardiac procedures [18]. Similarly, left PNI after cryoballoon ablation of the 
pulmonary veins has also been reported [19]. It is hypothesized that local 
focused thermal energy at the time of ablation may cause direct neuronal 
damage to the phrenic nerve by axonal coagulation necrosis (from hyperthermic 
injury), or by cooling and freezing the axonal tissue thus interrupting nerve 
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conduction (from hypothermic injury). Intracardiac echocardiography has been 
utilized for continuous diaphragmatic visualization during cryoballoon ablation of 
the pulmonary veins [20]. This technique allows monitoring of phrenic nerve 
function during ablation preventing the need of fluoroscopy, thus significantly 
minimizing radiation to both the patient and the operator. It should be noted that 
the diaphragm itself may suffer collateral injury from ablations performed in the 
ventricles to treat ventricular arrhythmias. 
 
Diaphragm Injury during Treatment for HCC 
Although surgical resection remains the first line curative treatment for 
hepatocellular carcinoma (HCC), most patients are unable to undergo this 
invasive procedure because of advanced disease stage, severe liver dysfunction, 
poor clinical status, and/or other comorbidities. Therefore, less invasive 
techniques such as image-guided percutaneous tumor ablation have been 
adopted for the treatment of unresectable HCC [21]. Thermal ablations located 
close to vital structures such as diaphragm are technically challenging because 
of the risk of unintended collateral damage. Hence, it is essential to select a 
proper method for ablation therapy of liver tumors, especially treating ones 
located near vital structures and those that are difficult to visualize and approach 
by percutaneous techniques. 
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There have been many instances where the diaphragm has suffered injury from 
ablation procedures involving treatment of HCC. In one study, 5 out of 29 (17%) 
patients who underwent percutaneous RFA of hepatic tumors adjacent to the 
diaphragm suffered injury which was clinically apparent with right shoulder pain 
[22]. Furthermore, there have been reports of pneumothorax induced by RFA for 
HCC treatment beneath the diaphragm under real-time computed tomography-
fluoroscopic guidance [23-26]. 
Numerous techniques have been attempted to prevent thermal injury to 
the diaphragm and abutting structures to and near the liver during ablations of 
the liver. Artificial ascites (formulated with 5% dextrose in water solution) around 
the liver is considered as a simple and safe technique for the treatment of hepatic 
dome tumors abutting the diaphragm [27]. In order to minimize diaphragmatic 
injury, percutaneous RFA in conjunction with artificial ascites has been 
successfully attempted [28-31]. An improvement in the therapeutic window has 
been shown by separating the RFA zone from the diaphragm by downward 
displacement of the liver with the use of this simple and inexpensive technique 
[32]. Alternatively, there are reports in which artificial ascites has not shown a 
heat-sink effect on the volume of the ablation zone after percutaneous RFA for 
the treatment of a hepatic tumor abutting the diaphragm [33]. Thoracoscopic 
RFA, allowing visualization of therapy, has also been suggested to be a feasible 
technique [34, 35]. RFA in combination with artificial pleural effusion has also 
been demonstrated to be a safe and beneficial treatment option that offers 
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excellent local control through visualization of HCC under the diaphragm [36-38]. 
When performed under ultrasound guidance with strict temperature monitoring 
[39] or under thoracoscopic visualization with ultrasonography [40], percutaneous 
MWA of liver tumors adjacent to the diaphragm has been shown to be a safe and 
highly effective treatment. 
 The primary objectives of the present study were to gain new insights to the 
changes in both physiological and biomechanical properties of the diaphragm 
muscle in response to applied ablative therapies. To do so, we performed in vitro 
analyses on isolated swine diaphragm muscle bundles using methods detailed in 
Part 1 of our paired reports (Chapter 2). 
 
Materials and Methods 
 
Tissue Preparation 
 These investigations were approved by the University of Minnesota 
Institutional Animal Care and Use Committee. Fresh respiratory diaphragm tissue 
biopsies were obtained from healthy castrated male Yorkshire-cross swine 
(n=56, mean weight of approximately 70 kg) that were euthanized as part of 
another unrelated protocol. Briefly, following resection, the diaphragm tissue was 
pinned in a dissection dish, dissected in oxygenated, temperature-controlled 
skeletal muscle Krebs-Ringer solution, and muscle bundles were prepared. The 
physiological testing was performed using tissue baths, and biomechanical 
testing was performed using a uniaxial testing machine as described in detail in 
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Chapter 2.  The diaphragmatic tissue response to the following five different 
ablation modalities was investigated: 
 
 Radiofrequency ablation: RFA (484 KHz sinusoidal waveform) at five 
different ablation doses was studied: 50°C, 55°C, 60°C, 65°C, and 70°C 
(corresponding to 348 J, 580 J, 812 J, 1043 J, and 1275 J energy levels, 
respectively).  
 Cryoablation:  Cryoablation exposure (operated in the clinical mode, 
approximately -75°C) at four different ablation doses was studied: 15 sec, 
30 sec, 60 sec, and 120 sec. 
 Microwave ablation: MWA (1.3 GHz continuous sinusoidal waveform) with 
ablation duration between 60 sec and 240 sec at six different ablation 
doses was studied: 168 J, 289 J, 410 J, 821 J, 1231 J, and 1642 J. 
 HIFU ablation: HIFU ablation (2.5 MHz sinusoidal waveform, 80% duty 
cycle) at six different ablation doses was studied: 98 J, 116 J, 132 J, 232 
J, 464 J, and 696 J. 
 Chemical ablation: Chemical ablations with all four agents (acetic acid, 
ethanol, hypertonic sodium chloride, and urea) were performed 
independently by injecting the chemical ablative agent individually at six 
different ablation doses: 10 µl, 25 µl, 40 µl, 50 µl, 75 µl, and 100 µl. 
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Data Analyses 
 Statistical analyses were performed using ANOVA and the Tukey test to 
identify differences in peak force and baseline force for all ablation modalities 
where a p<0.05 is considered statistically significant. All data are presented as 
mean  standard deviation. 
 
Results 
 
Results of Physiological Assessment 
 A total number of 212 muscle bundles were studied for physiological 
assessment in tissue baths as shown in Table 3. The table summarizes muscle 
bundle characteristics and allocations to different ablative modalities. As seen in 
this table, the parameters length, diameter, mass, initial peak force, and baseline 
force of muscle bundles were similar across the different groups. 
 The percent change in peak force and baseline force in response to all 
ablation modalities were calculated for the diaphragm tissue as shown in Figure 
16 to Figure 33. There was a dose-dependent sustained reduction in peak force 
and a transient increase in baseline force following treatment with all ablative 
modalities. With some ablative modalities (e.g., RFA, hypertonic sodium 
chloride), the peak force reduced initially, but showed some improvement over 
the 3-hour recovery period. This phenomenon of partial improvement in peak 
force was more pronounced at lower ablation doses. Although there was a dose-
dependent transient increase in baseline force for all ablation modalities, the 
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baseline force recovered consistently below the pre-ablation level at the 3-hour 
recovery period (except for acetic acid). An interesting finding was observed with 
100 µl dose of hypertonic sodium chloride where the baseline force did not 
exhibit the dose-dependent response. Typically, the transient elevation in 
baseline force was maintained for a period of approximately one hour post-
ablation; later it decreased below the pre-ablation levels. This phenomenon was 
not observed for the following therapies: (1) acetic acid where the baseline force 
remained at elevated levels, and (2) in cases of hypertonic sodium chloride and 
urea, where the baseline force reduced to pre-ablation levels within 
approximately 15 minutes. The percent reduction in peak forces for all chemical 
ablation modalities, except acetic acid, was similar at every ablation dose. 
Among all the chemical ablative agents utilized for performing ablations, acetic 
acid was the most potent agent as it caused the maximum reduction in peak 
force at every ablation dose. The post-ablation percent change in baseline force 
for ethanol was consistently the highest at every ablation dose, and that of 
hypertonic sodium chloride was consistently the lowest. For control and control-
remove muscle bundles, similar changes in peak force and baseline force were 
observed (as shown in Figure 34 and Figure 35), suggesting that unmounting the 
muscle bundles from the tissue baths for ablations had minimal impact on 
subsequent muscle physiological response. The peak force and baseline force of 
muscle bundles injected with Krebs-Ringer solution were similar for every 
injected dose and no significant dose-effects were observed (as shown in Figure 
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32 and Figure 33). Moreover, the fact that peak forces and baseline forces for 
muscle bundles injected with Krebs-Ringer solution were very similar to those of 
control and control-remove muscle bundles suggests minimal (if any) mechanical 
damage resulted from injection of chemical agents or the Krebs-Ringer solution. 
 For all thermal ablation modalities (RFA, CRA, MWA, and HIFU), 
statistically significant differences (p<0.05) were observed for both dose and time 
variables, as calculated using the Tukey test. For all chemical ablation agents, 
statistically significant differences (p<0.05) were observed for dose, time, and 
agent (Krebs-Ringer solution versus chemical ablative agent) variables, 
calculated using the Tukey test. 
 
Results of Biomechanical Assessment 
 A total number of 733 muscle bundles were studied for biomechanical 
assessment which included the 212 muscle bundles which were also used in the 
physiological assessment described above. All muscle bundles were subjected to 
a uniaxial pull test, and force versus stretch data were obtained for all the 
samples. At the completion of the uniaxial pull test, an assessment was made 
where each muscle bundle avulsed; this is summarized in Table 4 as a 
percentage of avulsion location of muscle bundles for each treatment along with 
the number of samples in each case. Figure 40 shows the graphical distribution 
of avulsion locations for all muscle bundles. For biomechanical assessment, only 
the muscle bundles that avulsed at or near the center of the muscle bundle were 
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included in the analysis. Based on these data, the key biomechanical parameters 
of all samples in each treatment group were calculated as shown in Table 5. As 
seen in the table, the initial cross-sectional area and volume of the muscle 
bundles were similar across different groups. The avulsion force was defined as 
the value of the maximum force that was required to cause tissue avulsion. Since 
the force required to avulse the tissue was dependent on cross-sectional area of 
the muscle bundle, the avulsion force was normalized to the cross-sectional area 
and is reported in units of N/mm2. The avulsion strain was defined as the ratio of 
stretch to the point of avulsion and the original length of the muscle bundle; the 
total strain was defined as the ratio of stretch to the point where force returned to 
zero following avulsion and the original length of the muscle bundle. The avulsion 
energy was defined as the integral of area under the force-displacement curve 
until the point of avulsion; the total energy was defined as the integral of area 
under the entire force-displacement curve. Since energy required to avulse the 
tissue was dependent on avulsion force and stretch distance, energy was 
normalized to the volume of the tissue and is reported in units of mJ/mm3. Cross-
sectional area normalization of avulsion force and volume normalization of 
energy allowed comparative assessment between different treatment groups. 
The elastic modulus, avulsion and total strain, and avulsion and total energy of 
samples were also calculated, allowing assessment of relative stiffness of the 
samples between each group. As an example, an average model of stress-strain 
characteristics of non-ablated (control) swine diaphragm muscle bundles was 
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developed by averaging all samples (n=187) as shown in Figure 41. The “true 
stress-strain” relationship (Cauchy’s stress) was also calculated by taking into 
account the reduction in cross-sectional area of the samples during the stretch. 
The average avulsion stress and Cauchy’s avulsion stress were calculated to be 
0.11 MPa and 0.24 MPa, respectively, and the avulsion strain was calculated to 
be 1.35. Note that Cauchy’s stress was found to be 2.18 times higher than the 
conventional stress. In a similar manner, the stress-strain characteristics of all 
muscle bundles in every treatment group were calculated (graphs not shown); 
the key biomechanical parameters are summarized in Table 5.  
 The percent change in each of the six biomechanical parameters in each 
treatment group were calculated with respect to control samples (n=187, non-
ablated) as shown in Table 6. A positive value indicates an increase and a 
negative value a decrease with respect to controls. Percent change in avulsion 
force, elastic modulus, strain, and energy are shown along with individual 
statistical significance (p<0.05, marked in bold). The avulsion force increased for 
every ablative treatment except RFA and MWA. There was a 31% increase in 
avulsion force following treatment with acetic acid and a reduction of 38% 
following treatment with MWA. The elastic modulus increased following treatment 
with every ablative modality except RFA and MWA. There was a 90% increase in 
elastic modulus following treatment with CRA and a 58% reduction following 
treatment with MWA. The avulsion and total strain decreased following treatment 
with every ablation modality except MWA. A significant reduction in avulsion and 
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total energy was observed following application of CRA. Dose effects of each of 
the six biomechanical parameters for all ablation modalities were analyzed using 
ANOVA. Unlike physiological results, statistically significant dose effects were not 
observed in biomechanical properties following the application of any ablation 
modality, as shown in Figure 42 to Figure 50. 
 
Discussion 
 
 This study demonstrates that both physiological and biomechanical 
properties of swine respiratory diaphragm are altered when subjected to various 
ablation therapies. Although the mechanisms of action of every ablation modality 
are unique and complex, they are discussed briefly to highlight the mechanisms 
of tissue injury that result in reduction on peak force post-ablation. RFA energy is 
a form of alternating electrical current that dissipates within the tissue and 
generates a lesion by mode of resistive (electrical) heating [41, Chapter 2]; this 
results in protein denaturation and coagulation necrosis. CRA works by freezing 
tissue in a discrete and focused manner to destroy cells in a target location. It 
has been reported that the application of cryoenergy results in the formation of 
an ice -ball at the target area that causes freezing, thawing, hemorrhage, 
inflammation, fibrosis, and apoptosis [42]. In the case of HIFU, high-intensity US 
waves are focused in a small region of the target tissue that induce deep 
hyperthermia and ultimately tissue ablation through two primary modes of tissue 
injury: thermally-induced injury (from thermal energy/effects) and mechanically-
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induced injury (from mechanical energy/effects). The temperature at the 
transducer focus can reach over 65°C within seconds, denaturing cellular 
proteins and resulting in coagulative necrosis [43]. MWA therapy results in 
dielectric heating of tissue when high frequency electromagnetic radiation 
stimulates oscillations of dipole molecules such as water within the cellular and 
extracellular medium, which converts the electromagnetic energy into oscillating 
kinetic energy. This energy is dissipated as heat at the target location which 
ultimately results in thermal injury [44]. CHA, on the other hand, uses chemical 
agents at lethal concentrations that work by denaturing proteins and creating 
focal tissue damage and lesion, ultimately leading to tissue necrosis in the 
location of injection [45]. 
 A dose-dependent sustained reduction in peak force was observed for each 
ablation modality investigated. At the cellular level, the protein structure dictates 
its specificity, and the three-dimensional (tertiary) structure is particularly 
important for its overall function. When this specific three-dimensional structure is 
disrupted as a result of exposure to extreme temperatures during ablation, the 
protein loses its functionality and undergoes denaturation [46]. Typically, the 
application of hyperthermic temperatures during ablative procedures cause cell 
membrane collapse, protein denaturation, and cessation in enzymatic function, 
as well as mitochondrial dysfunction further leading to coagulation necrosis [47]. 
Similarly, it is considered that achieving hypothermic temperatures during 
cryoablation procedures induces direct cellular injury from ice crystal formation, 
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vascular ischemia, and apoptosis [48, 49]. In contrast, dehydration, membrane 
lysis, disruption of structural organization of proteins, and protein denaturation 
are the hallmarks following chemical ablation [45]. These cascaded events are 
considered to lead to disruption of the protein structure and function, which 
include the contractile myofilaments, intrinsic, and extrinsic proteins of the cell 
[42]. When viewed at the muscle level, the ability of the diaphragmatic muscle to 
elicit an electromechanical response resulting in contraction is dependent on the 
viability of the muscle fibers. Since ablation results in immediate tissue injury 
leading to cell death, tissue viability is compromised [47] and results in reduction 
of peak force. Moreover, as expected, a higher level of ablative dose is expected 
to cause an increased level of cellular injury. This is consistent with a trend in 
reduction in peak force with increasing levels of ablative dose that was observed 
in this study. Yet, in some cases, especially at lower doses, the peak force 
reduced initially, but showed some recovery over the 3-hour measurement 
period. This could be explained by the effects of skeletal muscle stunning that 
have been reported following ischemic injury [50]. One way to further interpret 
these force reductions is by considering the underlying cellular functions 
associated with ischemic injury which are induced by ablative procedures. For 
example, contractile dysfunction has been reported to occur rapidly during 
ablation, as a consequence of many factors, one of which includes ischemic 
injury [51]. One of the proposed mechanisms involves the generation of inorganic 
phosphate, largely attributed to the breakdown of creatine phosphate reserves 
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shortly after ischemic injury. Accumulation of inorganic phosphate inhibits the 
contractile proteins and may be the earliest factor responsible for the loss of 
contractility during ablations [52]. A second factor is the rapid fall of intracellular 
pH which inhibits Ca2+ binding to contractile proteins and thus further reduces 
contractility. It is generally considered that the initial decrease in contractility 
during ablation is fully reversible if the ablative dose is well below the threshold 
that causes tissue injury. However, if the ablative dose exceeds the threshold 
window, then contractile function does not return to baseline levels, even if there 
is no cell death associated with the ablative exposure. This failure of recovery of 
contractile function is termed "stunning," and is slowly reversible over a period of 
time until a plateau is reached. There appear to be two mechanisms, possibly 
interrelated, that are responsible for the stunning effect. The first is the 
generation of reactive oxygen species and the second is the selective proteolysis 
of proteins that is thought to be due to activation of proteases by the rise in 
cytosolic calcium [52]. 
 In our study, a dose-dependent transient increase in baseline force as a 
function of increasing ablative dose was observed. This response may also be 
considered to occur due to the stunning effect. As discussed above, as a result of 
ablation exposure, muscle cells generally become incapable of eliciting an 
electromechanical response (i.e., either contracting or relaxing). This condition is 
called physiologic contracture, which is caused by the lack of ATP within the 
muscle fibers [53]. It has been reported that at very low ATP levels, active 
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transport of Ca2+ ions into the sarcoplasmic reticulum slows (due to impaired 
SERCA function), thus Ca2+ ions accumulate within the sarcoplasm, and ATP is 
unavailable to bind to the myosin molecules that have formed cross-bridges with 
the actin myofilaments [54, 55]. As a consequence, the previously formed cross-
bridges cannot release, resulting in physiologic contracture. These effects not 
only result in elevated baseline forces following ablations, but the toxic Ca2+ 
overload causes a variety of pathological changes including necrosis and 
apoptosis [56]. In general, it has been observed that a reversible increase in tonic 
resting muscle tension is observed at temperatures between 45°C and 50°C. 
Typically, above 50°C (isotherm of irreversible tissue injury), the muscle elicits 
evidence of irreversible contracture [57]. It is deemed that the induced 
hyperthermia and hypothermia causes Ca2+ accumulation in the diaphragm 
muscle cells which ultimately leads to Ca2+ overload [58, 59]. Furthermore, these 
observations have been confirmed with calcium-sensitive Fluo-3 AM fluorescent 
dye studies, where hyperthermic increases in muscle tension as a result of 
increased intracellular Ca2+ concentration correlated well with increased Fluo-3 
AM fluorescence [60]. It can be concluded that exposure to extreme 
temperatures results in significant increases in intracellular Ca2+, probably as a 
result of nonspecific transmembrane transit through thermally induced 
sarcolemmal pores [57]. With increased intracellular Ca2+ entry, impaired ability 
of the sarcoplasmic reticulum to sequester Ca2+ and dysfunctional ion pump 
kinetics (due to lack of ATP, Ca2+ overload within the cytosol) ensue. In this case, 
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cell contracture and death occur at lower temperatures than expected. In our 
study we had an interesting observation with all muscle bundles that were 
ablated with acetic acid. After approximately 30 min of ablation, microbubble 
droplets were observed on the ablated region of the muscle bundles caused by 
excessive dehydration as shown in Figure 51. The mechanisms of chemical 
ablation with acetic acid, and other chemical agents used in this investigation, 
are based on the induction of intracellular dehydration, intracellular protein 
damage, and thrombo-ischemic effects on the muscle cells [61]. This eventually 
resulted in: (1) contracture which caused an increase in baseline force, (2) 
cellular injury which caused reduction in peak force, and (3) protein denaturation 
and dehydration which caused stiffness and an increase in avulsion force. 
 In this investigation, the main objective was to perform the tissue bath study 
(for physiological assessment) and then follow up with the uniaxial pulls (for 
biomechanical assessment). No dose-dependent response was consistently 
observed in any of the six biomechanical parameters as a result of treatment with 
all ablation modalities. In part, this was due to many confounding factors, some 
of which are alluded to in “Part 1” of the article (Chapter 2). One possible 
explanation for these observations is that the ablation doses used for 
physiological assessment did not cause a significant change in biomechanical 
properties of the diaphragmatic tissue. This hypothesis was tested by ablating a 
separate set of diaphragm muscle bundles at much higher ablative doses, 
typically a combination of longer durations or multiple exposures, and then 
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performing the biomechanical uniaxial pulls (data not shown). It was observed 
that when these muscle bundles were mounted in tissue baths, no peak forces 
could be registered. This was, in part, due to much higher levels of cellular injury 
which resulted in significant compromise of the contractile protein network, hence 
complete loss of contractility. However, when these muscle bundles were 
subjected to uniaxial pulls, significant changes in biomechanical properties were 
noted. For example, with respect to controls, the average avulsion forces 
typically: (1) increased by 12% when muscle bundles were exposed to three RFA 
of 1-min duration each, (2) increased by 25% when muscle bundles were 
exposed to four MWA of 4-min duration each, and (3) decreased by 45% when 
muscle bundles were exposed to two CRA of 4-min duration each. All these 
ablations were performed sequentially, side-by-side, near the center of the 
muscle bundle. As noted before, when these muscle bundles were mounted in 
tissue baths after ablations, no contractions could be elicited even at supra-
maximal stimulation levels suggesting severe cellular injury. Since no 
contractions could be elicited, physiological assessment protocol could not be 
performed on these muscle bundles, and at these ablative doses. Thus, ablation 
doses were selected that were not only clinically relevant, but also with a view of 
an acceptable model, so that both tissue bath studies and uniaxial pull studies 
could be performed on the same muscle bundles. These observations suggest 
that the sensitivity of both techniques (tissue baths and uniaxial pulls) may be 
quite different. In other words, significantly higher ablative energies are required 
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before any appreciable change in biomechanical properties of the diaphragmatic 
tissue can be observed. Moreover, due to variability introduced from multiple 
sources, the uniaxial pull measurements may not be sensitive enough to 
discriminate small differences in biomechanical properties resulting from the 
ablation dose levels selected in this study. Clinically, an increase in avulsion 
force means that it would require a higher force to cause tissue avulsion. This 
may be due to many factors of which the primary ones are denaturation of 
proteins, elastin and collagen. Collagen is the most abundant structural protein in 
mammals [62], making up 25% to 35% of the whole-body protein content. 
Moreover, collagen within the extracellular matrix is the primary structural protein 
providing a mechanical scaffold for cells within tissues [63]. Ablations cause 
coagulation necrosis of the tissue during which collagen undergoes post-
translational changes that alter its organization, which in turn is thought to 
contribute to tissue stiffness [64]. Hence, an increase in avulsion force was 
observed in a majority of the ablation modalities investigated. It should be noted 
that the ablations typically resulted in a localized tissue injury which either 
caused a biomechanical “weakness” or “strengthening” near the ablated region. It 
was observed that post-ablation, the muscle bundles typically avulsed at the 
ablated region or at the healthy-ablated tissue interface. 
 We consider that this series of experiments offers a unique ability to collect 
both physiological and biomechanical data, with a high level of consistency and 
repeatability. This enabled us to closely explore highly relevant ablative doses, 
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those that might be encountered clinically. It is understood that there are three 
potential differences as far as tissue response is concerned between the intact 
whole diaphragm and muscle bundles. One, the intact diaphragm is susceptible 
to secondary collateral injury from ablative procedures performed in a different 
organ. The extent of collateral injury depends on the type of ablative energy 
used, duration, and proximity to the diaphragm. Moreover, these injuries 
generally tend to be localized to a region of the diaphragm. Our set of 
experiments mimics the collateral injury by directly ablating the diaphragmatic 
muscle bundles in localized regions with various ablative treatments. Although 
the way diaphragm incurs damage may be different between the secondary 
collateral injuries versus direct injury, the end result is the same—cellular injury 
leading to diaphragmatic dysfunction. In view of this, future investigations could 
more closely mimic the collateral damage by including a biopsy of the primary 
target organ between the ablative source and the diaphragmatic muscle bundle.  
 Second, there will be small stimulation and electro-mechanical differences 
between the intact diaphragm versus diaphragmatic muscle bundles; muscle 
bundles are bathed in Krebs solution in tissue baths, whereas intact diaphragm is 
perfused with normal blood within the body. However, stimulation within a muscle 
bundle requires similar voltage gradients and transmembrane potentials to elicit a 
contraction as stimulation with the intact diaphragm; we feel that it is likely to 
show similar responses and trends in action potential initiation and propagation.  
 Lastly, the biomechanical parameters of the intact diaphragm within its 
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native environment will be different than those of isolated muscle bundles. We 
believe this is not only because of the bulk muscle volume, but also because of 
its adhesion to surrounding structures and relation to surrounding organs. In 
order to perform a fair and consistent comparison between muscle bundles 
exposed to various treatments, all biomechanical data were normalized either to 
the muscle bundle cross-sectional area or volume based on the quantity 
measured. Nevertheless, it is these responses and trends that we feel are 
important to guide further research. 
 In this investigation, we employed four thermal ablative modalities and four 
chemical ablative agents. Each ablative technique, although similar in purpose, 
has specific and optimal indications. Choice of the most appropriate ablative 
modality is vital to the success of any ablative procedure. The type of tissue to be 
ablated, regional blood flow, and the size of desired lesion are three important 
factors in this decision. Each ablation modality has its unique advantages. For 
example, the noninvasive, high-precision nature of HIFU makes it attractive in 
stationary or superficial regions. Among all ablation modalities, RFA has been in 
practice for the longest time which makes it an attractive modality of choice. One 
of the advantages of a CRA probe is that it adheres to the target location by 
forming an ice-ball. Therefore, CRA works well in areas where catheter instability 
is high due to relative motion between the probe and the target location. MWA is 
one of the newer ablation techniques offering noncontact therapy application by 
electric field radiation and dielectric heating. Although it may be applicable to a 
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broader spectrum of tissues, its long-term effectiveness still needs to be 
evaluated. Compared to any thermal ablation modality, CHA is the most cost-
effective option as it does not require any capital equipment for performing 
ablations. Although relatively inexpensive, it is restricted to use in target areas 
with low blood perfusion rates to minimize dilution and wash out, and prevent 
systemic side effects by localizing the action of injected ablative agent. 
 Since no similar studies have been performed in this area previously, it was 
not possible to compare these results with literature. It is important to note that 
our study approach can be considered to have a few limitations. For example, 
only a selected number of ablation settings were used in this study, cumulative 
effects of ablations were not studied, and only uniaxial pulls were done. 
Moreover, we did not test RFA using irrigated catheters, cryoballoon ablation 
catheters, phased-array HIFU transducers, different MWA antenna designs, and 
different chemical ablative agents, all of which may have resulted in different 
findings. Furthermore, this model can only investigate acute effects of ablation, 
i.e., within hours after ablation. Nevertheless, we hope to make this work 
translational by utilizing human tissue when it becomes available. The results 
from this investigation can be used to better understand device-tissue interaction, 
and to aid in novel medical device design. 
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Conclusion 
 
 In this investigation we utilized novel in vitro methodologies to assess how 
physiological and biomechanical properties of diaphragmatic tissue change as a 
result of exposure to various ablative modalities. The results show that these 
methodologies are applicable for analyzing a spectrum of ablation modalities, 
ones used in this investigation as well as future options, for example, laser 
ablation and irreversible electroporation. 
 To our knowledge, these are first reports of comparing the effects of 
ablation modalities and dosages on both the physiological and biomechanical 
properties of isolated functional diaphragm muscle bundles. We observed unique 
dose responses for each ablation modality investigated as well as therapeutic 
differences regarding their effects on the muscle parameters studies. The 
understanding of diaphragmatic tissue properties has wide applications ranging 
from basic research to novel medical device design. This unique data set could 
provide important insights to both clinicians and medical device designers. 
Results from these studies could enable head-to-head comparison of ablative 
modalities to determine their effects on tissue response. Interpretation of these 
results can further be used to reduce complication rates, as well as increase 
effectiveness and overall efficacy of therapies. Moreover, increasing knowledge 
in this area is fueling the demand for introducing new procedures, modifying 
current ones, and reducing procedural time to positively impact the efficiency and 
efficacy of treatment delivered. 
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Figure 16: Dose effects of percent change in peak force of swine 
diaphragm post radiofrequency ablation (RFA) 
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Figure 17: Dose effects of percent change in baseline force of swine 
diaphragm post radiofrequency ablation (RFA) 
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Figure 18: Dose effects of percent change in peak force of swine 
diaphragm post cryoablation (CRA) 
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Figure 19: Dose effects of percent change in baseline force of swine 
diaphragm post cryoablation (CRA) 
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Figure 20: Dose effects of percent change in peak force of swine 
diaphragm post microwave ablation (MWA) 
 
‐100
‐50
0
50
100
150
200
250
168 J 289 J 410 J 821 J 1231 J 1642 J
%
 C
ha
ng
e 
in
 B
as
el
in
e 
Fo
rc
e
 
Figure 21: Dose effects of percent change in baseline force of swine 
diaphragm post microwave ablation (MWA) 
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Figure 22: Dose effects of percent change in peak force of swine 
diaphragm post HIFU (high-intensity focused ultrasound) ablation 
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Figure 23: Dose effects of percent change in baseline force of swine 
diaphragm post HIFU (high-intensity focused ultrasound) ablation 
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Figure 24: Dose effects of percent change in peak force of swine 
diaphragm post acetic acid ablation 
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Figure 25: Dose effects of percent change in baseline force of swine 
diaphragm post acetic acid ablation 
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Figure 26: Dose effects of percent change in peak force of swine 
diaphragm post ethyl alcohol ablation 
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Figure 27: Dose effects of percent change in baseline force of swine 
diaphragm post ethyl alcohol ablation 
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Figure 28: Dose effects of percent change in peak force of swine 
diaphragm post NaCl ablation 
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Figure 29: Dose effects of percent change in baseline force of swine 
diaphragm post NaCl ablation 
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Figure 30: Dose effects of percent change in peak force of swine 
diaphragm post urea ablation 
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Figure 31: Dose effects of percent change in baseline force of swine 
diaphragm post urea ablation 
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Figure 32: Dose effects of percent change in peak force of swine 
diaphragm post injection of Krebs-buffer solution 
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Figure 33: Dose effects of percent change in baseline force of swine 
diaphragm post injection of Krebs-buffer solution 
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Figure 34: Percent change in peak force of control and control-remove 
swine diaphragm muscle bundles 
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Figure 35: Percent change in baseline force of control and control-remove 
swine diaphragm muscle bundles 
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Figure 36: Dose effects on peak force of swine diaphragm for all thermal 
ablative modalities 
 
 
 
Figure 37: Dose effects on baseline force of swine diaphragm for all 
thermal ablative modalities 
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Figure 38: Dose effects on peak force of swine diaphragm for all chemical 
ablative modalities 
 
 
 
Figure 39: Dose effects on baseline force of swine diaphragm for all 
chemical ablative modalities 
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Figure 40: Avulsion location for each treatment displayed as percentage for 
all muscle bundles tested in this investigation 
 
Figure 41: Average model of stress-strain characteristics of non-ablated 
“control” swine diaphragm muscle bundles (n=187) 
The maximum stress was 0.11 MPa and maximum Cauchy-stress was 0.24 
MPa. The avulsion strain was 1.35. 
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Figure 42: Dose effects of radiofrequency ablation (RFA) on biomechanical 
properties of swine diaphragm muscle bundles 
 
 
 
 
Figure 43: Dose effects of cryoablation (CRA) on biomechanical properties 
of swine diaphragm muscle bundles 
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Figure 44: Dose effects of microwave ablation (MWA) on biomechanical 
properties of swine diaphragm muscle bundles 
 
 
 
Figure 45: Dose effects of high-intensity focused ultrasound (HIFU) 
ablations on biomechanical properties of swine diaphragm muscle bundles 
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Figure 46: Dose effects of chemical ablation with acetic-acid on 
biomechanical properties of swine diaphragm muscle bundles 
 
 
 
Figure 47: Dose effects of chemical ablation with ethanol on biomechanical 
properties of swine diaphragm muscle bundles 
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Figure 48: Dose effects of chemical ablation with hypertonic sodium 
chloride on biomechanical properties of swine diaphragm muscle bundles 
 
 
Figure 49: Dose effects of chemical ablation with urea on biomechanical 
properties of swine diaphragm muscle bundles 
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Figure 50: Dose effects of Krebs injections on biomechanical properties of 
swine diaphragm muscle bundles 
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Figure 51: A swine diaphragm muscle ablated with 50 µl of acetic acid 
Microbubbles on the ablated region of the muscle bundle are caused by 
excessive dehydration, which further leads to tissue necrosis. 
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Table 3: Mean  SD characteristics of swine diaphragm muscle bundles 
that underwent physiological testing in tissue baths (n=212) 
A set of 4 muscle bundles were exposed to every ablation dose 
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Table 4: Tabulation of the avulsion location of swine diaphragm muscle 
bundles (n=733) as a percentage for each ablative modality 
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Table 5: Mean  SD dimensional characteristics and biomechanical 
parameters of swine diaphragm muscle bundles that avulsed at or near the 
center of the muscle bundle 
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Table 6: Percent change in biomechanical properties of swine diaphragm 
muscle bundles post ablation with different ablative modalities 
All values are with respect to controls (n=187, non-ablated) muscle bundles.  A 
positive value indicates an increase and a negative value a decrease with 
respect to controls.  Percent change in avulsion force, elastic modulus, strain, 
and energy are shown along with individual statistical significance (p<0.05, 
marked in bold). 
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4. The Assessment of Physiological and Biomechanical 
Properties of Isolated Swine Esophagus in Response to 
Clinically Applied Ablative Therapies 
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Executive Summary 
 
 Atrial fibrillation is one of the most common sustained cardiac arrhythmia, 
whose prevalence is increasing with age and incidence with time.  Catheter 
ablation is a common medical procedure performed worldwide for the treatment 
of atrial fibrillation.  Although believed to be a generally safe procedure, in small 
percentage of cases, it can cause collateral injury to the surrounding structures 
including the esophagus, which can have important clinical implications.  Such 
collateral injury of the esophagus may result in altered structural and/or 
physiological changes that are dependent on both the level of ablative energy 
applied and the extent of tissue injury produced.  Thus, it is important to 
understand the physiological and biomechanical properties of the esophagus that 
may be potentially affected by various modes of ablative therapies.  Such 
knowledge may not only help maximize the efficacy of ablative procedures, but 
also aid in minimizing procedural complications.  In this investigation, we have 
characterized specific physiological and biomechanical properties of the 
esophageal muscle bundles when exposed to five different therapeutic ablation 
modalities (radiofrequency ablation, cryoablation, high-intensity focused 
ultrasound ablation, microwave ablation, and chemical ablation using acetic acid, 
ethanol, hypertonic sodium chloride, and urea).  The physiological properties 
were assessed by performing in-vitro tissue bath studies to measure changes in 
peak forces (strength of contractions) as well as baseline forces (resting muscle 
tension) in response to ablation.  The biomechanical properties were assessed 
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by performing uniaxial stress tests to measure the force-displacement responses, 
stress-strain characteristics, and calculations of avulsion forces and elastic 
moduli in response to ablative therapies.  In general, we observed dose-
dependent sustained reduction in peak force and a transient increase in baseline 
force following treatment with all ablative modalities.  Yet, no dose-dependent 
responses were consistently observed relative to the biomechanical responses 
following ablations.  The data presented here may provide novel insights into the 
effects of ablations on the esophagus which may in turn allow further 
improvements in ablative techniques to increase the overall safety and efficacy of 
cardiac and esophageal ablative procedures. 
 
Introduction 
 
The esophagus is a hollow, muscular, tubular organ connecting the 
pharynx to the stomach that plays an important role in digestion by conveying 
boluses of food from the pharynx to the stomach [1].  Any form of injury to the 
esophagus or its innervation can significantly alter its function [2], which may 
compromise the gastro-intestinal system.  Although injury to the esophagus can 
occur in many ways, this article focuses on esophageal injury especially in the 
form of collateral damage from ablative treatments for atrial fibrillation (AF). 
AF is the most common sustained cardiac arrhythmia whose prevalence is 
increasing with age, and incidence with time [3].  The median age for patients 
with AF is 66.8 years for men, and 74.6 years for women [4].  Approximately 2.5 
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million people are living with AF and as many as 12 million people are expected 
to have the condition by 2050 [4].  Although the first line of management of AF is 
primarily done through medication, depending on the disease state, AF duration, 
and circulatory instability, electrophysiological studies are performed in the heart 
that allow electrical mapping of myocardium to isolate areas responsible for 
irregular rhythm.  These studies are often performed along with catheter ablation 
of abnormal electrical pathways causing disturbance in normal heart rhythm [5].  
Since its inception in the early 1980's [6,7], catheter ablation has become one of 
the most useful and widely employed therapeutic modalities for treating medically 
refractory, intractable, and disabling AF.  With over 50,000 and 60,000 cardiac 
ablation procedures performed each year in the USA and Europe, respectively, 
indications for its use continue to expand.  Along with known benefits, there are 
significant complications associated with the ablative procedures that can be as 
high as 5% [8].  Some of the potential complications include: (1) vascular access 
bleeding, (2) vascular injury resulting from catheter manipulations, (3) 
cardioembolic events, and (4) collateral injury from delivery of ablative energies 
within the heart [9,10].  Specifically, the most frequent complications are vascular 
related, followed by esophageal injury, phrenic nerve injury, pericardial 
effusion/tamponade, neurologic events (stroke and transient ischemic attacks), 
and injury to lungs [8].  One of the complications of particular importance to 
interventional cardiologists and electro-physiologists is the creation of 
atrioesophageal fistulas (AEF) which often have fatal consequences [11,12]. 
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 Catheter ablations are routinely performed in the left and right atrium (LA 
and RA) to isolate the pulmonary veins (PVs) for treatment and management of 
AF [13,14].  In general, the goal of ablations is to create a series of transmural 
lesions in the LA, however, in most of the ablation modalities (like radiofrequency 
ablation and cryoablation), only the temperature and duration of the energy 
delivered can be controlled [15].  Since there is no accurate way to control the 
depth of the lesion created, it is possible to create a lesion that is too deep, 
consequently causing injury to adjacent vital structures.  More importantly, it has 
been observed that heat generated from ablative energy that is dissipated within 
the LA by the ablation probe can result in esophageal injury without the probe 
coming into direct contact with the esophagus [11].  Hence, it has been well 
documented that these ablative procedures are associated with high risk of 
esophageal thermal injury because of the close proximity of the esophagus to the 
LA posterior wall that renders it susceptible to unintended collateral damage [16].  
Esophageal injury can range from superficial ulceration and gastroparesis, to the 
rare but catastrophic AEF [17].  AEF are a known complication resulting from 
collateral damage from ablative procedures performed in the LA with variable 
incidences that could be as high as 1%, and having a high rate of mortality [18].  
The etiology of esophageal injury is multifactorial, and AEF have been shown to 
result from application of many different forms of ablative energies that include: 
(1) radiofrequency ablation [19,20]; (2) cryoballoon ablation [21,22]; and (3) high-
intensity focused ultrasound ablation [23].  Ablations are also performed in the 
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cardiac chambers (atria or ventricles) for management and treatment of 
arrhythmogenic substrates such as supraventricular tachycardia, idiopathic 
ventricular tachycardia, and ventricular ectopic beats [24,25,26,27] that could 
also be associated with collateral injury of surrounding structures including the 
esophagus. 
 Numerous studies have been performed to establish a relationship between 
the esophagus and the posterior LA wall as it relates to the relevance for 
performing ablations in the LA and PVs [16,28,29,30].  In summary, the following 
observations were reported: (1) the left-sided PVs are closer than the right-sided 
PVs, (2) typically, presence and thickness of pericardial fat pads are more 
prominent near the superior PVs than inferior PVs, (3) the length of contact 
between esophagus and posterior LA wall was longer in the AF patients than 
normal subjects, and (4) patients with AF had less fat-pad around the inferior 
PVs than normal subjects.  In addition, in a cadaveric study, although the 
proximity of the esophageal wall to the endocardial surface of the LA was found 
to be variable, the distance was <5 mm.  Moreover, it is conceivable that 
enlargement and thinning of the atrial wall in patients with AF could make this 
distance even shorter.  Thus, in view of these important observations, a great 
precaution must be exercised while performing ablations around left-sided PVs.  
In addition, it is believed that the presence of fat-pads may have an insulating 
effect, however, whether it actually provides protection against fistula formation is 
not clear and needs to be investigated. 
  135 
Because esophagus is susceptible to collateral damage, it is essential to 
understand the physiological and biomechanical properties of esophageal tissue 
under various therapeutic ablative treatments.  This will not only allow us to 
understand the interactions of esophageal tissue in response to ablation, but also 
help in developing tools, techniques, and refining procedures to minimize and 
prevent collateral damage.  The ablative modalities employed in this investigation 
were: radiofrequency ablation (RFA), cryoablation (CRA), high-intensity focus 
ultrasound ablation (HIFU), microwave ablation (MWA), and chemical ablation 
(CHA).  Four chemical agents were used: 99.97% glacial acetic acid, 200 proof 
ethanol, 30% hypertonic sodium chloride solution, and 8M urea.  The 
physiological assessment included measurement of changes in peak force 
(strength of contractions) as well as baseline force (resting muscle tension) in 
tissue baths [31,32]; and biomechanical assessment included measurement of 
uniaxial stress-strain characteristics of tissue samples in an uniaxial testing 
machine (Chapter 2). 
The primary objectives of the present study were to gain new insights as 
to the changes in both physiological and biomechanical properties of the 
esophagus in response to applied ablative therapies. To do so, we performed in 
vitro analyses on isolated swine esophageal muscle bundles using 
methodologies developed by our laboratory (Chapter 2). 
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Methods 
 
Tissue Preparation 
 The study was approved by the University of Minnesota Institutional Animal 
Care and Use Committee.  Fresh esophagus tissue biopsies were obtained from 
healthy castrated male Yorkshire-cross swine (n=24, mean weight of 
approximately 70 kg), which were euthanized as part of another unrelated 
protocol.  Following resection, the esophagus tissue was pinned in a dissection 
dish, dissected in oxygenated, temperature-controlled Krebs-Ringer solution.  
The muscle bundle preparation involved initially cleaning up the biopsy by 
removing excess fat and surrounding connective tissue so that well defined 
muscle bundles could be prepared.  The external muscularis and internal 
squamous epithelium layers were first separated and then tissue bundles of both 
the muscularis layer and squamous epithelium layer were prepared.  Muscle 
bundles of muscularis layer were prepared along the internal circular layer of 
muscle fibers of muscularis externa in an identifiable cuboidal shape having 
lengths of 15 to 25 mm, widths of 3 to 5 mm, and thickness of 1.5 to 3 mm.  
Tissue bundles of squamous epithelial layer were prepared in an identifiable 
cylindrical shape having lengths of 15 to 25 mm and diameters of 1.5 to 3mm.  
The physiological testing was performed using tissue baths and biomechanical 
testing was performed using a uniaxial testing machine as previously described 
in detail (Chapter 2, submitted for publication).  Note that the squamous 
epithelium is a non-contractile tissue; hence, only biomechanical tests were 
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performed on these tissue bundles.  However, both physiological and 
biomechanical tests were performed on the muscularis muscle bundles.The 
esophageal tissue responses to the following five different ablation modalities 
were investigated: 
Radiofrequency Ablation: RFA (484 KHz sinusoidal waveform) at five different 
ablation doses were studied: 50 °C, 55 °C, 60 °C, 65 °C, and 70 °C 
(corresponding to 440 J, 740 J, 840 J, 1060 J, and 1200 J energy levels, 
respectively). 
Cryoablation:  Cryoablation exposure (operated in the clinical mode, 
approximately -75 °C) at four different ablation doses were studied: 15 sec, 30 
sec, 60 sec, and 120 sec. 
Microwave Ablation: MWA (1.3 GHz continuous sinusoidal waveform) with 
ablation duration between 60 sec and 240 sec at six different ablation doses 
were studied: 226 J, 318 J, 526 J, 1052 J, 1579 J, and 2105 J. 
HIFU Ablations: HIFU ablations (2.5 MHz sinusoidal waveform, 80% duty cycle) 
at five different ablation doses were studied: 228 J, 342 J, 456 J, 570 J, and 684 
J. 
Chemical Ablations: Chemical ablations with all four agents (acetic acid, ethanol, 
hypertonic sodium chloride, and urea) were performed independently by injecting 
the chemical ablative agent individually at four different ablation doses: 10 µl, 25 
µl, 50 µl, and 100 µl. 
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Data Analyses 
 Statistical analyses were performed using ANOVA and Tukey tests to 
identify differences in peak forces and baseline forces for all ablation modalities, 
where a p<0.05 was considered statistically significant.  All data were presented 
as means  standard deviations. 
 
Results 
 
Results of Physiological Assessment 
 A total number of 168 muscle bundles were studied for physiological 
assessment in tissue baths as shown in Table 7.  The table summarizes the 
muscle bundle characteristics and allocations to different ablative modalities.  As 
can be observed in this table, the lengths, widths, thicknesses, masses, initial 
peak forces, and baseline forces of muscle bundles were similar for each group 
investigated. 
 The percent change in peak force and baseline force in response to all 
ablation modalities were calculated for the esophagus tissue as shown in Figure 
52 through Figure 67.  There were dose-dependent sustained reductions in peak 
force and a transient increase in baseline force following treatment with each 
ablative modality.  With some ablative modalities (eg: RFA, MWA, sodium 
chloride), the peak force reduced initially, but showed some improvement over 
the 3-hour in vitro recovery period.  This phenomenon was more pronounced at 
low therapy doses relative to the high ones.  Although there were dose-
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dependent transient increases in baseline forces for all ablation modalities, the 
baseline forces were observed to recover consistently below the pre-ablation 
level at the 3-hour recovery period (except for acetic acid).  Typically, the 
transient elevations in baseline forces were maintained for a period of 
approximately one hour post-ablation following which they reduced below pre-
ablation levels.  This phenomenon was not observed in following therapies: (1) 
acetic acid where the baseline force remained at elevated levels, and (2) sodium 
chloride, where the baseline force reduced to pre-ablation levels within 
approximately 15 minutes.  Among all the chemical ablative agents utilized for 
performing ablations, acetic acid was the most potent agent as it caused the 
maximum reduction in peak force at every ablation dose.  Similar changes in 
peak force and baseline force were observed for control and control-remove 
muscle bundles (as shown in Figure 70 and Figure 71) suggesting that 
unmounting the muscle bundles from the tissue baths for performing ablations 
had minimal impact on subsequent physiological response.  The peak force and 
baseline force of muscle bundles injected with Krebs-Ringer solution were similar 
for every injected dose, thus no significant dose-effects were observed (as 
shown in Figure 68 and Figure 69).  Moreover, the fact that peak forces and 
baseline forces for muscle bundles injected with Krebs-Ringer solution were very 
similar to that of control and control-remove muscle bundles, suggests minimal (if 
any) mechanical damage resulting from injection of chemical agents or the 
Krebs-Ringer solution. 
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 For all thermal ablation modalities (RFA, CRA, MWA, and HIFU), 
statistically significant differences (p<0.05) were observed for both dose and time 
variables calculated using the Tukey test.  For all chemical ablation agents, 
statistically significant differences (p<0.05) were observed for dose, time, and 
agent (Krebs-Ringer solution versus chemical ablative agent) variables 
calculated using the Tukey test. 
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Results of Biomechanical Assessment 
 A total number of 563 muscle bundles were studied for biomechanical 
assessment which included the 168 muscle bundles studied for physiological 
assessment as described above.  All muscle bundles were subjected to uniaxial 
pull test and thus, force versus stretch data was obtained for each sample.  At 
the completion of each uniaxial pull test, an assessment was made where the 
given muscle bundle avulsed; which is summarized in Table 8 as a percentage of 
avulsion location of muscle bundles for each treatment group along with the 
number of samples in each case.  Figure 76 provides a graphical distribution of 
avulsion locations for all muscle bundles investigated.  Importantly, for 
subsequent biomechanical assessments, only the muscle bundles that avulsed 
at or near the center of the muscle bundle were included in the analysis.  Based 
on these data, the key biomechanical parameters of all samples in each 
treatment group were calculated as shown in Table 9.  As can be observed from 
this table, the initial cross-sectional area and volume of the muscle bundles were 
similar across the different therapeutic groups.  The avulsion force was defined 
as the value of the maximum force that was required to cause tissue avulsion.  
Since force required to avulse the tissue was dependent on cross-sectional area 
of the muscle bundle, the avulsion force was normalized to the cross-sectional 
area and is reported in the units of N/mm2.  The avulsion strain was defined as 
the ratio of stretch to the point of avulsion and the original length of the muscle 
bundle; whereas the total strain was defined as the ratio of stretch to the point 
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where force returned to zero following avulsion and the original length of the 
muscle bundle.  The avulsion energy was defined as the integral of area under 
the force-displacement curve until the point of avulsion; whereas the total energy 
was defined as the integral of area under the entire force-displacement curve.  
Since energy required to avulse the tissue was dependent on avulsion force and 
stretch distance, energy was normalized to the volume of the tissue and is 
reported in the units of mJ/mm3.  Cross-sectional area normalization of avulsion 
force and volume normalization of energies allowed comparative assessment of 
these quantities between different treatment groups.  The elastic modulus, 
avulsion and total strain, and avulsion and total energy of samples were also 
calculated that allowed assessment of relative stiffness of samples between each 
group.  As an example, an average model of stress-strain characteristics of non-
ablated (control) swine esophagus muscle bundles was developed by averaging 
all samples (n=297) as shown in Figure 77.  The “true stress-strain” relationship 
(Cauchy’s stress) was also calculated by taking into account the reduction in 
cross-sectional area of each sample during the stretch.  The average avulsion 
stress and Cauchy’s avulsion stress were calculated to be 0.33 MPa and 0.72 
MPa, respectively, and the avulsion strain was calculated to be 1.35.  The 
Cauchy’s stress was found to be 2.18 times higher than conventional stress.  In a 
similar manner, the stress-strain characteristics of all muscle bundles in every 
treatment group were also calculated (graphs not shown); however, the key 
biomechanical parameters are summarized in Table 9. 
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 The percent change in each of the six biomechanical parameters in each 
treatment group were calculated with respect to control samples (n=297, non-
ablated) as shown in Table 10.  As can be observed in this table, a positive value 
indicates an increase and a negative value a decrease with respect to controls.  
Percent change in avulsion force, elastic modulus, strain, and energy are shown 
along with individual statistical significance (p<0.05, marked in bold).  Statistically 
significant increase in avulsion forces (range: 17.25% to 43.81%) were observed 
for each ablative treatment except CRA and sodium chloride, where an increase 
was observed, but the response was not statistically significant.  Similarly, an 
increase in elastic moduli (range: 12.55% to 45.35%) were observed for each 
ablative treatment except CRA and sodium chloride, where a minor reduction 
was observed.  In general, reductions in the avulsion and total strains were 
observed; and increases in the avulsion and total energies were observed for 
every ablative modality investigated.  Dose effects for each of the six 
biomechanical parameters for each ablation modality were analyzed using 
ANOVA.  Unlike physiological results, statistically significant dose effects were 
not observed in biomechanical properties for any ablation modality as shown in 
Figure 78 through Figure 86. 
 The formation of an AEF is characterized by an abnormal connection 
between the esophagus and the atria.  Thus, in order for the fistula to form, it 
must affect both the muscularis and squamous epithelial layers.  We separately 
tested the previously dissected squamous epithelium to assess its biomechanical 
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properties (n=26).  As compared to the muscularis layer, all biomechanical 
parameters of squamous epithelium layer were consistently higher, which were 
calculated to be: (1) avulsion force = 0.78 N/mm2 (66.4% higher), (2) elastic 
modulus = 0.75 N/mm2 (7.5% higher), (3) avulsion strain = 1.54 (15.5% higher), 
(4) total strain = 1.93 (10.5% higher), (5) avulsion energy = 339.9 mJ/mm3 
(145.2% higher), and (6) total energy = 407.7 mJ/mm3 (128.2% higher).  In other 
words, the squamous epithelium possessed greater stiffness as compared to the 
muscle layer. 
 
 
Discussions 
 
 This study demonstrates that both physiological and biomechanical 
properties of swine esophagus are altered when subjected to various ablative 
therapies.  The mechanisms of action of every ablation modality are unique and 
complex; they are discussed in detail in Chapter 3.  The cellular mechanisms of 
injury, protein denaturation, membrane collapse, cessation of enzymatic function, 
mitochondrial dysfunction, Ca2+ overload, further leading to coagulation necrosis 
and apoptosis are also discussed in detail in Chapter 3, hence not repeated here.  
Like the diaphragmatic tissue, we had an interesting observation with the 
esophageal tissue as well.  After approximately 30 min of ablation, microbubble 
droplets were observed on the ablated region of the muscle bundles caused by 
excessive dehydration as shown in Figure 87.  The mechanisms of chemical 
ablation with acetic acid, and other chemical agents used in this investigation are 
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based on the induction of intracellular dehydration, intracellular protein damage, 
and thrombo-ischemic effects on the muscle cells.  This eventually resulted in: 
(1) contracture which caused an increase in baseline force, (2) cellular injury 
which caused reduction in peak force, and (3) protein denaturation and 
dehydration which caused stiffness and an increase in avulsion force. 
 In this investigation, the main objective was to perform the tissue bath study 
(for physiological assessment) and then follow up with the uniaxial pulls (for 
biomechanical assessment).  No dose-dependent response was consistently 
observed in any of the six biomechanical parameters as a result of treatment with 
all ablation modalities.  This was in part, due to many confounding factors, some 
of which are alluded to in “part 1” of the article.  One possible explanation for 
these observations is that the ablation doses used for physiological assessment 
did not cause a significant change in biomechanical properties of the esophageal 
tissue.  This hypothesis was tested by ablating a separate set of esophagus 
muscle bundles at much higher ablative doses, typically a combination of longer 
durations or multiple exposures, and then performing the biomechanical uniaxial 
pulls (data not shown).  It was observed that when these muscle bundles were 
mounted in tissue baths, no peak forces could be registered.  This was in part 
due to much higher levels of cellular injury which resulted in significant 
compromise of the contractile protein network, hence complete loss of 
contractility.  However, when these muscle bundles were subjected to uniaxial 
pulls, significant changes in biomechanical properties were noted.  For example, 
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with respect to controls, the average avulsion forces typically: (1) increased by 
25% when esophageal muscle bundles were exposed to three RFA of 1 min 
duration each, (2) increased by 9% when esophageal muscle bundles were 
exposed to two CRA of 4 min duration each.  Alternatively, with respect to 
controls, the average elastic modulus typically: (1) decreased by 33% after RFA, 
and (2) decreased by 24% after CRA.  All these ablations were performed 
sequentially, side-by-side, near the center of the muscle bundle.  As noted 
before, when these muscle bundles were mounted in tissue baths after ablations, 
no contractions could be elicited even at supra-maximal stimulation levels 
suggesting severe cellular injury.  Since no contractions could be elicited, 
physiological assessment protocol could not be performed on these muscle 
bundles, and at these ablative doses.  Thus, ablation doses were selected that 
were not only clinically relevant, but also with a view of an acceptable model so 
that both tissue bath studies and uniaxial pull studies could be performed on the 
same muscle bundles.  These observations suggest that the sensitivity of both 
techniques (tissue baths and uniaxial pulls) may be quite different.  In other 
words, significantly higher ablative energies are required before any appreciable 
change in biomechanical properties of the esophageal tissue can be observed.  
Moreover, due to variability introduced from multiple sources, the uniaxial pull 
measurements may not be sensitive enough to discriminate small differences in 
biomechanical properties resulting from the ablation dose levels selected in this 
study.  Clinically, an increase in avulsion force means that it would require a 
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higher force to cause tissue avulsion.  This may be due to many factors of which 
the primary ones are denaturation of proteins, elastin and collagen. 
 It is considered here that our series of experiments offered a unique ability 
to collect both physiological and biomechanical data, with high level of 
consistency and repeatability.  This enabled us to closely explore highly relevant 
ablative doses, those that might be encountered clinically.  It is understood that 
there are three potential differences as far as tissue response is concerned 
between the intact whole esophagus and esophageal muscle bundles.  One, the 
intact esophagus is susceptible to secondary collateral injury from ablative 
procedures performed in a different organ.  The extent of collateral injury 
depends on the type of ablative energy used, duration, and proximity to the 
esophagus.  Moreover, these injuries generally tend to be localized to a region of 
the esophagus.  Our set of experiments mimics the collateral injury by directly 
ablating the esophageal muscle bundles in localized regions with various ablative 
treatments.  Although the way esophagus incurs damage may be different 
between the secondary collateral injuries versus direct injury, the end result is the 
same; that is cellular injury leading to esophageal dysfunction.  In view of this, 
future investigations could more closely mimic the collateral damage by including 
a biopsy of primary target organ between the ablative source and the esophageal 
muscle bundle.  Second, there will be small stimulation and electro-mechanical 
differences between the intact esophagus versus esophageal muscle bundles; as 
muscle bundles are bathed in Krebs solution in tissue baths, whereas intact 
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esophagus is perfused with normal blood within the body.  However, stimulation 
within a muscle bundle requires similar voltage gradients and transmembrane 
potentials to elicit a contraction as stimulation with the intact esophagus; and we 
feel that it is likely to show similar responses and trends in action potential 
initiation and propagation.  Lastly, the biomechanical parameters of the intact 
esophagus within its native environment will be different than those of isolated 
esophageal muscle bundles.  We believe this is not only because of the bulk 
muscle volume, but also because of its adhesion to surrounding structures and 
relation to surrounding organs.  In order to perform a fair and consistent 
comparison between muscle bundles exposed to various treatments, all 
biomechanical data was normalized either to the muscle bundle cross-sectional 
area or volume based on the quantity measured.  Nevertheless, it is these 
responses and trends that we feel are important to guide further research. 
 In this investigation, we employed four thermal ablative modalities and four 
chemical ablative agents.  Each ablative technique, although similar in purpose, 
has specific and optimal indications.  Choice of the most appropriate ablative 
modality is vital to the success of any ablative procedure.  The type of tissue to 
be ablated, regional blood flow, and the size of desired lesion are three important 
factors in this decision.  Each ablation modality has its unique advantages.  For 
example, the non-invasive, high-precision nature of HIFU makes it attractive in 
stationary or superficial regions.  Among all ablation modalities, RFA has been in 
practice for the longest time which makes it an attractive modality of choice.  One 
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of the advantages of a CRA probe is that it adheres to the target location by 
forming an ice-ball.  Therefore, CRA works well in areas where catheter 
instability is high due to relative motion between the probe and the target 
location.  MWA is one of the newer ablation techniques offering non-contact 
therapy application by electric field radiation and dielectric heating.  Although it 
may be applicable to a broader spectrum of tissues, its long-term effectiveness 
still needs to be evaluated.  Compared to any thermal ablation modality, CHA is 
the most cost-effective options as it does not require any capital equipment for 
performing ablations.  Although cheap, it is restricted to use in target areas with 
low blood perfusion rates to minimize dilution and wash out, and prevent 
systemic side effects by localizing the action of injected ablative agent. 
 Since no similar studies have been performed in this area previously, it was 
not possible to compare these results with literature.  It is important to note that 
our study approach can be considered to have a few limitations.  For example, 
only a selected number of ablation settings were used in this study, cumulative 
effects of ablations were not studied, and only uniaxial pulls were done.  
Moreover, we did not test RFA using irrigated catheters, cryoballoon ablation 
catheters, phased-array HIFU transducers, different MWA antenna designs, and 
different chemical ablative agents, all of which may have resulted in different 
findings.  Furthermore, this model can only investigate acute effects of ablation, 
i.e. within hours after ablation.  Nevertheless, we hope to make this work 
translational by utilizing human tissue when it becomes available.  The results 
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from this investigation can not only be used in understanding device-tissue 
interaction, but also aid in novel medical device design. 
 
Conclusions 
 
 In this investigation we utilized novel in vitro methodologies to assess the 
potential for esophageal injury following the therapeutic delivery of clinically 
applied ablative therapies.  Specifically, how physiological and biomechanical 
properties of esophageal tissue change as a result of exposure to various 
ablative modalities were assessed.  These results demonstrate that these 
methodologies are applicable for analyzing a spectrum of ablation modalities; 
ones that are used in this investigation and others that could be used in the 
future, for example, laser ablation and irreversible electroporation. 
 To our knowledge this is the first study of its kind to compare the effects of 
ablation modalities and dosages on both the physiological and biomechanical 
properties of isolated functional esophagus muscle bundles.  We observed 
unique dose responses for each ablation modality investigated as well as 
therapeutic differences as to their effects on the muscle parameters studies.  The 
understanding of esophageal tissue properties has wide applications ranging 
from basic research to novel medical device design.  This unique data set could 
provide important insights to both clinician as well as medical device designers 
developing clinical applied procedures.  Results from these studies could enable 
head-to-head comparison of employed ablative modalities to determine their 
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effects on tissue response.  Interpretation of these results can further be used to 
reduce complication rates, as well as increase effectiveness and overall efficacy 
of therapies.  Moreover, increasing knowledge in this area is fueling the demand 
of introducing new procedures, modifying current ones, and reducing procedural 
time to positively impact the efficiency and efficacy of treatment delivered. 
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Figure 52: Dose effects of percent change in peak force of swine 
esophagus post radiofrequency ablation (RFA) 
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Figure 53: Dose effects of percent change in baseline force of swine 
esophagus post radiofrequency ablation (RFA) 
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Figure 54: Dose effects of percent change in peak force of swine 
esophagus post cryoablation (CRA) 
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Figure 55: Dose effects of percent change in baseline force of swine 
esophagus post cryoablation (CRA) 
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Figure 56: Dose effects of percent change in peak force of swine 
esophagus post microwave ablation (MWA) 
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Figure 57: Dose effects of percent change in baseline force of swine 
esophagus post microwave ablation (MWA) 
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Figure 58: Dose effects of percent change in peak force of swine 
esophagus post high-intensity focused ultrasound ablation (HIFU) 
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Figure 59: Dose effects of percent change in baseline force of swine 
esophagus post high-intensity focused ultrasound ablation (HIFU) 
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Figure 60: Dose effects of percent change in peak force of swine 
esophagus post chemical ablation with acetic acid 
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Figure 61: Dose effects of percent change in baseline force of swine 
esophagus post chemical ablation with acetic acid 
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Figure 62: Dose effects of percent change in peak force of swine 
esophagus post chemical ablation with ethanol 
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Figure 63: Dose effects of percent change in baseline force of swine 
esophagus post chemical ablation with ethanol 
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Figure 64: Dose effects of percent change in peak force of swine 
esophagus post chemical ablation with sodium chloride 
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Figure 65: Dose effects of percent change in baseline force of swine 
esophagus post chemical ablation with sodium chloride 
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Figure 66: Dose effects of percent change in peak force of swine 
esophagus post chemical ablation with urea 
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Figure 67: Dose effects of percent change in baseline force of swine 
esophagus post chemical ablation with urea 
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Figure 68: Dose effects of percent change in peak force of swine 
esophagus post injection with Krebs-buffer solution 
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Figure 69: Dose effects of percent change in baseline force of swine 
esophagus post injection with Krebs-buffer solution 
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Figure 70: Percent change in peak force of swine esophagus for control 
and control-remove muscle bundles 
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Figure 71: Percent change in baseline force of swine esophagus for control 
and control-remove muscle bundles 
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Figure 72: Dose effects on peak force of swine esophagus for all thermal 
ablative modalities 
 
 
 
Figure 73: Dose effects on baseline force of swine esophagus for all 
thermal ablative modalities 
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Figure 74: Dose effects on peak force of swine esophagus for all chemical 
ablative modalities 
  
  
Figure 75: Dose effects on baseline force of swine esophagus for all 
chemical ablative modalities 
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Figure 76: Avulsion location for each treatment displayed as percentage for 
all swine esophagus muscle bundles tested for biomechanical assessment 
  165 
0 0.5 1 1.5 2 2.5 3
-0.1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
Strain
St
re
ss
 (M
Pa
)
Cauchy
 
 
Figure 77: Average model of stress-strain characteristics of swine 
esophagus 
Average model of stress-strain characteristics of non-ablated “control” swine 
esophagus muscle bundles (n=297). The maximum stress was 0.33 MPa and 
maximum Cauchy-stress was 0.72 MPa. The avulsion strain was 1.35. 
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Figure 78: Dose effects of radiofrequency ablation (RFA) on biomechanical 
properties of swine esophagus muscle bundles 
 
 
 
Figure 79: Dose effects of cryoablation (CRA) on biomechanical properties 
of swine esophagus muscle bundles 
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Figure 80: Dose effects of microwave ablation (MWA) on biomechanical 
properties of swine esophagus muscle bundles 
 
 
 
Figure 81: Dose effects of high-intensity focused ultrasound ablation 
(HIFU) on biomechanical properties of swine esophagus muscle bundles 
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Figure 82: Dose effects of chemical ablation with acetic-acid on 
biomechanical properties of swine esophagus muscle bundles 
 
 
 
Figure 83: Dose effects of chemical ablation with ethanol on biomechanical 
properties of swine esophagus muscle bundles 
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Figure 84: Dose effects of chemical ablation with sodium chloride on 
biomechanical properties of swine esophagus muscle bundles 
 
 
 
Figure 85: Dose effects of chemical ablation with urea on biomechanical 
properties of swine esophagus muscle bundles 
 
  170 
 
 
Figure 86: Dose effects of Krebs injections on biomechanical properties of 
swine esophagus muscle bundles 
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Figure 87: A swine esophagus muscle ablated with 50 µl of acetic acid 
Microbubbles on the ablated region of the muscle bundle are caused by 
excessive dehydration, which further leads to tissue necrosis 
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Table 7: Mean  SD characteristics of swine esophageal muscle bundles 
that underwent physiological testing in tissue baths (n=168) 
A set of 4 muscle bundles were exposed to every ablation dose 
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Table 8: Tabulation of the avulsion location of swine esophagus muscle 
bundles (n=563) as a percentage for each ablative modality 
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Table 9: Mean  SD dimensional characteristics and biomechanical 
parameters of swine esophagus muscle bundles that avulsed at or near the 
center of the muscle bundle 
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Table 10: Percent change in biomechanical properties of swine esophagus 
muscle bundles post ablation with different ablative modalities 
All values are with respect to controls (n=297, non-ablated) muscle bundles.  A 
positive value indicates an increase and a negative value a decrease with 
respect to controls.  Percent change in avulsion force, elastic modulus, strain, 
and energy are shown along with individual statistical significance (p<0.05, 
marked in bold). 
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5. Comparative Assessment of Physiological and 
Biomechanical Properties of Human Esophagus in 
Response to Therapeutic Ablative Treatments 
 
Preface 
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Introduction 
 
Our lab has unique research collaboration with LifeSource (St. Paul, MN).  
LifeSource is an organization with a mission of saving lives by transplanting 
donated organs and tissues in patients needing a transplant.  This collaboration 
allowed us to perform research on fresh human tissue (obtained within few hours 
of death) that was deemed non-transplantable.  We utilized this unique 
opportunity by performing research on human esophagus that was received 
along with the heart-lung bloc.  Collateral injury to the esophagus is a known 
complication of catheter ablations performed in the left atrium and left pulmonary 
veins.  In order to better understand the esophageal response to ablative 
therapies, it is essential to understand its physiological and biomechanical 
properties.  Thus, in this paper, we detail the physiological and biomechanical 
results obtained after ablating the human esophagus with 3 different ablative 
modalities (RFA, CRA, and HIFU).  We also utilized the squamous epithelium 
dissected from human esophagi to compare the biomechanical properties of both 
the muscularis and squamous epithelium layers.  Once the techniques and 
methodologies were perfected, experiments were performed to study the tissue 
response to above mentioned ablative modalities. 
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Methods 
  
Tissue Preparation 
 Fresh human tissue biopsies of esophagus (n=7) were obtained through 
research collaboration with LifeSource (St. Paul, MN).  Following dissectional 
separation from the heart-lung bloc, the esophagus tissue was pinned in a 
dissection dish, dissected in oxygenated, temperature-controlled Krebs-Ringer 
solution.  The muscle bundle preparation involved initially cleaning up the biopsy 
by removing excess fat and surrounding connective tissue so that well defined 
muscle bundles could be prepared.  The external muscularis and internal 
squamous epithelium layers were first separated and then tissue bundles of both 
the muscularis layer and squamous epithelial layer were prepared.  Muscle 
bundles of muscularis layer were prepared along the internal circular layer of 
muscle fibers of muscularis externa in an identifiable cuboidal shape having 
lengths of 15 to 25 mm, widths of 3 to 5 mm, and thickness of 1.5 to 3 mm.  
Tissue bundles of squamous epithelial layer were prepared in an identifiable 
cylindrical shape having lengths of 15 to 25 mm and diameters of 1.5 to 3 mm.  
The physiological testing was performed using tissue baths and biomechanical 
testing was performed using a uniaxial testing machine as described in detail in 
Chapter 2 (submitted for publication).  Note that the squamous epithelium is a 
non-contractile tissue; hence, only biomechanical tests were performed on these 
tissue bundles.  However, both physiological and biomechanical tests were 
  179 
performed on the muscularis muscle bundles.  The esophageal tissue response 
to the following three different ablation modalities was investigated: 
Radiofrequency Ablation: RFA (484 KHz sinusoidal waveform) at four different 
ablation doses were studied: 55 °C, 60 °C, 65 °C, and 70 °C (corresponding to 
534 J, 750 J, 972 J, and 1188 J energy levels, respectively). 
Cryoablation:  Cryoablation exposure (operated in the clinical mode, 
approximately -75 °C) at four different ablation doses were studied: 15 sec, 30 
sec, 60 sec, and 120 sec. 
HIFU Ablations: HIFU ablations (2.5 MHz sinusoidal waveform, 80% duty cycle) 
at four different ablation doses were studied: 272 J, 352 J, 448 J, and 480 J. 
 
Data Analyses 
 Statistical analyses were performed using ANOVA and the Tukey test to 
identify differences in peak forces and baseline forces for all ablation modalities 
where a p<0.05 is considered statistically significant.  All data are presented as 
mean  standard deviation. 
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Results 
 
Figure 88 shows a representative example of human esophageal 
muscularis muscle bundle contraction elicited by electro-mechanical stimulation.  
Also shown in the figure is a value of typical resting muscle tension and peak 
force that was generated from muscle bundles mounted in tissue baths.  Figure 
89 shows a comparison between the swine and human esophageal electro-
mechanical response.  The contraction duration was approximately 0.7 sec for 
swine esophagus samples and approximately 7 sec for human esophagus 
samples.  Contrasting differences were observed in the electro-mechanical 
response of human and swine esophagus muscle bundles.  Depending on which 
section of the human esophagus (superior, middle, or inferior) the muscle 
bundles were prepared, different response was observed, representative 
examples are shown in Figure 90.  These differences may be attributed to the 
gradual transition and spatial distribution of the skeletal, smooth, and mixed 
muscle fibers, and also due to the differences in motor innervation of neural 
supply along the entire length of the human esophagus [1,2,3].  Figure 91 and 
Figure 93 show the comparison of stress-strain characteristics of esophageal 
muscularis layer and squamous epithelial layer, respectively, between the two 
species.  A comparison of biomechanical parameters of both species, and for 
both layers was also done which is shown in Figure 92 and Figure 94.  In 
general, biomechanical properties of swine were always higher than that of 
human tissue. 
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A total number of 48 muscle bundles were studied for physiological 
assessment in tissue baths as shown in Table 11. The table summarizes the 
muscle bundle characteristics and allocations to different ablative modalities. As 
can be seen in this table, the dimensional characteristics of all muscle bundles 
were similar across different treatment groups.  However, a large variation was 
observed in the peak forces which were attributed to tissue viability.  The 
esophagus along with the heart-lung bloc was received in an ice package. It is 
conceivable that the longer the tissue sat in the package, the longer the tissue 
sustained injury due to cell death.  Hence, this could have contributed to the high 
variability in initial peak forces and baseline forces of muscle bundles observed 
with human samples. 
 
Discussions 
 
It was observed that the avulsion force and elastic modulus increased for 
both the muscularis and squamous epithelium layers as a result of RFA, but 
decreased as a result of CRA.  Moreover, the avulsion energy (which is a 
combination of peak force and avulsion stretch) increased following exposure to 
RFA and decreased following exposure to CRA.  These results could have 
important implications in terms of perforations during cardiac ablation 
procedures.  A reduction in avulsion force and energy required to cause 
avulsions means that the tissue would be susceptible to tearing/perforations with 
forces smaller than when ablations were initiated. 
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Figure 88: Human esophagus electro-mechanical response 
A representative example of human esophageal muscularis muscle bundle 
contraction elicited by electro-mechanical stimulation.  This muscle bundle has a 
resting muscle tension of approximately 3.5 grams and is generating a peak 
force of approximately 21.5 grams.  The contraction duration is approximately 10 
sec. 
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Figure 89: Comparison of electro-mechanical response of swine and 
human esophageal muscle bundles 
The data is normalized to the peak force of individual muscle bundle samples.  
Both the swine and human esophageal muscle bundles were stimulated once 
every 30 seconds with a train of 8 square-wave pulses of 1.0 ms duration and a 
pulse interval of 30 ms.  The approximately contraction duration of swine 
esophagus was 0.7 sec, whereas, the approximate contraction duration of 
human esophagus was 7 seconds. 
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Figure 90: Variability in electro-mechanical response of human esophagus 
 
Variability in the electro-mechanical response of human esophagus was 
observed while performing tissue bath studies.  This variability could be attributed 
to a number of reasons, for example, (1) the spatial distribution (gradual 
transition) of skeletal, smooth, and mixed muscle fibers along the entire length of 
the human esophagus, (2) differences in motor neural supply to the esophagus 
(striated muscles of the human esophagus are innervated by the lower motor 
neurons in the brain stem, whereas, smooth muscle are innervated by the nerve 
fibers that originate in the dorsal motor nucleus of the vagus).  Nevertheless, a 
thorough understanding of this anatomic and electrical variability is crucial to 
assessing differences in species, designing medical devices, and measuring 
esophageal response to ablative therapies. 
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Figure 91: Stress-Strain response of swine and human esophagus 
muscularis layer 
Average stress-strain model of non-ablated samples from both species was 
created.  Characteristic differences between the two species were observed, 
where stress-strain behavior of swine was consistently higher than human 
samples. 
 
 
 
Figure 92: Comparative assessment of human and swine esophagus 
biomechanical properties of muscularis layer 
With respect to the human values, the percent change in swine values were: (1) 
avulsion force (+141.50%), (2) elastic modulus (+140.81%), (3) avulsion strain (-
15.77%), (4) total strain (-21.44%), (5) avulsion energy (+119.95%), (6) total 
energy (+95.54%).  All values were statistically significant. 
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Figure 93: Stress-Strain response of swine and human esophagus 
squamous epithelium layer 
Average stress-strain model of non-ablated samples from both species was 
created.  Characteristic differences between the two species were observed, 
where stress-strain behavior of swine was consistently higher than human 
samples. 
 
 
Figure 94: Comparative assessment of human and swine esophagus 
biomechanical properties of squamous epithelium layer 
With respect to the human values, the percent change in swine values were: (1) 
avulsion force (+51.50%), (2) elastic modulus (-32.88%), (3) avulsion strain 
(+84.02%), (4) total strain (+21.31%), (5) avulsion energy (+198.23%), (6) total 
energy (+104.56%).  All values were statistically significant. 
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Figure 95: Dose effects of percent change in peak force of human 
esophagus post RFA 
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Figure 96: Dose effects of percent change in baseline force of human 
esophagus post RFA 
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Figure 97: Dose effects of percent change in peak force of human 
esophagus post CRA 
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Figure 98: Dose effects of percent change in baseline force of human 
esophagus post CRA 
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Figure 99: Dose effects of percent change in peak force of human 
esophagus post HIFU ablation 
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Figure 100: Dose effects of percent change in baseline force of human 
esophagus post HIFU ablation 
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Figure 101: Percent change in peak force of “control” human esophagus 
muscle bundles 
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Figure 102: Percent change in baseline force of “control” human 
esophagus muscle bundles 
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Figure 103: Avulsion location for each treatment displayed as percentage 
for all human esophagus muscle bundles tested for biomechanical 
assessment 
 
 
 
Figure 104: Avulsion location for each treatment displayed as percentage 
for all human esophageal squamous epithelium tissue bundles tested for 
biomechanical assessment 
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Table 11: Mean  SD characteristics of human esophageal muscle bundles 
that underwent physiological testing in tissue baths (n=48) 
A set of 4 muscle bundles were exposed to RFA and CRA ablation modalities 
and a set of 2 muscle bundles were exposed to the HIFU ablation modality. 
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Table 12: Tabulation of the avulsion location of human esophagus 
muscularis layer muscle bundles (n=120) and squamous epithelium layer 
tissue bundles (n=44) as a percentage for each ablative modality 
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Table 13: Mean  SD dimensional characteristics and biomechanical 
parameters of human esophagus muscularis layer muscle bundles and 
squamous epithelium layer tissue bundles that avulsed at or near the 
center of the bundle 
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Table 14: Percent change in biomechanical properties of human esophagus 
muscularis layer muscle bundles and squamous epithelium layer tissue 
bundles post ablation with different ablative modalities 
All values are with respect to respective controls.  A positive value indicates an 
increase and a negative value a decrease with respect to controls.  Percent 
change in avulsion force, elastic modulus, strain, and energy are shown along 
with individual statistical significance (p<0.05, marked in bold). 
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6. Assessment of Physiological and Biomechanical 
Properties of Human Vastus Lateralis in Response to 
Therapeutic Ablative Treatments 
 
Ashish Singal, Charles L. Soule, Paul A. Iaizzo 
 
Preface 
 
Our lab is one of the diagnostic centers for an autosomal dominant 
disorder called malignant hyperthermia (MH).  We often receive a biopsy of a 
human skeletal muscle (usually vastus lateralis) for clinical assessment of MH.  
Whenever possible, the waste human tissue left following the MH studies was 
utilized for assessment of physiological and biomechanical properties of the 
vastus lateralis skeletal muscle.  Although there are vast similarities in different 
muscles of the body, there may be unique differences in each muscle type, in 
terms of how the muscle responds to ablative therapies and their biomechanical 
properties.  Hence, the methodologies described in this investigation were used 
to quantify the effects of ablation on the physiological and biomechanical 
properties of the vastus lateralis muscle obtained from humans. 
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Introduction 
 
The role of thermal ablative therapies continues to expand.  Treating 
cardiac arrhythmias as well as ablative treatment of soft tissue hepatic and renal 
tumors has become common [1,2].  Musculoskeletal therapies of radiofrequency 
ablation of osteoid osteoma are performed with good outcomes [3].  While rare, 
skeletal muscle metastases of primary tumors have been reported, RFA has 
been indicated for treatment of these metastases [4,5,6,7,8].  Furthermore, RFA 
treatment of varicose veins and chronic venous ulcers has been utilized 
successfully [9,10]. 
In general there is a low but significant occurrence of complications using 
thermal ablative therapies [11].  Among those seen during atrial and pulmonary 
vein isolation treatments are esophageal injury, phrenic nerve injury, pericardial 
effusion/tamponade, and injury to lungs [11].  Furthermore, there have been 
reports of pneumothorax induced by RFA for hepatocellular carcinoma treatment 
beneath the diaphragm under real-time computed tomography-fluoroscopic 
guidance [12,13,14,15].  As applications of musculoskeletal thermo ablative 
modalities increase, it is likely to see similar trends in collateral damage.  Further 
complicating potential musculoskeletal ablative therapies is presentation of 
compromised surrounding tissues.  For instance osteoblastomas and osteiod 
osteomas can present with skeletal muscle atrophy [16,17].  To better 
understand how thermal ablative therapies might affect nearby skeletal muscle, it 
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is essential to study both their physiological and biomechanical properties in 
response to various therapeutically used ablative modalities. 
In our lab, we have developed methodologies (Chapter 2, in press) that 
systematically allowed assessment of both physiological and biomechanical 
properties of human vastus lateralis muscle in response to radiofrequency 
ablation (RFA), cryoablation (CRA), and microwave ablation (MWA). 
 
Methods 
 
These studies were approved by the Institutional Review Board at the 
University of Minnesota.  The human vastus lateralis muscle used in this study 
was tissue considered as waste tissue following completion of a clinical 
diagnostic contracture test for MH.  Muscle fiber segments approximately 40 mm 
in length and 15 mm in width were dissected under local anesthesia or with 
anesthetics not considered to trigger MH [18].  These fiber segments were 
immediately placed in oxygenated Krebs buffer solution and transported to the 
lab (within 5 minutes) where it was pinned in a dissection dish and further 
dissected in oxygenated Krebs buffer solution to make smaller muscle bundles of 
approximately 25 mm in length and 2 mm in diameter in an identifiable cylindrical 
shape for physiological contracture testing [19,20]. 
Following completion of the MH contracture testing, waste tissue muscle 
bundles including bundles not required for contracture testing and those bundles 
exposed to 10 minutes of 3% halothane (not less than 90 minutes after halothane 
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exposure was stopped) were included in this study.  These muscle bundles were 
used for physiological and biomechanical assessment as described previously 
[Singal et al, 2014].  The muscle bundles were exposed to the following ablation 
modalities and doses, which were used in this investigation: 
Radiofrequency Ablation: RFA at three different ablation doses were studied: 50 
°C, 60 °C, and 70 °C (corresponding to 312 J, n=4; 739 J, n=5; and 1169 J, n=5, 
respectively). 
Cryoablation: CRA at three different ablation doses were studied: 15 sec (n=3), 
30 sec (n=3), and 60 sec (n=3). 
Microwave Ablation: MWA at three different ablation doses were studied: 410 J 
(n=3), 821 J (n=4), and 1231 J (n=3). 
Controls: Both control (n=10) and control-remove (n=8) muscle bundles were 
evaluated. Control muscle bundles were those that were left in the tissue baths; 
and control-remove muscle bundles were those that that were exposed to the 
same conditions as the experimental group, except no ablations were performed. 
 
Results 
 
A total of 87 muscle bundles were prepared from biopsies obtained from 9 
patients for physiological and biomechanical assessment.  RFA, CRA, and MWA 
modalities were used for performing ablations.  The RF ablation parameters were 
recorded during RFA, and the plot of average power as a function of average 
temperature is shown in Figure 105.  A best, linear fit model was used to 
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calculate the average power at respective ablation doses, which was further used 
to calculate the ablation energy at the RF catheter.  Figure 106 shows 
representative examples of muscle bundles that were ablated with the above 
mentioned ablation modalities.  Figure 107 through Figure 112 show the dose 
effects of percent change in peak force and baseline force for all three ablation 
modalities.  A dose dependent sustained reduction in peak force and a transient 
increase in baseline force were observed in each treatment case.  The baseline 
force consistently returned near or below the pre-ablation level for every ablation 
modality investigated.  Similar changes in peak force and baseline force of 
control and control-remove muscle bundles were observed (Figure 113 and 
Figure 114).  This suggests that there were minimal changes in muscle 
physiology when muscle bundles were removed from tissue baths for performing 
ablations.  Table 15 shows the biomechanical parameters of muscle bundles 
tested in each treatment group.  As can be seen in Table 16, in general, there 
was a reduction in every biomechanical parameter in every treatment group with 
respect to controls, except in the MWA group.  A statistically significant increase 
in the elastic modulus and a non-significant increase in the avulsion force were 
observed as a result of MWA.  Table 17 shows the percent avulsion location for 
every ablation modality which is graphically shown in Figure 115.  
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Discussion 
 
Avulsion forces were consistently higher than physiologically induced 
forces.  With our stimulation protocol, twitch forces on top of the normal baseline 
force was generally much less than half of avulsion forces seen in either control 
group.  Interestingly though, during contracture testing for MH the additive doses 
of caffeine especially can bring physiological forces much closer to avulsion.  In 
fact, at 32 mM caffeine concentration, the dose used to identify the validity of the 
contracture testing with maximal sustained contracture, the total physiological 
forces can reach as high as 75% of these avulsion forces (data not shown).  With 
such a low margin of error in avulsion forces these data reinforce the importance 
of not only maintaining good technique in dissection of the tissue bundles, but 
also in tying suture loops to the ends of cut tissue like the vastus lateralis.  
Whereas intact tendon to tendon muscle bundles allow the additional strength of 
connective tissue at the suture tissue interface, these cut bundles are tied directly 
to the muscle fibers creating a compression of tissue near the suture.  This 
compression has already been shown to cause a zone of depolarization at the 
suture underpinning the physiological changes that these sutures cause [18].  
For biomechanical assessment, superglue was applied on both ends of the 
muscle bundle to strengthen the suture-tissue interface so that higher percentage 
of avulsions could be obtained near the center of the muscle bundle. 
In general for both RFA and MWA treatments, physiological response to 
ablations was more sensitive to the ablations while CRA had a similar response 
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compared to swine diaphragm tissue (Chapter 3, in press).  These changes 
could be related to either tissue type or species differences.  If these differences 
are related to tissue type though it suggests that physiologically collateral 
damage by heating thermal therapies could be greater in treating 
musculoskeletal disorders. In patients such as those presenting with muscle 
atrophy, collateral damage could be more problematic. 
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Figure 105: Average power versus catheter tip temperature for human 
vastus lateralis 
Plot of average RF power as a function of average temperature (n=25) at the RF 
catheter tip measured during the ablation.  The samples were exposed to varying 
levels of RF dose (increasing temperature), out of which 3 different doses were 
selected to study the dose effects (50 °C, 60 °C, and 70 °C).  A linear curve was 
fitted through the data to obtain the best fit equation what was used to calculate 
the average power at respective ablation temperatures. 
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Figure 106: Representative examples of human vastus lateralis samples 
ablated with MWA (A), B (CRA), C (RFA).  Control samples (non-ablated) are 
shown in D 
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Figure 107: Dose effects of percent change in peak force of human vastus 
lateralis post RFA 
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Figure 108: Dose effects of percent change in baseline force of human 
vastus lateralis post RFA 
  205 
‐120
‐100
‐80
‐60
‐40
‐20
0
15 s 30 s 60 s
%
 C
ha
ng
e 
in
 P
ea
k 
Fo
rc
e
 
Figure 109: Dose effects of percent change in peak force of human vastus 
lateralis post CRA 
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Figure 110: Dose effects of percent change in baseline force of human 
vastus lateralis post CRA 
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Figure 111: Dose effects of percent change in peak force of human vastus 
lateralis post MWA 
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Figure 112: Dose effects of percent change in baseline force of human 
vastus lateralis post MWA 
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Figure 113: Percent change in peak force of control and control-remove 
human vastus lateralis muscle bundles 
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Figure 114: Percent change in baseline force of control and control-remove 
human vastus lateralis muscle bundles 
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Figure 115: Avulsion location for each treatment displayed as percentage 
for all human vastus lateralis muscle bundles tested in this investigation 
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Table 15: Mean  SD dimensional characteristics and biomechanical 
parameters of human vastus lateralis muscle bundles that avulsed at or 
near the center of the muscle bundle 
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Table 16: Percent change in biomechanical properties of human vastus 
lateralis muscle bundles post ablation with different ablative modalities. 
All values are with respect to controls (n=8, non-ablated) muscle bundles.  A 
positive value indicates an increase and a negative value a decrease with 
respect to controls.  Percent change in avulsion force, elastic modulus, strain, 
and energy are shown along with individual statistical significance (p<0.05, 
marked in bold). 
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Table 17: Tabulation of the avulsion location of human vastus lateralis 
muscle bundles (n=78) as a percentage for each ablative modality 
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7. The Assessment of Physiological and Biomechanical 
Properties of Isolated Swine and Human Trabeculae in 
Response to Clinically Applied Ablative Therapies 
 
Ashish Singal, Charles L. Soule, Paul A. Iaizzo 
 
Preface 
 
Our plan is to submit this article as a research paper in the Journal of Medical 
Devices 2015. 
 
Introduction 
 
Catheter ablations are often performed in the heart to treat drug refractory, 
idiopathic, and intractable arrhythmias.  Specifically, ablations are performed in 
the left and right atrium (LA and RA), pulmonary veins (PVs), and the ventricles 
for treatments of atrial fibrillation (AF) [1] or ventricular arrhythmias [2].  In 
general, the goal of ablations is to create a series of transmural lesions to 
selectively ablate (and kill) the arrhythmogenic substrate responsible for irregular 
rhythm.  In most of the ablative modalities used clinically today (like 
radiofrequency ablation and cryoablation), only the temperature and duration of 
the energy delivered can be controlled [3].  Since there is no accurate way to 
control the radial extent and depth of the lesion created, it is possible to create a 
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lesion that is too wide or too deep, consequently causing injury to healthy 
endocardium or even adjacent vital structures.  Nevertheless, delivery of ablative 
energy results in alterations of physiological and biomechanical properties of 
myocardium.  In this investigation, we sought out to investigate how the 
physiological and biomechanical properties of human and swine trabecular 
muscle bundles are affected by two ablation modalities: radiofrequency ablation 
(RFA) and high-intensity focused ultrasound (HIFU). 
  
Methods 
 
The study was approved by the University of Minnesota Institutional 
Animal Care and Use Committee.  Fresh ventricular biopsies were obtained from 
healthy castrated male Yorkshire-cross swine (n=3, mean weight of 
approximately 70 kg).  Fresh biopsies from human hearts (n=3) were obtained 
through research collaboration with LifeSource (St. Paul, MN).  The heart 
biopsies were dissected in oxygenated cardiac Krebs solution to prepare isolated 
muscle bundles from endocardial trabeculations.  Muscle bundles were prepared 
in an identifiable cylindrical shape having lengths of 10 to 15 mm and diameters 
of 2 to 4 mm.  The physiological testing was performed using tissue baths and 
biomechanical testing was performed using a uniaxial testing machine as 
described in detail in Chapter 2.  The tissue response to following two ablation 
modalities was investigated: 
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Radiofrequency Ablation: RFA was performed using the RF generator operating 
at 484 KHz sinusoidal waveform.  Human and swine trabeculae muscle bundles 
were studied at five different ablation doses ranging between: 50 °C, 55 °C, 60 
°C, 65 °C, and 70 °C.  A total of 16 human and 8 swine trabecular muscle 
bundles were utilized for RFA testing.  All RFA were performed under a constant 
catheter-tip force of 10 grams (0.1 N) under the uniaxial machine. 
HIFU Ablations: HIFU ablations (2.5 MHz sinusoidal waveform, 80% duty cycle) 
at two different ablation doses were studied for human trabeculae muscle 
bundles only at the following doses: 286 J and 715 J.  A total of 6 human 
trabeculae muscle bundles were utilized for HIFU ablation testing. 
Controls: There were two sets of control muscle bundles.  One, that were left in 
the tissue bath for the entire experiment; and two, that were removed from the 
tissue baths and exposed to the same set of ablation conditions as the 
experimental muscle bundles, except they were not ablated.  A total of 2 human 
trabeculae muscle bundles were used, and 6 swine trabeculae muscle bundles 
were used as control muscle bundles. 
A separate group of swine trabeculae muscle bundles (n=23) were ablated 
with 200 proof ethanol.  These muscle bundles were only tested for uniaxial pulls 
following ablations with ethanol. 
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Data Analyses 
 Statistical analyses were performed using ANOVA and the Tukey test to 
identify differences in peak forces and baseline forces for both ablation 
modalities (RFA and HIFU) where a p<0.05 is considered statistically significant.  
All data are presented as mean  standard deviation. 
 
Results 
 
Figure 116 show comparison of normalized electro-mechanical response 
of swine and human trabeculae muscle bundles, which were observed to be very 
similar.  These twitch responses were measured in the tissue baths with 1 ms 
electrical field stimulation from platinum electrodes adjacent to the muscle 
bundles.  Figure 117 and Figure 118 show the percent change in peak force and 
baseline force of human trabeculae muscle bundles, respectively, in response to 
RFA.  In this case, data was acquired for duration of 75 min post-RFA.  Although 
some dose-effect trends can be observed in peak force, but no consistent trends 
are observed in baseline force.  As can be observed, the percent reduction in 
peak force is related to the ablative dose, where a larger reduction is observed at 
higher doses.  Moreover, the results have high variability which can be attributed 
to a small sample size of muscle bundles tested.  Figure 119 and Figure 120 
show the percent change in peak force and baseline force of human trabeculae 
muscle bundles, respectively, in response to HIFU ablations.  In this case, data 
was acquired for duration of 135 min post HIFU ablations.  Although only 2 
ablation doses were used, no dose effects were evident in ether the peak forces 
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or baseline forces.  Figure 123 and Figure 124 illustrate the percent change in 
peak force and baseline force, respectively, of swine trabeculae muscle bundles 
in response to RFA.  Once again, no dose effects were evident in either peak 
force or baseline force in response to RFA.  The transient increase in peak force 
at 70 °C suggests that the given muscle bundle may not have completely 
recovered and stabilized following mounting in the tissue bath.  The respective 
control and control-remove characteristics are also shown for both species in 
Figure 121, Figure 122, Figure 125, and Figure 126. 
 Figure 127 shows the stress-strain characteristics of swine and 
human trabeculae muscle bundles.  As can be observed in this figure, the 
highest stresses were measured from the moderator bands that are found in the 
right ventricle of the heart; which typically extend from the inter-ventricular 
septum to the base of the anterior papillary muscle.  The moderator bands 
naturally possess a cylindrical shape and are far more uniform in shape than the 
rest of the trabecular muscle bundles that were dissected.  Because of their 
uniform cylindrical shape, the cardiac muscle fiber bundles are densely packed in 
a longitudinal fashion, which not only impart mechanical strength to the lateral 
and medial wall of the right ventricle, but also efficiently transmit action 
potentials.  Thus, the moderator bands registered the maximum forces as they 
were longitudinally stretched resulting in highest stress-strain characteristics.  
However, because of their native cylindrical shape, a dog-bone shape could not 
be imparted to the moderator band muscle bundles.  Due to this, during the 
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uniaxial pull, the suture often slipped from either the top or bottom end of the 
muscle bundle.  Figure 128 shows the average stress-strain model derived by 
averaging the individual stress-strain response of each of the swine and human 
trabeculae muscle bundles.  Table 18 shows the dimensional characteristics and 
biomechanical parameters of swine and human trabeculae muscle bundles that 
were tested in this investigation.  As can be observed in this table, with respect to 
controls, for the human trabeculae muscle bundles, the average avulsion force 
and elastic modulus increased by 69.6% and 163.6%, respectively, following 
treatment with HIFU ablation.  Alternatively, the average avulsion force and 
elastic modulus decreased by 17.4% and 12.1%, respectively, following 
treatment with RFA.  In case of swine trabeculae muscle bundles, the avulsion 
force and elastic modulus increased by 60.9% and 33.3%, respectively, following 
treatment with RFA.  Alternatively, the average avulsion force and elastic 
modulus decreased by 17.4% and 25%, respectively, following treatment with 
ethanol.  No significant changes were observed in the biomechanical properties 
of study-control muscle bundles in both species.  On an average, the avulsion 
force and elastic modulus between the two species was found to be similar, that 
is, 0.23 N/mm2 and approximately 0.35 N/mm2, respectively.  However, the 
avulsion strain and total strain for both species was found to be different with 
swine being lower than human.  Hence, the energies required for avulsion and 
total energy were lower for the swine species as well. 
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Discussions 
 
Our laboratory has developed unique methodologies to assess the 
physiological and biomechanical properties of tissues.  In this investigation we 
tested the response of isolated trabeculae muscle bundles of swine and human 
to different ablative modalities.  We report that the tissue properties of both 
species tested change, and that they respond differently to ablative modalities, 
which can be measured using the methodologies detailed previously (Chapter 2).  
To our knowledge no literature exists exploring the comparative changes in 
tissue properties as a result of application of different therapeutic ablative 
modalities, but work is ongoing in our laboratory to study these investigations. 
The variability observed in these results is large which is due to 
multifactorial reasons.  One of the major reasons for variability is the viability of 
the tissue before the experiment is started.  Specifically, the duration from time of 
death of the donor to the time when isolated muscle bundles are prepared and 
mounted in tissue baths for study is quite variable.  Our experience has shown 
that longer duration affects the viability of the cardiac tissue due to hypoxia, 
ischemia, and cellular injury.  It has been shown that myocardium is a 
metabolically demanding active organ relying on a constant source of oxygen, 
which is highly susceptible to ischemic and hypoxic injury [4].  Moreover, we 
have consistently observed that the isolated trabeculae muscle bundles from 
either species do not generally generate large forces.  Often the peak forces 
measured in tissue baths are <1 gram after mounting, and typically the baseline 
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forces would rise for approximately 1 hour until they stabilize.  The rise in 
baseline forces (rising baseline tension) is often correlated with contracture or 
some form of cellular injury.  It should be noted that the muscle bundles rely on 
passive diffusion for nutrients and oxygen to diffuse into the core of the muscle 
bundle.  Hence, the viability of muscle fibers is in a way related to the diameter of 
the muscle bundle, where a thicker diameter muscle bundle may suffer a far 
greater hypoxic injury as compared to a thinner diameter muscle bundle.  
Ultimately, the small peak forces limit the number of muscle bundles that can be 
utilized for experimental studies.  Another source of variability is because of the 
small/limited sample size.  We believe that increasing the sample size would 
reduce variability and increase in the confidence level of results. 
All RFA on trabeculae muscle bundles in both species were performed 
under a constant catheter-tip force of 10 grams (0.1 N) under the uniaxial 
machine.  The muscle bundle were stretched and pinned longitudinally in the 
ablation dish.  The catheter had a hemispherical round tip that approached the 
muscle bundle perpendicularly to apply a constant force on the muscle bundle.  
Because of the cylindrical shape of the muscle bundle and round shape of the 
catheter-tip, the catheter would slip lying next to the muscle bundle and not 
imparting the constant force as planned.  Unlike other muscle bundles tested 
(like, diaphragm and esophagus), this issue was specific to the trabecular muscle 
bundles because of their morphology and shape.  The differences observed in 
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dose-effects as a result of RFA could be possible explained by catheter-tissue 
interaction behavior. 
It is hoped that as more data are collected on swine and human tissue 
samples, the questions regarding species differences and differences between 
healthy and diseased state can be answered. 
 
Conclusions 
 
Here we employed a novel in vitro methodological approach to begin to 
understand how ablative modalities may influence properties of cardiac 
trabeculae from swine and human species.  Despite current clinical use, 
questions regarding dosing, thermal injury, choice of modality, and device-tissue 
interactions remain unanswered. 
Our data shows that ablations performed at clinically relevant doses 
influences the properties of trabeculae of both species.  Higher ablative energies 
result in higher levels of cellular injury in both species causing larger reductions 
in peak forces.  However, due to high variability in baseline force (resting muscle 
tension), no firm conclusions could be made.  Though, higher baseline forces 
result in contracture, which is considered as a surrogate of cellular injury. 
The peak stress to avulsion for swine trabeculae was found to be 
approximately 50% higher than human samples; however, the avulsion-strain 
was approximately 40% lower.  These results could have important clinical 
implications, especially for interventional catheter design for procedures where 
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cardiac interventions are required.  Nevertheless, further work is needed to 
determine if these differences are due to species differences or from healthy 
versus diseased myocardium. 
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Figure 116: Comparative electro-mechanical response of swine and human 
trabeculae 
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Figure 117: Percent change in peak force of human trabeculae muscle 
bundles post RFA 
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Figure 118: Percent change in baseline force of human trabeculae muscle 
bundles post RFA 
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Figure 119: Percent change in peak force of human trabeculae muscle 
bundles post HIFU ablation 
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Figure 120: Percent change in baseline force of human trabeculae muscle 
bundles post HIFU ablation 
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Figure 121: Percent change in peak force of control and control remove 
muscle bundles of human trabeculae 
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Figure 122: Percent change in baseline force of control and control remove 
muscle bundles of human trabeculae 
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Figure 123: Percent change in peak force of swine trabeculae muscle 
bundles post RFA 
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Figure 124: Percent change in baseline force of swine trabeculae muscle 
bundles post RFA 
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Figure 125: Percent change in peak force of control muscle bundles of 
swine trabeculae 
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Figure 126: Percent change in baseline force of control muscle bundles of 
swine trabeculae 
 
  227 
0 1 2 3 4 5
-0.2
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
Strain
St
re
ss
 (M
Pa
)
Human Trabeculae (Non-Ablated)
0 0.5 1 1.5 2 2.5 3 3.5 4
-0.2
0
0.2
0.4
0.6
0.8
1
1.2
Strain
St
re
ss
 (M
Pa
)
Swine Trabeculae (Non-Ablated)
Moderator BandModerator Bands
 
Figure 127: Stress-strain characteristics of swine and human trabeculae 
muscle bundles 
Stress-strain characteristics of swine trabeculae (left, n=117) and human 
trabeculae (right, n=34) muscle bundles.  The moderator bands naturally possess 
a cylindrical shape and are far more uniform in shape than the rest of the 
trabecular muscle bundles that were dissected.  They registered maximum forces 
during the uniaxial pulls.  
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Figure 128: Average model of stress-strain characteristic of swine (left) and 
human (right) trabeculae 
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Table 18: Mean  SD dimensional characteristics and biomechanical 
parameters of human and swine trabeculae muscle bundles 
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Thesis Summary 
Ablation is a routine medical procedure that is used worldwide.  As with 
any medical procedure, a thorough understanding of the procedural details, 
underlying biophysics, and device-tissue interactions is essential.  For the 
clinician, this understanding is paramount to deliver safe and efficacious therapy.  
For the medical device engineer, this knowledge is fundamental to design and 
develop medical devices.  Since ablative energy directly affects the target tissue, 
it is necessary to assess the changes in tissue properties as a result of ablations.  
Moreover, there are a plethora of ablative modalities used clinically, which makes 
the problem not only complex, but also challenging.  In view of this, the question 
still remains: What is the impact of ablative modalities on tissues? 
 As part of these research investigations, there were several learnings.  
These learnings provided a platform for development of study protocols, 
execution of ablative studies, analysis of data, and drawing conclusions.  These 
conclusions helped answer some questions, but opened up a whole new 
spectrum of areas worth investigation in future.  Highlighted below are learnings, 
conclusions, and future outlook. 
 
Learnings: 
 Ablations are performed throughout the human body in numerous 
anatomical locations for treating various carcinomas and disease 
conditions 
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 In general, ablative modalities are characterized in two categories: thermal 
and chemical 
 Although there are numerous ablative modalities that are used clinically, 
for my studies, I used 4 thermal ablation modalities (radiofrequency 
ablation, cryoablation, microwave ablation, and high-intensity focused 
ultrasound ablations), and 4 chemical ablative agents (acetic acid, 
ethanol, hypertonic sodium chloride, and urea)  
 Some of the other ablative modalities include: laser ablation, irreversible 
electroporation, photodynamic therapy, electrosurgical, and ablations 
using nanoparticles 
 Typically, the location and size of tumor dictates the choice of ablation 
modality, however, therapy choices and applications continue to expand 
 Although considered to be relatively safe procedures, ablative treatments 
can result in significant collateral injury to adjacent structures that might 
have severe clinical implications 
 Examples of collateral injury include damage to the diaphragm while 
performing ablations in the liver for treatment of liver carcinoma, and 
damage to the esophagus while performing ablations in the heart for 
treatment of atrial fibrillation 
 The incidence and prevalence of collateral injury due to various ablative 
modalities is variable 
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 Several techniques and procedures have been implemented to reduce the 
incidence of collateral injury, but it still remains an unsolved medical need 
 Ablations directly affect the target tissue properties 
 In order to assess the quality and efficacy of applied ablative therapy, and 
minimize collateral injury, it is essential to understand how tissues respond 
to ablations 
 In an attempt to gain this understanding, changes in physiological and 
biomechanical properties of ablated tissues in response to ablative 
energies were quantified 
 However, the question still remains: What is the impact of ablative 
modalities on tissues? 
 
Conclusions: 
 We developed unique methodologies to study the physiological and 
biomechanical properties of tissues in response to various ablative 
modalities 
 These methodologies are applicable for analyzing a spectrum of ablation 
modalities; ones that were used in this investigation and others that could 
be used in the future, for example, laser ablation, irreversible 
electroporation, photodynamic therapy, and electro-surgery. 
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 Designed and conducted over 125 experiments and executed 
approximately 2500 isolated muscle bundle studies from 19 different 
tissues (8 human and 11 swine) 
 To our knowledge this is the first study of its kind to compare the effects of 
ablation modalities and dosages on both the physiological and 
biomechanical properties of isolated functional muscle bundles. 
 Physiological and biomechanical properties of different tissues that are 
susceptible to collateral injury during ablative treatments were 
characterized. 
 Our results demonstrated noteworthy dose responses in physiological 
properties for each tissue type and each ablation modality investigated. 
 Specifically, a given tissue responds to different ablative modalities 
differently, and a  given ablative modality affects different tissues 
differently 
 We are now capable of selecting ablative doses at appropriate clinical 
settings to perform ablations, as well as studying dosing requirements to 
achieve a given level of tissue injury. 
 Each ablative technique, although similar in purpose, has specific and 
optimal indications. 
 Choice of the most appropriate ablative modality is vital to the success of 
any ablative procedure.  The type of tissue to be ablated, regional blood 
  233 
flow, and the size of desired lesion are three important factors in this 
decision. 
 Each ablation modality has its unique advantages.  For example, the non-
invasive, high-precision nature of HIFU makes it attractive in stationary or 
superficial regions.  Among all ablation modalities, RFA has been in 
practice for the longest time which makes it an attractive modality of 
choice.  One of the advantages of a CRA probe is that it adheres to the 
target location by forming an ice-ball.  Therefore, CRA works well in areas 
where catheter instability is high due to relative motion between the probe 
and the target location.  MWA is one of the newer ablation techniques 
offering non-contact therapy application by electric field radiation and 
dielectric heating.  Although it may be applicable to a broader spectrum of 
tissues, its long-term effectiveness still needs to be evaluated.  Compared 
to any thermal ablation modality, CHA is the most cost-effective options as 
it does not require any capital equipment for performing ablations.  
Although cheap, it is restricted to use in target areas with low blood 
perfusion rates to minimize dilution and wash out, and prevent systemic 
side effects by localizing the action of injected ablative agent. 
 Unique methodologies were developed to test the mechanical strength of 
tissues under the uniaxial pull machine 
 Sophisticated algorithms along with automated data analysis routines 
were implemented to translate raw data into tangible, meaningful results 
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 Our results did not demonstrate dose responses in biomechanical 
properties for any tissue investigated, due to multifactorial reasons 
 Significant changes in biomechanical properties were observed as a result 
of ablative treatments in terms of altered avulsion forces, elastic moduli, 
strains, and energies 
 Conventional and true (Cauchy) stress-strain characteristics of each tissue 
type were derived 
 Nevertheless, in spite of all the advances in the field, ablations are still 
considered a combination of art and science 
 
Future: 
 The translational component of this work could span a broad spectrum, 
such as: (1) provide novel insights into precise ablation techniques, (2) 
provide data for procedural modeling and dosing optimization, (3) 
assessment of post-ablation differences between healthy and diseased 
tissues, (4) increasing the safety and efficacy of ablative procedures. 
 The knowledge gained from these investigations can help the medical 
community by making an impact in the following areas:  (1) reducing 
procedure times, (2) reducing procedure costs, (3) minimizing procedure 
invasiveness, and (4) increasing procedure safety and effectiveness to 
achieve better outcomes. 
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 The innovative component of this work could serve as a platform for 
developing new tools and medical devices, such as novel catheters, that 
can assess the electrical and biomechanical properties of ablated tissue in 
real-time that further helps to increase the safety and efficacy of ablative 
procedures. 
 Combined knowledge of tissue properties can aid in better understanding 
of the device-tissue interactions to minimize collateral injury to surrounding 
structures while performing ablations. 
 The methodologies developed herein can allow experimentation with other 
ablative modalities to include, laser, irreversible electroporation, 
photodynamic therapy, and electro-surgery. 
 Assessment of physiological and biomechanical properties can potentially 
increase the efficacy and effectiveness of ablation procedures performed. 
 Although there were 19 different tissue types assessed in this 
investigation, this methodology can be applied to investigate any tissue 
 Assessment of catheter-tip contact force measurements as that plays a 
key role in catheter based ablation therapies 
 It is clear that understanding of collateral damage at the cellular level, 
isolated tissue level, and whole heart level will be important to the future of 
this evolving era of ablations. 
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To conclude, the work included in this thesis was highly collaborative and 
novel pursuits.  These are innovative methodologies that have been developed in 
the Visible Heart Lab and can be applied to make a positive impact in the field of 
ablations. 
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Appendix 1: Assessment of Physiological Properties of 
Respiratory Diaphragm: Preliminary Ablation Studies 
Performed in Tissue Baths 
 
Introduction: A series of studies were performed to develop the methodologies 
for assessing physiological properties of various tissues in response of ablative 
treatments.  Initial studies were performed to investigate if ablations could be 
performed within the tissue baths itself, so that removal of the muscle bundles 
from the tissue baths to perform ablations could be avoided.  The experience 
gained from executing these studies helped mature the overall experimental 
protocol; and results from these studies helped mature the physiological 
assessment methodologies. 
 
Methods: The same RFA and CRA ablation systems/equipment as described in 
the “Methods” chapter was used in these investigations.  After the pre-ablation 
data was acquired, RFA and CRA catheters were introduced inside the tissue 
baths as shown in Figure 129 to perform ablations on muscle bundles within the 
tissue baths itself.  Ablation catheters were stabilized by hand and by mounting 
on a stand during ablations.  RFA was performed at 6 different doses: 50 °C 
(n=5), 55 °C (n=3), 60 °C (n=5), 65 °C (n=3), 70 °C (n=5), and 80 °C (n=2).  The 
RFA system settings were set to 50 W of RF power and 1 min ablation duration.  
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CRA was performed at 6 different doses: 15 sec (n=4), 30 sec (n=4), 60 sec 
(n=11), 120 sec (n=11), 180 sec (n=12), and 240 sec (n=7).  The CRA system 
was operated in clinical mode with CRA temperatures of approximately -75 °C. 
 
Results: Figure 132 and Figure 133 illustrate the dose effects of percent change 
in peak force and baseline force, respectively, for swine diaphragm muscle 
bundles in response to RFA.  Although a sustained reduction in peak force and a 
transient increase in baseline force with increasing levels of RF dose were 
observed, they were not consistent, especially at higher doses.  Moreover, the 
variability in peak force and baseline data was very high which could have been 
from the lack of effective coupling between the RFA catheter and the muscle 
bundle.  Figure 134 and Figure 135 illustrate the dose effects of percent change 
in peak force and baseline force, respectively, for swine diaphragm muscle 
bundles in response to CRA.  As can be seen, no dose dependent responses 
were observed in either peak force or baseline force, and variability in results 
was very high. 
 
Discussions: This study investigated whether ablations could be performed 
within the tissue baths and whether this would be an acceptable methodological 
model for further studies.  Catheter stability in relation to the muscle bundle and 
application of a constant force during ablations were found to be major factors 
influencing the quality of ablations.  This investigation showed that although 
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ablations can be performed within the tissue bath, there are inherent challenges 
that need to be overcome. 
 In case of RFA, significant slippage between the RFA catheter and the 
muscle bundle was observed.  It was hard to keep the RFA catheter steady while 
performing RFA ablations which made the ablations very subjective.  The 
catheter slippage (or unintended movement with respect to the muscle bundle) 
was primarily due to the inherent tension in the catheter and tremors from the 
subject’s hands that were easily transmitted to the muscle bundle via the 
catheter.  This prevented consistent and steady contact between the catheter 
and the muscle bundle, which compromised optimum RF energy delivery to the 
tissue.  Another important observation was the delivery of RF energy significantly 
affecting the operation of tissue bath amplifiers which caused high-frequency 
interference (484 kHz) and disruption in acquired signal quality.  An example of 
corruption in peak force and baseline force data is shown in Figure 130 and 
Figure 131.  In fact, there was a concern that the tissue bath system amplifiers 
could suffer unintentional damage if RF energy within the tissue baths was not 
properly grounded. 
 In case of CRA, once the ice-ball formed, there was a firm contact between 
the CRA catheter and the muscle bundle.  However, because of the inherent 
tension in the catheter and tremors from subject’s hands, there was relative 
movement and slippage between the catheter and the muscle bundle.  This 
subjected the muscle bundle to unintended stresses and strains that affected the 
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baseline force of the muscle bundle.  Moreover, during CRA, due to initial 
slippage of the catheter, the user could not precisely control the exact location of 
ablation on the muscle bundle.  This was because as soon as the CRA machine 
was turned on, the ice-ball started to form and based on where the catheter tip-
electrode was, that’s where the catheter got adhered to the muscle bundle, and 
that’s where the ablation resulted. 
 
Conclusion: Although RFA and CRA could be performed within the tissue baths, 
due to the challenges discussed above, this was not an acceptable 
methodological model for performing physiological studies in response to ablative 
treatments.  The methods were refined to achieve consistency, repeatability and 
reproducibility in application and delivery of ablative energies.  These methods 
were used for further studies and are discussed in detail in Chapter 2.  Moreover, 
due to the nature of HIFU and MWA setup, these ablative treatments could not 
be performed within the tissue baths unless significant modifications to the tissue 
baths or the system setup were done.  Since this was outside the scope of this 
thesis, this idea was not pursued further.  Though, this could be one of the future 
expansions of this work. 
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A B
 
Figure 129: RFA and CRA performed in tissue baths 
Illustration of RFA (A) and CRA (B) being performed on a swine diaphragm 
muscle bundle inside the tissue bath.  The return electrode for RFA is placed 
inside the tissue bath behind the muscle bundle (not visible in inset).  The 
ablation catheters are held as stationary as possible by hand in both treatments.  
The RFA and CRA catheters apply a lateral force (value unknown) on the 
respective muscle bundles during ablations causing the muscle bundles to 
bend/bulge, which in turn affects the baseline tension. 
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• Ablations performed in one bath causes interference in 
other baths
• Severity of data corruption depends on the level and 
duration of interference
• Severity of interference is unpredictable
• An example is illustrated here – Peak Force (this slide) and 
Baseline Force (next slide)
 
Figure 130: RF interference in tissue bath during peak force analysis 
 
 
Figure 131: RF interference in tissue bath during baseline force analysis 
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Figure 132: Dose effects of percent change in peak force of swine 
diaphragm post RFA in tissue bath 
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Figure 133: Dose effects of percent change in baseline force of swine 
diaphragm post RFA in tissue bath 
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Figure 134: Dose effects of percent change in peak force of swine 
diaphragm post CRA in tissue bath 
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Figure 135: Dose effects of percent change in baseline force of swine 
diaphragm post CRA in tissue bath 
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Appendix 2: Study Data Management 
 
Introduction: Large amounts of physiological data were acquired using tissue 
baths and biomechanical data using uniaxial machine.  Briefly, the goal of this 
appendix is to highlight the key steps and custom software programs utilized in 
data acquisition and analysis as illustrated in Figure 136.  The additional figures 
in this appendix illustrate the key steps involved with physiological and 
biomechanical data collection. 
 
Tissue Bath Studies: Tissue bath data was acquired using custom built 
LabView software at a sampling rate of 250 Hz.  On a typical experiment day, for 
a 5 hour experiment, approximately 72 million data points were acquired 
simultaneously from 16 tissue baths. 
 
Uniaxial Pull Studies: Biomechanical data was acquired using a custom pull 
program on the uniaxial machine at a sampling rate of 100 Hz.  On a typical 
experiment day, for approximately 32 samples (16 experimental and 16 control), 
approximately 1 million data points were acquired. 
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Physiological 
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• Data acquired 
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that makes raw 
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and text) with 
peak force and 
baseline force
Data Analysis 
(Step 2)
• Matlab program 
to read the 
excel file and 
calculate the % 
change in peak 
force and 
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and dose effects
Biomechanical 
Data Acquisition
• Data 
acquisition 
using uniaxial 
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100 Hz)
Data Analysis 
(Step 1)
• Matlab
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sample file and 
calculate all six 
biomechanical 
parameters
Data Analysis 
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samples and 
calculate the 
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Figure 136: Steps highlighting data acquisition and analysis for 
physiological and biomechanical studies 
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Figure 137: Methods for Physiological Assessment: Dissection 
The first step involved the dissection of the tissue.  Shown are the freshly 
obtained swine diaphragm and esophagus tissues.  Also shown is the human 
esophagus on the right panel.  In case of esophageal tissue, the muscularis and 
squamous epithelium layers were first separated.  Each tissue was cleaned, 
connective tissue removed, and muscle bundles were prepared. 
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Figure 138: Methods for Physiological Assessment: Tissue Baths 
The muscle bundles were mounted in 16 parallel tissue baths (4 shown).  A 
zoomed-in version of the tissue bath is shown in the panel on the right.  The 
bottom suture of the tissue was mounted on an immobile hook and the top suture 
was connected to a force transducer.  Two platinum electrodes were positioned 
on either side of the muscle bundle to provide electrical stimulation.  The 
approximately volume of each tissue bath was 50 ml which was filled with Krebs 
buffer.  Each tissue bath was water jacketed to maintain a constant temperature 
of 37 °C and oxygenated to keep the tissue viable. 
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Figure 139:  Methods for Physiological Assessment: Stabilization 
Following mounting in tissue baths, each muscle bundle was allowed to stabilize 
and accommodate to the new in-vitro environment.  Voltage stabilization was 
performed by adjusting the stimulating voltage to achieve the maximal twitch 
response (peak force).  Length-tension optimization was performed by adjusting 
the baseline force (resting muscle tension) by stretching the muscle bundle to an 
optimum length that resulted in maximal twitch force response.  The classic 
length-tension curve is shown that further illustrates the length-tension 
optimization. 
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Figure 140: Methods for Physiological Assessment: Pre-Ablation Data 
Collection 
 
The plateauing of the amplitude of twitch force (peak force) marked the 
completion of stabilization period for each muscle bundle.  Following which the 
pre-ablation data was collected.  Peak force and baseline force for each muscle 
bundle was digitally recorded.  As a representative example, the peak force and 
baseline force of a given muscle bundle is shown, which is 9 grams and 2 grams 
of force, respectively. 
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Figure 141: Methods for Physiological Assessment: Ablations (Swine 
Diaphragm) 
 
A representative example of the swine diaphragm muscle bundles is shown 
following exposure to every single ablation modality investigated.  Shown in far 
right is a control muscle bundle that can be compared to all the ablated muscle 
bundles.  Notice that the chemical ablative modalities have a wider spread in 
tissue ablation/necrosis as compared to the thermal ablative modalities.  MWA 
and HIFU have a focused ablative effect as compared to RFA and Cryo.  Local 
hemorrhage and inflammation can be observed in the case of Cryo. 
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Figure 142: Methods for Physiological Assessment: Ablations (Swine 
Esophagus) 
 
A representative example of the swine esophagus muscle bundles is shown 
following exposure to every single ablation modality investigated.  The muscle 
bundle on the far right is a control muscle bundle that can be compared to all the 
ablated muscle bundles. 
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Figure 143: Hyperthermic and hypothermic tissue damage 
 
A pictorial representation showing morphologic changes the tissue undergoes 
when it is subjected to hyperthermic and hypothermic temperatures.  Notice that 
the physiological effects of application of hyperthermic temperatures are typically 
irreversible.  On the other hand, unlike hyperthermia, effects of application of 
hypothermic temperatures are typically reversible within a given range of 
application.  In clinical medicine these effects are exploited by performing 
cryomapping which allows the physician to test the region where cryoablation is 
being performed to assess whether permanent ablation would terminate the 
arrhythmia.   
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Figure 144: Hyperthermic and hypothermic thermal spectrum 
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Figure 145: Volume analysis of chemical agents 
 
A pictorial representation of amount of chemical ablative agent injected into a 
muscle bundle that is considered an incompressible material.  A typical swine 
diaphragm muscle bundle has a volume of approximately 200 µl.  Chemical 
agent volumes varying between 10 µl and 100 µl were injected into the muscle 
bundle.  As can be seen, it was relatively easier to internalize a smaller volume of 
chemical agent within the muscle bundle as compared to a larger volume.  
Moreover, the ablative effect of chemical agents has a much wider spread as 
compared to thermal ablative modalities. 
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Figure 146: Methods for Physiological Assessment: Post-Ablations 
Recovery 
Following ablations, each muscle bundle was allowed to recover for a period of at 
least 3 hours.  A representative example of data collection from a given muscle 
bundle is shown.  The peak force versus time graph illustrates the mounting of 
muscle bundle in the tissue bath, the stabilization period, the pre-ablation data 
collection, the application of ablation (RF-ON and RF-OFF), and the post-ablation 
recovery period.  As can be seen, data was continuously collected throughout the 
duration of the experiment.  However, for display and analysis purposes, data 
was samples every 15 minutes which is shown as colored arrows corresponding 
to the colored bars in the bar graph.  
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Figure 147: Methods for Biomechanical Assessment: Arrange Samples 
 
Following completion of the physiological assessment protocol, the samples were 
arranged systematically based on treatment and ablative dose to perform the 
biomechanical assessment as shown in the inset. 
  288 
Methods: Biomechanical Assessment
Weak
Point
 =  FA
 
 
Figure 148: Methods for Biomechanical Assessment: Application of Super 
Glue 
 
Tying sutures on either ends of the muscle bundle reduces the cross-sectional 
area at that point.  As a result, the stresses at the suture-tissue interface go up 
which makes the muscle bundle vulnerable to breakage at that point.  In order to 
strengthen the muscle bundle at the suture-tissue interface and avoid breakage 
at the sutures, a small application (1 or 2 drops) of super glue was applied.  A lot 
of pilot studies were performed during which various super glues were 
tried/tested before finalizing a liquid-based super glue that cured within a few 
seconds and provided a strong suture-tissue interface. 
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Figure 149: Methods for Biomechanical Assessment: Mounting on Uniaxial 
Machine 
 
Each muscle bundle was mounted on the uniaxial pull machine to perform the 
pull.  The fixtures required to mount the muscle bundle was not trivial.  Numerous 
pilot studies were performed with various designs of fixtures as shown in the 
illustration.  The main challenges were tissue slippage from the fixture, 
inappropriate bundle breakage, excessive time required to screw and unscrew 
the fixture.  The final design was made up of stainless-steel hooks, which was 
elegant, simple to use and allowed easy mounting and unmounting of the muscle 
bundle.  It also had a high success rate of pulls with no issue of tissue slippage. 
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Figure 150: Methods for Biomechanical Assessment: Recording Sample 
Dimensions 
 
Once the muscle bundle was mounted on the uniaxial machine, the muscle 
bundle was stretched just enough so that the sample hangs freely under the 
influence of gravity and registers minimal load on the monitor.  This was 
considered the starting/initial length of the sample.  Initial length and diameter of 
each sample was measured before the pull started so that biomechanical 
parameters could be calculated. 
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Figure 151: Methods for Biomechanical Assessment: Perform Pull 
 
Uniaxial pull was performed for each sample.  A representative example of load 
versus stretch graph is shown for a given sample until the sample avulsed as 
shown in the inset.  The stretch characteristics, force transducer rating, and 
technical details are also mentioned. 
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Figure 152: Methods for Biomechanical Assessment: Assign Avulsion 
Location 
 
The figure illustrates sample avulsions at various locations along the 
length/longitudinal axis of the muscle bundle.  Five different locations were 
determined.  Any samples that avulsed at the suture or slipped out of the suture 
(top or bottom) were excluded from analysis.  Any samples that avulsed at or 
near the center of the muscle bundle were included in the analysis. 
  293 
Center Avulsion
Center‐Top Avulsion
Center‐Bottom Avulsion
At Top Suture = EXCLUDED
At Bottom Suture = EXCLUDED
At Healthy‐Ablated 
Tissue Interface
Ablation Site
Control (Non‐Ablated)
Muscle Bundles
AblatedMuscle Bundles
At Healthy‐Ablated 
Tissue Interface
At Bottom Suture =
EXCLUDED
At Top Suture =
EXCLUDED
 
 
Figure 153: Pictorial representation of Avulsion 
 
A pictorial representation of avulsion location is shown.  Any sample 
avulsing/breaking at the sutures or slipping out of the sutures (top or bottom) 
were excluded; and center and near center avulsions were included in the overall 
statistical analysis.  As shown, following ablation, the muscle bundle could avulse 
at the center, or in the zone of the healthy-ablated tissue interface. 
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Figure 154: A representative example of force-stretch graph 
 
A representative example of force-stretch graph of a given sample is shown.  
Also shown are the 6 biomechanical parameters that were calculated for each 
sample.  In order to perform a fair comparison between samples of the same 
tissues, different tissues, and different species, all forces were normalized to the 
cross-sectional area of the sample, and all energies were normalized to the 
volume of the sample.  A sophisticated program was developed that allowed 
calculation of the initial linear region of the force-stretch graph to calculate the 
elastic modulus of each sample. 
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Figure 155: Methods for Biomechanical Assessment: Measure Mass 
 
The last step in the biomechanical assessment involved measuring the mass of 
each sample. 
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Appendix 3: Statistical Results of Swine Diaphragm 
Introduction: The following graphs/figures/tables/illustrations are supplementary 
information for swine diaphragm muscle bundles that was not included in the 
individual chapters.  Hence, this information is included in this appendix to allow 
better understanding of the results and for completeness.  
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Figure 156: Plot of average power and catheter tip ablation temperature for 
swine diaphragm 
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Figure 157: Plot of average power and catheter tip ablation temperature for 
swine diaphragm 
 
Ablation 
Temperature (°C) 
Average Power 
(W, µ) 
Ablation 
Duration (s) 
Energy, E = W.s 
(J, µ) 
50 6.0 ± 1.87 60 360 ± 112 
55 10.09 ± 3.56 60 605 ± 214 
60 12.40 ± 2.59 60 744 ± 155 
65 17.54 ± 3.33 60 1052 ± 200 
70 21.60 ± 6.04 60 1296 ± 362 
Table 19: Dose table for RFA, showing the catheter tip ablation 
temperature, average power, ablation duration, and energy during RFA of 
swine diaphragm 
 
Average Power (W) Ablation Duration (s) Energy (J) 
2.80 60 168 
4.82 60 289 
6.84 60 410 
6.84 120 821 
6.84 180 1231 
6.84 240 1642 
Table 20: Dose table for MWA of swine diaphragm, showing average power, 
duration and energy 
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Average Power (W) Ablation Duration (s) Energy (J) 
49 2 98 
58 2 116 
66 2 132 
58 4 232 
58 8 464 
58 12 696 
 
Table 21: Dose table for HIFU ablations of swine diaphragm, showing 
average power, duration, and energy 
 
0 10 20 30 40 50 60 70
-1
0
1
2
3
4
5
Distance (mm)
A
vu
ls
io
n 
Fo
rc
e 
(N
)
Avulsion Force All Samples (Raw Data)
 
 
Figure 158: Raw data of force versus stretch data of swine diaphragm 
control muscle bundles 
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Figure 159: Stress-strain curve of swine diaphragm control muscle bundles 
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Figure 160: Change in cross-sectional area of muscle bundles as a function 
of stretch 
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Figure 161: Cauchy’s stress-strain curve of swine diaphragm control 
muscle bundles 
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All 
Samples 
Avulsion 
Force 
(N/mm2) 
Elastic 
Modulus 
(N/mm2) 
Avulsion 
Strain 
(l/L) 
Total 
Strain 
(l/L) 
Avulsion 
Energy 
(mJ/mm3) 
Total 
Energy 
(mJ/mm3)
Controls 
(n=327) 
0.17  
0.08 
0.34  
0.20 
1.10  
0.39 
1.59  
0.65 
43.60  
31.06 
65.75  
50.23 
RF 
(n=111) 
0.16  
0.08 
0.33  
0.21 
0.90  
0.30 
1.20  
0.42 
35.06  
22.20 
47.76  
29.87 
Cryo 
(n=58) 
0.19  
0.08 
0.66  
0.39 
0.63  
0.25 
0.80  
0.34 
24.11  
15.08 
31.59  
17.80 
MWA 
(n=24) 
0.12  
0.03 
0.16  
0.07 
1.27  
0.48 
2.08  
0.84 
37.82  
14.64 
58.58  
24.09 
HIFU 
(n=49) 
0.17  
0.07 
0.49  
0.29 
0.78  
0.28 
1.12  
0.50 
32.86  
25.83 
46.98  
33.94 
AAcid 
(n=16) 
0.25  
0.08 
0.47  
0.15 
0.61  
0.17 
0.89  
0.23 
49.34  
18.89 
69.86  
25.75 
EtOH 
(n=34) 
0.18  
0.08 
0.39  
0.16 
0.71  
0.21 
1.01  
0.36 
38.80  
24.11 
55.64  
39.48 
NaCl 
(n=21) 
0.21  
0.07 
0.37  
0.13 
0.88  
0.20 
1.20  
0.28 
50.77  
23.83 
67.11  
29.75 
Urea 
(n=25) 
0.19  
0.05 
0.38  
0.11 
0.85  
0.18 
1.28  
0.34 
46.64  
14.86 
67.51  
25.97 
Krebs 
(n=30) 
0.22  
0.07 
0.41  
0.15 
0.89  
0.18 
1.23  
0.24 
47.14  
17.78 
67.87  
29.03 
 
Table 22: Biomechanical parameters of all swine diaphragm muscle 
bundles 
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All 
Samples 
% Diff 
Avulsion 
Force 
% Diff 
Elastic 
Modulus 
% Diff 
Avulsion 
Strain 
% Diff 
Total 
Strain 
% Diff 
Avulsion 
Energy 
% Diff 
Total 
Energy 
RF 
(n=111) 
-7.78 
p=0.1359 
-4.18 
p=0.5124
-17.84 
p<0.005 
-24.31 
p<0.005 
-19.59 
p=0.0078 
-27.37 
p<0.005 
Cryo 
(n=58) 
+7.27 
p=0.2873 
+93.17 
p<0.005 
-42.57 
p<0.005 
-49.54 
p<0.005 
-44.71 
p<0.005 
-51.95 
p<0.005 
MWA 
(n=24) 
-33.09 
p<0.005 
-54.10 
p<0.005 
+16.06 
p=0.0352
+30.89 
p<0.005 
-13.26 
p=0.3669 
-10.90 
p=0.4891
HIFU 
(n=49) 
-0.23 
p=0.9749 
+41.59 
p<0.005 
-29.06 
p<0.005 
-29.50 
p<0.005 
-24.64 
p=0.0218 
-28.54 
p=0.0119
AAcid 
(n=16) 
+45.29 
p<0.005 
+79.02 
p<0.005 
-44.68 
p<0.005 
-43.80 
p<0.005 
+13.16 
p=0.4650 
+6.26 
p=0.7453
EtOH 
(n=34) 
+5.46 
p=0.5272 
+12.23 
p=0.2279
-35.42 
p<0.005 
-36.64 
p<0.005 
-11.01 
p=0.3829 
-15.38 
p=0.2561
NaCl 
(n=21) 
+21.66 
p=0.0441 
+8.27 
p=0.5138
-19.77 
p=0.0114
-24.73 
p=0.0061
+16.43 
p=0.3005 
+2.07 
p=0.9023
Urea 
(n=25) 
+12.38 
p=0.2039 
+11.89 
p=0.3044
-22.21 
p=0.0020
-19.42 
p=0.0192
+6.96 
p=0.6288 
+2.67 
p=0.8627
Krebs 
(n=30) 
+24.21 
p=0.0080 
+18.68 
p=0.0820
-18.51 
p=0.0047
-22.88 
p=0.0025
+8.11 
p=0.5395 
+3.23 
p=0.8198
 
Table 23: Percent change in biomechanical properties of swine diaphragm 
muscle bundles post ablation with different ablative modalities 
Values of avulsion force, elastic moduli, strain, and energy are shown along with 
statistical significance (marked by blue color).  A positive value indicates an 
increase, and negative value a decrease with respect to control swine diaphragm 
muscle bundles (n=327). 
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Figure 162: Statistical analysis for swine diaphragm RFA peak force 
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Figure 163: Statistical analysis for swine diaphragm RFA baseline force 
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Figure 164: Statistical analysis for swine diaphragm CRA peak force 
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Figure 165: Statistical analysis for swine diaphragm CRA baseline force 
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Figure 166: Statistical analysis for swine diaphragm MWA peak force 
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Figure 167: Statistical analysis for swine diaphragm MWA baseline force 
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Figure 168: Statistical analysis for swine diaphragm HIFU peak force 
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Figure 169: Statistical analysis for swine diaphragm HIFU baseline force 
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Figure 170: Statistical analysis for swine diaphragm acetic acid peak force 
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Figure 171: Statistical analysis for swine diaphragm acetic acid baseline 
force 
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Figure 172: Statistical analysis for swine diaphragm ethanol peak force 
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Figure 173: Statistical analysis for swine diaphragm ethanol baseline force 
  309 
100 - 75
100 - 50
75 - 50
100 - 40
75 - 40
50 - 40
100 - 25
75 - 25
50 - 25
40 - 25
100 - 10
75 - 10
50 - 10
40 - 10
25 - 10
100-10-20-30
D
os
e
If an interval does not contain zero, the corresponding means are significantly different.
Tukey Simultaneous 95% CIs
Differences of Means for NaCl Peak Force
 
Figure 174: Statistical analysis for swine diaphragm hypertonic sodium 
chloride peak force 
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Figure 175: Statistical analysis for swine diaphragm hypertonic sodium 
chloride baseline force 
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Figure 176: Statistical analysis for swine diaphragm urea peak force 
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Figure 177: Statistical analysis for swine diaphragm urea baseline force 
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Figure 178: Statistical analysis for swine diaphragm Krebs injection peak 
force 
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Figure 179: Statistical analysis for swine diaphragm Krebs injection 
baseline force 
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Appendix 4: Statistical Results of Swine Esophagus 
Introduction: The following graphs/figures/tables/illustrations are supplementary 
information for swine esophagus muscle bundles that was not included in the 
individual chapters.  Hence, this information is included in this appendix to allow 
better understanding of the results and for completeness. 
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Figure 180: Relationship between average power and catheter tip ablation 
temperature for all experimental runs of RF ablation on swine esophagus 
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Figure 181: Relationship between average power and catheter tip ablation 
temperature for all experimental runs of RF ablation on swine esophagus 
 
 
Ablation 
Temperature (°C) 
Average Power 
(W, µ) 
Ablation 
Duration (s) 
Energy, E = Ws 
(J, µ) 
50 7.33 ± 0.58 60 440 ± 35 
55 12.33 ± 1.15 60 740 ± 69 
60 14.00 ± 0.00 60 840 ± 0 
65 17.67 ± 1.53 60 1060 ± 92 
70 20.00 ± 2.00 60 1200 ± 120 
 
Table 24: Dose table for RFA, showing the catheter tip ablation 
temperature, average power, ablation duration, and energy during RFA of 
swine esophagus 
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Average Power (W) Ablation Duration (s) Energy (J) 
3.76 60 226 
5.30 60 318 
8.77 60 526 
8.77 120 1052 
8.77 180 1579 
8.77 240 2105 
 
Table 25: Dose table for MWA of swine esophagus, showing average 
power, duration, and energy 
 
Average Power (W) Ablation Duration (s) Energy (J) 
57 4 228 
57 6 342 
57 8 456 
57 10 570 
57 12 684 
 
Table 26: Dose table for HIFU ablations of swine esophagus, showing 
average power, duration, and energy 
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Figure 182: Raw data of force versus stretch of swine esophagus control 
muscle bundles 
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Figure 183: Stress-strain curve of swine esophagus control muscle 
bundles 
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Figure 184: Change in CSA of muscle bundles as a function of stretch 
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Figure 185: Cauchy’s stress-strain curve for swine esophagus muscle 
bundles 
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Figure 186: Swine esophagus change in peak force profile after RF ablation 
A representative example showing change in peak force profile following low RF 
dose (55 °C, top graph) and high RF dose (65 °C, bottom graph). 
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All 
Samples 
Avulsion 
Force 
(N/mm2) 
Elastic 
Modulus 
(N/mm2) 
Avulsion 
Strain 
(l/L) 
Total 
Strain 
(l/L) 
Avulsion 
Energy 
(mJ/mm3) 
Total 
Energy 
(mJ/mm3) 
Controls 
(n=347) 
0.47   
0.17 
0.70  
0.40 
1.34  
0.40 
1.75  
0.57 
138.64  
66.75 
178.70  
84.37 
RF 
(n=32) 
0.58  
0.17 
0.89  
0.29 
1.15  
0.24 
1.60   
0.38 
152.43  
65.35 
200.59  
77.05 
Cryo 
(n=16) 
0.59  
0.17 
0.67  
0.20 
1.41  
0.27 
1.84  
0.33 
208.80  
83.93 
260.15  
92.35 
MWA 
(n=28) 
0.64  
0.17 
0.80  
0.21 
1.25  
0.28 
1.72  
0.42 
200.03  
75.10 
253.34  
91.46 
HIFU 
(n=16) 
0.60  
0.18 
0.96  
0.28 
0.99  
0.17 
1.23  
0.30 
146.28  
50.84 
194.71  
73.65 
AAcid 
(n=16) 
0.67  
0.19 
1.01  
0.39 
1.04  
0.23 
1.55  
0.23 
169.17  
55.62 
221.11  
59.23 
EtOH 
(n=32) 
0.48  
0.19 
0.71  
0.24 
1.05  
0.18 
1.48  
0.29 
128.45  
62.77 
177.08  
81.59 
NaCl 
(n=16) 
0.50  
0.13 
0.62  
0.10 
1.26  
0.21 
1.62  
0.36 
156.72  
63.02 
208.47  
88.32 
Urea 
(n=32) 
0.57  
0.26 
0.71  
0.31 
1.31  
0.29 
1.69  
0.32 
182.20  
89.00 
224.28  
108.58 
Krebs 
(n=16) 
0.60  
0.12 
0.66  
0.19 
1.45  
0.30 
1.93  
0.36 
211.46  
62.86 
279.51  
79.39 
 
Table 27: Biomechanical parameters of swine esophagus muscle bundles. 
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All 
Samples 
% Diff 
Avulsion 
Force 
% Diff 
Elastic 
Modulus 
% Diff 
Avulsion 
Strain 
% Diff 
Total 
Strain 
% Diff 
Avulsion 
Energy 
% Diff 
Total 
Energy 
RF 
(n=32) 
+23.48 
p<0.005 
+28.02 
p=0.0067
-14.26 
p=0.0087
-8.56 
p=0.1428
+9.95 
p=0.2631 
+12.25 
p=0.1582
Cryo 
(n=16) 
+26.30 
p=0.0052 
-4.07 
p=0.7756
+5.49 
p=0.4701
+5.18 
p=0.5248
+50.61 
p<0.005 
+45.58 
p<0.005 
MWA 
(n=28) 
+36.82 
p<0.005 
+14.40 
p=0.1847
-6.76 
p=0.2436
-1.42 
p=0.8198
+44.29 
p<0.005 
+41.77 
p<0.005 
HIFU 
(n=15) 
+28.54 
p=0.0034 
+37.18 
p=0.0125
-26.16 
p<0.005 
-29.85 
p<0.005 
+5.51 
p=0.6617 
+8.96 
p=0.4704
AAcid 
(n=16) 
+42.29 
p<0.005 
+44.49 
p=0.0023
-22.15 
p=0.0037
-11.26 
p=0.1659
+22.02 
p=0.0726 
+23.73 
p=0.0477
EtOH 
(n=32) 
+2.79 
p=0.6826 
+2.13 
p=0.8344
-21.37 
p<0.005 
-15.22 
p=0.0088
-7.34 
p=0.4073 
-0.91 
p=0.9166
NaCl 
(n=16) 
+7.21 
p=0.4381 
-10.51 
p=0.4602
-5.95 
p=0.4327
-7.28 
p=0.3728
+13.05 
p=0.2889 
+16.66 
p=0.1694
Urea 
(n=32) 
+20.54 
p=0.0041 
+1.12 
p=0.9135
-1.74 
p=0.7491
-3.21 
p=0.5806
+31.42 
p<0.005 
+25.50 
p=0.0046
Krebs 
(n=16) 
+27.21 
p=0.0035 
-5.89 
p=0.6797
+8.28 
p=0.2774
+10.16 
p=0.2135
+52.53 
p<0.005 
+56.41 
p<0.005 
Study 
Control 
(n=7) 
+20.58 
p=0.1395 
+14.07 
p=0.5138
-13.76 
p=0.2294
-11.87 
p=0.3335
+9.69 
p=0.5969 
+12.98 
p=0.4690
Table 28: Percent change in biomechanical properties of swine esophagus 
muscle bundles 
Analysis performed on all samples post ablation with different ablative modalities. 
Values of avulsion force, elastic moduli, strain, and energy are shown along with 
statistical significance (marked by blue color).  A positive value indicates an 
increase, and negative value a decrease with respect to control swine esophagus 
muscle bundles (n=347). 
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Figure 187: Statistical analysis for swine esophagus RFA peak force 
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Figure 188: Statistical analysis for swine esophagus RFA baseline force 
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Figure 189: Statistical analysis for swine esophagus CRA peak force 
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Figure 190: Statistical analysis for swine esophagus CRA baseline force 
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Figure 191: Statistical analysis for swine esophagus MWA peak force 
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Figure 192: Statistical analysis for swine esophagus MWA baseline force 
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Figure 193: Statistical analysis for swine esophagus HIFU peak force 
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Figure 194: Statistical analysis for swine esophagus HIFU baseline force 
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Figure 195: Statistical analysis for swine esophagus acetic acid peak force 
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Figure 196: Statistical analysis for swine esophagus acetic acid baseline 
force 
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Figure 197: Statistical analysis for swine esophagus ethanol peak force 
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Figure 198: Statistical analysis for swine esophagus ethanol baseline force 
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Figure 199: Statistical analysis for swine esophagus hypertonic sodium 
chloride peak force 
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Figure 200: Statistical analysis for swine esophagus hypertonic sodium 
chloride baseline force 
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Figure 201: Statistical analysis for swine esophagus urea peak force 
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Figure 202: Statistical analysis for swine esophagus urea baseline force 
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Figure 203: Statistical analysis for swine esophagus Krebs injection peak 
force 
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Figure 204: Statistical analysis for swine esophagus Krebs injection 
baseline force 
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Appendix 5: Calculation of Tissue Ablated Area in 
Response to Ablative Modalities 
 
Ashish Singal, Jennifer Chmura, Charles L. Soule, Paul A. Iaizzo 
 
Preface 
 This article will be submitted to the Journal of Medical Devices (2015). 
 
Introduction 
Both thermal and chemical ablative treatments result in tissue necrosis.  
Although numerous methods exist to assess the amount of tissue necrosis, we 
performed triphenyltetrazolium chloride (TTC) staining of muscle bundles to 
calculate the amount of ablated area for a subset of thermal and chemical 
ablation modalities.  ImageJ (freeware image processing and analysis software) 
was used for analysis. 
 
Methods 
Muscle bundles of swine trabeculae and diaphragmatic tissue were 
ablated as described previously and left in the tissue baths for at least three 
hours to study post-ablation effects on muscle physiology and recovery.  
Following completion of the physiological protocol, the muscle bundles were 
  331 
pictured before performing TTC staining.  An example of muscle bundles that 
were cryoablated is shown in Figure 205.  Cryoablations were performed towards 
the center of the muscle bundle and necrosed/ablated tissue can be seen in each 
sample.  In order to assess tissue viability, small subsets of muscle bundles were 
stained with 1% TTC in Trizma buffer (7.4 pH) at 37 °C for 2 hours post 
completion of the physiological assessment protocol.  As shown in Figure 206, 
each muscle bundle was completely soaked in individual tubular compartments 
containing TTC solution and then immersed in a water bath maintained at 
constant temperature.  TTC works by using a dehydrogenase enzyme that 
converts tetrazolium salt to a formazan pigment within viable tissue (red 
formazan derivative).  Thus, cells with preserved enzymatic activity undergo a 
cytochemical color change to red-maroon.  Whereas, cells that lack the 
enzymatic activity (dead and necrotic) are unable to metabolize the tetrazolium 
salt, do not stain, and turn pale or white.  This stain has been validated and 
widely used previously for identification of infarct regions in variety of models [1]. 
  
Figure 207 shows the muscle bundles after 2 hours of TTC staining.  The distinct 
color change demarcates the healthy and ablated region of the muscle bundles.  
The sutures on both ends of the muscle bundle were cut and thin slices of the left 
over cylindrical muscle bundle were prepared using a #11 surgical blade.  Slices 
were made as thin as possible along the entire length of the muscle bundle with 
approximately 3 mm inter-slice distance.  Each slice was placed sequentially 
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from top to bottom on gauze with the cross-sectional surface visible (Figure 208).  
Slices were then photographed with a camera, which were then used for analysis 
using the ImageJ software.  Figure 209 and Figure 210 are examples of swine 
diaphragm muscle bundles injected with Krebs-buffer solution.  As expected, no 
visible necrotic area is visible upon TTC staining.  These muscle bundles (Krebs 
injection) were used as controls. 
 
Data Analysis 
The cross-sectional images were analyzed using ImageJ software to 
calculate the ablated area as shown in Figure 211.  Two measurements were 
made for each cross-sectional surface of every sample: (1) the total 
circumferential surface area and, (2) the necrotic tissue area.  The surface area 
was calculated by selecting the circumferential surface of the muscle bundle 
using the “Freehand selections” tool in ImageJ, thus measuring the area within 
that selection.  The necrotic area on the muscle bundle cross-sectional surface 
was identified by the distinct pale-white color.  TTC staining distinguished viable 
tissue as red while necrotic tissue is pale-white.  Only areas of the distinctive 
pale-white color were considered necrotic, whereas red colored tissue was 
considered viable which was not affected by the ablative energy.  The necrotic 
tissue area was measured by selecting the regions of pale-white and thus, 
measuring the area within that selected region.  If an area was questionably part 
of a lesion, it was included regardless, therefore, results more accurately include 
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the area in between the healthy-ablated tissue zone.  The resulting surface areas 
and necrotic tissue areas for all the sections within a tissue bundle were added. 
The percent ablated area was calculated by taking the percent ratio of the area of 
necrotic tissue to that of the viable tissue.  Data are shown as mean  standard 
deviation. 
 
Results 
Figure 212 displays the percent of tissue ablated for all tissue samples 
with each ablation modality at various doses.  The control Krebs-injections 
showed no necrosis at any dose, suggesting that the necrosis seen in the 
ablated tissue samples is indeed a result of injury from ablations.  For every 
ablative modality, the percent ablated area was dose dependent.  In other words, 
a larger necrotic area was observed at higher ablation doses.  A consistent 
increase in percent ablated area was observed with increasing ablation dose, 
except at 25 µl dose of sodium chloride.    Acetic acid ablations displayed the 
greatest percentage of ablated tissue area, followed by cryoablation, and then 
ethanol and urea.  Ablations with hypertonic sodium chloride showed the least 
necrotic area as compared to all the ablative modalities. 
In another observation, the extent of necrosis caused by ablations also 
depended on the tissue type.  Figure 213 displays the percent of ablated tissue 
for diaphragm and trabeculae tissue types for two chemical ablative agents 
(acetic acid and ethanol).  For each ablative agent, and at each dose, a larger 
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ablated area was observed for trabeculae muscle bundles as compared to the 
diaphragm muscle bundles.  This difference was more profound with acetic acid 
than ethanol.  At a dose of acetic acid above 40 µL, the trabeculae muscle 
bundle were observed to be 100% ablated, while the diaphragmatic muscle 
bundles were 66% to 76% ablated. 
 
Conclusions 
These results are from preliminary studies.  We were able to detect 
changes in tissue morphology (color) as a result of TTC stating the tissue 
samples following ablation.  Although we have not tried reduced incubation 
times, we believe 2 hours is sufficient time for the TTC biochemical reaction to 
exhibit a distinct color change in tissue samples.  We found that ImageJ, 
freeware downloadable software is a good tool for image analysis and 
processing of these images. 
As described here, the authors believe that understanding and 
interpretation of these results could be of high value to interventional radiologists 
and physicians performing ablation procedures.  
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Figure 205: Cryoablated swine diaphragm muscle bundles post completion 
of physiological assessment protocol 
 
 
Figure 206: TTC staining of muscle bundles 
Each muscle bundle is immersed in individual tubular compartments containing 
TTC staining solution.  Samples were stained for 2 hours at 37 ° C 
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Figure 207: Cryoablated swine diaphragm muscle bundles after 2 hours of 
TTC staining 
 
 
Figure 208: Cross-sectional slices of swine diaphragm 
A surgical blade (#11) was used to cut thin cross-sectional slices of each muscle 
bundle post TTC staining.  The dark-red (viable tissue) and pale-white (necrotic 
tissue) affected by cryoablation can be visualized in each sample.  These cross-
sectional slices were used in ImageJ software to calculate percent ablated area.   
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Figure 209: Control (Krebs-buffer injected) swine diaphragm muscle 
bundles after 2 hours of TTC staining 
 
 
Figure 210: Cross-sectional slices of Krebs-buffer injected swine 
diaphragm muscle bundles 
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Figure 211: Ablated area determination using ImageJ software tool 
 
The leftmost muscle bundles are swine diaphragm muscle bundles injected with 
Krebs-buffer solution (controls).  In center and right column are swine trabeculae 
muscle bundles injected with 50 µL of ethanol and 50 µL of acetic acid, 
respectively.  The ablated regions are marked in each sample. 
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Figure 212: Dose effects of chemical and thermal ablative modalities on 
swine trabeculae and diaphragmatic muscle bundles on calculation of 
percent ablated area 
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Figure 213: Dose effects on percent ablated area of swine trabeculae and 
diaphragmatic muscle bundles in response to ablations with acetic acid 
and ethanol 
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Appendix 6: Assessment of Biomechanical Properties of 
Swine and Human Non-Contractile Tissues 
 
Ashish Singal, Charles L. Soule, Paul A. Iaizzo 
 
Preface 
Our plan is to submit this article in Journal of Medical Devices (2015). 
 
Introduction 
Scientific advances in the field of biomedical engineering are fueling the 
demand of new and improved medical devices and biomaterials.  As new 
medical devices and biomaterials are developed, scientists and engineers face 
the enduring task of testing these devices for reliability and quality.  However, 
one of the most desired characteristic of any prostheses is its ability to mimic, as 
close as possible, to the native tissue in both form and function.  In order to test 
these devices, plethora of standardized tests are used, one of them is the 
uniaxial pull test that allows assessment of the biomechanical properties of the 
biomaterial.  Tensile testing is an important method for the mechanical 
characterization of soft tissue. 
Moreover, results from tensile testing of biomaterials must not only be 
compared to some standards, but also match as closely as possible to the native 
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tissues.  Hence, testing of native tissue is as important as testing of new 
biomaterials so that standards can be established and universal benchmarks can 
be recognized. 
The testing of native tissues has a lot of potential.  It allows medical 
scientists and engineers to understand the basic and translational properties of 
tissues, test the performance, compatibility and quality of new biomaterials.  
More importantly, these test results can help in assessing how the biomaterials 
compare to the native tissues.  The tests are performed in vitro in controlled 
conditions without putting the patients at risk.  This testing allows for the 
evaluation of critical and complex issues in a controlled and repeatable manner 
without putting the patients at risk. 
In this investigation, we sought to assess the biomechanical properties of 
native swine and human tissues by performing uniaxial pull tests.  We hope that 
these results will be useful for understanding tissue properties, comparing tissue 
types, comparing species differences, and aid in design and development of 
newer biomaterials. 
 
Methods 
These studies were approved by the University of Minnesota Institutional 
Animal Care and Use Committee.  Fresh tissue biopsies were obtained from 
healthy castrated male Yorkshire-cross swine (n=85, mean weight of 
approximately 70 kg) which were euthanized as part of another unrelated 
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protocol.  Whenever possible, fresh human tissue biopsies (n=24) were obtained 
through research collaboration with LifeSource (St. Paul, MN, USA). 
Experimental samples included swine and human aorta, trachea, pericardium, 
lungs, and rectus abdominus muscle. 
The native biopsies were pinned in an oxygenated, temperature controlled 
dissection dish, and muscle bundles were prepared as described in detail in 
methods Chapter 2.  Tissue samples were prepared, as much as possible, in a 
dog bone shape [1], and superglue was used at either ends of the suture to 
impart added strength at the suture-tissue interface.  Uniaxial pulls were 
performed to calculate the following biomechanical parameters: (1) avulsion 
forces, (2) elastic modulus, (3) avulsion strain, (4) total strain, (5) avulsion 
energy, and (6) total energy. 
 
Results 
Table 29 shows the biomechanical properties of both swine and human 
tissue samples.  A total of 296 tissue sample were prepared from 5 different 
swine tissues and a total of 66 tissue samples were prepared from 4 different 
human tissues.  In both species, the avulsion forces and elastic moduli for 
pericardium were the highest, followed by trachea, aorta, and then lungs.  
Interspecies differences were observed for all tissue types.  In general, 
mechanical properties for swine tissue samples were consistently higher than 
human tissue samples.  For example, avulsion force of swine pericardium was 
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20% higher than human, and avulsion force of swine aorta was 34% higher than 
human as shown in Figure 214.  On the contrary, the avulsion force of human 
trachea was 58% higher than swine, and avulsion force of human lungs were 
73% higher than swine.  Rectus abdominus is a skeletal muscle whose avulsion 
forces compared well with some of the other skeletal muscles that we have 
measured (eg: diaphragm, with avulsion force of 0.17 N/mm2). 
 
Conclusions 
We have developed methodologies that can be used to quantify the 
biomechanical properties of various tissues.  These results can not only be used 
to understand tissue properties, but also aid in medical device design (eg: new 
biomaterials).  Although only uniaxial tests were performed, these results can be 
expanded to biaxial testing which may allow for additional information in multiple 
axes. 
These results can be beneficial in design and development of artificial 
heart valves made from pericardial tissue, segments of trachea in case of 
tracheal cancer, aortic stents in case of aortic aneurysms, and artificial lung 
segments in case of lung cancer. 
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(1) Morticelli 2013 (2) Georgakarakos 2014
 
 
Figure 214: Inter-species comparison of biomechanical properties of non-
contractile tissues 
Comparison of avulsion force and elastic modulus of swine and human 
pericardium and aorta tissue bundles.  The mechanical properties for swine 
tissue samples were consistently higher than human tissue samples. 
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Table 29: Mean  SD dimensional characteristics and biomechanical 
parameters of swine and human non-contractile tissue bundles 
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Appendix 7: Conus Arteriosus as an Alternate Pacing 
Site 
Ashish Singal, Noora Hussain, Robert Marcaccini, 
Anthony J Weinhaus, Paul A Iaizzo 
 
Published technical brief in the Journal of Medical Devices, Volume 7, Issue 3, 
030902 (Jul 03, 2013) 
 
 
 
Background 
 
  Since pacing for bradycardia began in the 1960s, physicians and medical 
device companies have focused on improving the software, hardware and 
longevity of implantable device, without paying substantial attention to the 
optimal pacing site within the right ventricle (RV).  Historically, apical pacing 
within the RV was chosen as it was easily accessible, the lead placements were 
relatively stable and/or rates of dislodgement/infections were low.  However, 
more recent studies have suggested potential deleterious effects of long-term RV 
apical pacing: i.e., some degree of induced heart failure with associated 
decreased hemodynamic [1] or ventricular function [2].  Both short-term [3] and 
long-term [4] studies on humans have confirmed these suggested adverse 
effects, more specifically including, abnormal ventricular activation times, right 
and left ventricular dysfunctions, which have been linked to genesis of heart 
failure.  These observations have fuelled growing interest to perform alternate 
site pacing, but to do so without the risks for dislodgements.  In other words, one 
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hopes to pace the heart in a more physiological manner exploiting the natural 
conduction system of the heart.  As such, alternative pacing methods have been 
proposed which include: 1) Right Ventricular Outflow Tract (RVOT) pacing; 2) 
Direct His Bundle Pacing (DHBP); and 3) Bi-Ventricular Pacing (BVP) pacing. 
  The RV can be divided into a posteroinferior inlet portion (sinus) that 
contains the tricuspid valve apparatus, an apical heavily trabeculated region 
(together known as the RV inflow tract, RVIT), and an anterosuperior outflow 
tract (infundibulum) that extends to the pulmonary valve.  Conus arteriosus 
(infundibulum) has been loosely defined in the literature, often as a conical 
extension of the right ventricle in the heart, from which the pulmonary artery 
originates; it is also called the arterial cone.  It has been interchangeably called 
infundibulum having a glabrous, or smooth walls [5].  In medical literature, the 
word infundibulum is a generic word describing a funnel or funnel-shaped 
structure or passage.  Wilcox defines outlet of the right ventricle as a complete 
muscular cone or the subpulmonary infundibulum, which extends from the 
ventricular base as a muscular sleeve and supports the leaflets of the pulmonary 
valve having parietal, septal and atrioventricular components. 
  A number of studies have focused on the hemodynamic benefits 
associated with pacing from the RVOT [6], which have resulted in RVOT as one 
of the most investigated alternate pacing sites [7].  Nevertheless, in general, the 
specific anatomy and features of the RVOT is poorly defined in the pacing 
literature.  More specifically, the RVOT term is loosely used to describe a variety 
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of pacing sites all the way from supra RV apical region to the summit of the 
conus arteriosus just inferior to the pulmonary valve.  Therefore, to better 
correlate the relationship between alternate pacing sites and improved cardiac 
function, an understanding of cardiac anatomy is essential. 
  In this investigation, we examined the region of RVOT in a large sample of 
human hearts, in particular, the conus arteriosus to develop an understanding of 
the anatomy and morphology of this anatomical landmark (Figure 215).  We 
suggest that selective walls of conus arteriosus may be potential pacing sites 
which not only allow utilization of the natural conduction system of the heart to 
minimize ventricular dyssynchrony, but may also allow better lead fixation 
techniques due to presence of trabeculation (i.e. minimize dislodgements). 
 
Methods 
Visual examinations/evaluations of conus arteriosus from 139 formalin-
fixed adult human cadaver heart specimens, of both sexes were performed.  The 
walls of conus arteriosus (or infundibulum) in each heart were classified into four 
regions: the anterior, posterior, medial and lateral wall.  Walls were visually 
examined and categorized as having a smooth morphology if the underlying 
tissue was smooth and trabeculated if the underlying tissue had a significantly 
coarse/rough appearance (i.e., due to the presence of trabeculae).  All 
observations were obtained by more than one investigator for added verification.  
Figure 216 shows all 4 defined walls of the conus arteriosus and provided are 
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examples of either trabeculated or smooth wall morphologies.  The border and 
demarcation between walls was determined by orienting the heart in anatomically 
correct position and referring to standard anatomical definitions. 
 
Results 
 
All four walls of conus arteriosus were visualized in all 139 formalin-fixed 
adult human cadaver heart specimens.  In 35.7% (45/126) hearts, the anterior 
wall was observed to elicit significant trabeculations.  Similarly, in 48.9% (64/131) 
hearts, the medial wall was trabeculated; in 1.4% (2/139) hearts, the posterior 
wall was trabeculated, and in 36.8% (50/136) hearts, the lateral wall was 
trabeculated.  In the following number of hearts/cases: (anterior = 13; medial = 8; 
posterior = 0; lateral = 3) visual interpretation could not be made, because the 
wall was either dissected out or not present in the specimen. 
 In approximately 30.2% (42/139) hearts, all 4 walls were smooth (Figure 
217).  In 0.7% (1/139) heart, all 4 walls were trabeculated.  In approximately 
9.4% (13/139) hearts, all three walls, i.e. anterior, medial and lateral walls were 
trabeculated.  Results are summarized in Figure 218. 
 
 
Interpretation 
 
We have described the region of conus arteriosus and shown that it may 
not always have smooth wall morphology as shown in medical literature.  Conus 
arteriosus is an important alternate pacing site for the electrophysiologic 
evaluation of hemodynamic function.  This is consistent with previous reports that 
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pacing in RVOT has both acute and chronic benefits in permanent cardiac 
pacing.  RVA pacing is associated with LV dyssynchrony resulting in decrease in 
global indexes of contractility and relaxation.  In contrast, pacing from the RVOT 
preserves cardiac performance and generates a normal, physiological activation 
pattern.  Therefore, RVOT serves to be a potential pacing site which not only 
allows utilization of the natural conduction system of the heart to minimize 
ventricular dyssynchrony, but may also allow easy lead fixation due to presence 
of trabeculations.  This may have important clinical significance in future of 
cardiac pacing, that is, understanding efficacy of alternate pacing sites, 
development of different types of pacing leads, tools such as catheters, stylets, 
and lead placement/implantation techniques. 
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Figure 215: Illustration of different pacing sites in the RV 
 
A: RV apical pacing site; B: RVOT low septal pacing site; C: RVOT high septal 
pacing site; D: Direct His Bundle pacing site on the membranous septum in the 
atrial aspect of tricuspid valve annulus.  In this investigation, visual examination 
of presence of trabeculations in the septal and free wall region of RVOT was 
performed [8]. 
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Figure 216: A look into a cadaver RVOT through the pulmonary valve 
 
A top-down view of the pulmonary artery looking down into the RVOT through the 
pulmonary valve.  The Anterior (Ant), Medial (Med), Posterior (Pos) and Lateral 
(Lat) walls of conus arteriosus are shown.  In this specimen, trabeculations can 
be seen in the anterior and medial walls, and smoothness can be seen in the 
posterior and lateral walls.  Also shown are the cusps of the pulmonary valve. 
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Figure 217: Longitudinal section of RVOT showing smooth morphology 
 
Longitudinal section of RVOT (conus arteriosus) reflected after incision in the 
anterior wall, showing smooth morphology of all 4 walls of the conus.  Also 
shown are the cusps of the pulmonary valve. 
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Figure 218: Percent trabeculations in RVOT (conus arteriosus) region 
 
Percent trabeculation and smoothness observed in all four walls of conus 
arteriosus in 139 formalin-fixed adult human cadaver hearts. 
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